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ABSTRACT
Methylation

reactions

are

important

for

the

establishment

and

maintenance of epigenetic methylation tags on DNA and histone molecules that
are critical for the development and life-long function of an organism. While
epigenetics has been studied extensively during embryological development and
age-related disease such as cancer, little is known about whether epigenetic
methylation enzyme expression change in normally aging or long-living
mammals. Because growth hormone (GH) plays an important role in determining
the lifespan of many organisms, we have focused our studies on the long-living
growth hormone deficient model the Ames dwarf mouse. We focused our studies
on epigenetic methylation in the liver, because of its role in GH signaling, IGF-1
signaling, and it’s responsiveness to changes in the methionine pathway which
govern DNA and histone methylation.
Our studies showed that DNA methyltransferase 1 (DNMT1) protein is
basally expressed less in the Ames dwarf compared to their wild-type
counterparts, despite higher or equivalent transcription, suggesting that some
form of post-transcriptional regulation is taking place. Global DNA methylation
levels in dwarf mice resisted age-related changes compared to wild type mice.
Histone methylation of key regulatory transcriptional markers, and total histone
H3 expression were also altered in dwarf mice.

xi

We demonstrated that the protein abundance of a potential regulatory
protein of DNMT1 (DEAD-box helicase 20) significantly higher in Ames dwarf
mice at 3, 12, and 24 months of age. Metallothionein1 (MT1) mRNA expression
was much higher in dwarf mice especially at 3 months of age. Also there were
differences in the methylation of putative CpG islands of the MT1. Growth
hormone administration influenced DNA methyltransferase and DDX20 protein
expression in dwarf mice and areas of methylation in the predicted MT1 CpG
island. MicroRNA 140-3p which pairs with DDX20 for post-transcriptional
regulation of DNMT1 was also studied.
Studies using growth hormone receptor knockout mice and over-expressing
growth hormone transgenic mice DNMT transcription and interspersed repeat
methylation were also studied to discover continuities with previous experiments in
Ames dwarf mice. Taken together, this study offers valuable insight about the
changes in the epigenetic methylation mechanisms and markers due to aging.

xii

CHAPTER I
INTRODUCTION
Epigenetics
Even though every cell type in the mammalian organism contains the
same genome, each cell type expresses its own sets of genes and proteins
which are necessary for function in complex multicellular organisms such as
humans. Epigenetic refers to heritable forms of gene expression that cannot
be attributed to a change in the DNA sequence (Robin Holliday, 2006).
Epigenetic modifications on DNA and proteins contribute to cell differentiation,
function, and gene expression and influence the observable phenotype of
mammalian organisms. Epigenetic studies started with observations of
heritable phenotypic traits that were passed on from mother to daughter cells
during

cell

division.

During

embryological

development,

these

traits

determined cell type, organ formation, and eventually a multi-organ organism
(Tost, 2010). It was understood as early as the 1950s that there were
mechanisms responsible for the timing and regulation of gene expression and
DNA packaging which were key to development (Robin Holliday, 2006).
Epigenetics in this context led to the study of the epigenome, a heritable
regulatory mechanism consisting of markers on DNA or proteins associated
with DNA, that affects DNA packaging and expression of genes, non-coding
RNA, and retroviral elements.
1

Epigenetics came into the social and scientific forefront following the
publication of a few landmark studies. Nutritional insufficiencies were found to
affect the phenotype of human offspring even to the second generation through
the "Dutch famine studies" and Dr. Bygren's Swedish studies (Bygren et al.,
2001; Heijmans et al., 2008). These reports changed the debate from nature
(genetic control) versus nurture (environmental control) in phenotype expression
to nature and nurture having equal importance on the phenotypic plasticity and
fitness of an organism even during development (Jang & Serra, 2014). Maternal
administration of demethylating agents such as bisphenol A or methyl-rich diets
demonstrated that environmental maternal factors had an obvious and persistent
impact on offspring phenotype (Jang & Serra, 2014; Morgan et al., 1999). Agouti
mice are also prone to diabetes and cancer (Calvanese et al., 2009;
Schellenberg et al., 2011). This challenged the rejection of Lamarck’s principles
of inheritable adaption and environmental influence that are continually being
rethought, revised and reintroduced to the scientific community through the study
of epigenetics (Gravina & Vijg, 2010; Robin Holliday, 2006; Jablonka & Lamb,
1989).
As early as the 1960’s, it was thought that epigenetics may influence
aging, but epigenetic regulation of human aging really came to the forefront with
studying the phenotypic discordance among aging human monozygotic twins
(Berdyshev et al., 1967; Fraga et al., 2005; Poulsen et al. 2007). Many of the
most well-known epigenetic changes controlling gene expression have been
studied in age-related diseases such as cancer, rheumatoid arthritis, and
2

Alzheimer’s disease. Yet much remains to be done to understand how these
changes are beneficial or detrimental to an aging organism and how this could be
translated into medical treatments to enhance longevity and a higher quality of
function during aging. Before these changes and their effects on gene expression
and genome integrity can be discussed in detail, the mechanisms and markers
related to these epigenetic changes must first be introduced and defined.
Epigenetic markers and mechanisms
There

are

several

epigenetic

markers

including

methylation,

hydroxymethylation, which are covalent DNA modifications, and histone
modifications that include but are not limited to methylation, phosphorylation,
acetylation, ubiquitination, and sumoylation in mammals (Chia & Rotwein, 2010;
Guibert & Weber, 2013; Strahl & Allis, 2000). Epigenetic markers are responsible
for regulating the expression of the genome in each cell or cell-type. Without
epigenetic regulation, the differentiation of cells and development of multicellular
organisms wouldn’t be possible. One well-studied epigenetic modification in
somatic cells is DNA methylation. This marker consists of a covalent insertion of
a methyl group onto the five prime carbon of the nucleotide cytosine typically
preceding an adjacent guanine on the same strand known as a CpG
dinucleotide. These dinucleotides make up around 1% of the total genome and
are most densely packed in gene regions known as CpG islands (Bestor, 2000;
Ehrlich et al., 1982; Tost, 2010). Gene regions make up approximately 2-3% of
the entire genome and CpG islands, which are regions of CpG dinucleotides of
between 100 and 5000 bps, are mostly located (50-60%) in gene promoter
3

regions. CpG islands are thought to regulate transcription positively or negatively
depending on the gene but are generally hypomethylated in differentiated cells
(Singal & Ginder, 1999). High levels of DNA methylation at the CpG island or
promoter regions are mostly associated with the repression of gene expression,
X chromosome inactivation, genomic imprinting, and the repression of repetitive
elements that contain ancestral retroviral sequences able to transpose
themselves into other areas of the genome if expressed (Shin et al., 2011; Tost,
2010). High levels of methylation are also typically associated with proteins that
bind DNA into heterochromatin, a tightly packed form of DNA that is sequestered
from transcriptional proteins such as transcription factors and RNA polymerases.
DNA methylation is catalyzed by DNA methyltransferases, or DNMTs, which
consist of three catalytically active families, DNMT1, DNMT3a, and DNMT3b.
DNMT3L which is included in this family, contains homogeneity in sequence but
lacks catalytic sequences and activity. However, DNMT3L affects the affinity of
other DNMTs for their substrates and thus remains an important cofactor for
DNMT

activity

(Bestor,

2000;

Cheng

&

Blumenthal,

2008).

DNA

methyltransferases catalyze the removal of a methyl group from the substrate Sadenosylmethionine (SAM), which is the major methyl donor for every
methyltransferase reaction in a cell, and transfers it to specific cytosines on the
DNA molecule. This reaction relies on the availability of SAM in the nuclear
compartment (Wallace & Fan, 2010). DNA methyltransferases have specific
activity for methylating either hemi-methylated DNA, or can form de novo
methylation reactions, such as DNMT3a and 3b. Since DNMT1 has the highest
4

affinity for hemi-methylated DNA that is used as a template and is more
abundant during cell division and DNA synthesis, it has been termed a
maintenance methyltransferase
1999).

DNMT1

is

considered

(Bestor & Verdine, 1994; Robertson et al.,
the

most

active

and

abundant

DNA

methyltransferase in mammalian cells. DNMT3a and 3b are de novo
methyltransferases not requiring a template strand for methyl marker replication.
They preferentially methylate heterochromatin and are required for the
methylation of repetitive DNA (Bachman et al., 2001; Liang et al., 2002a).
However, DNMTs associate with different genomic areas upon differentiation and
may play different roles (Challen et al., 2012; Jones & Liang, 2009). For instance,
DNMT3a is enriched in intergenic heterochromatin, whereas DNMT1 and
DNMT3b are more associated with intragenic regions and areas of transcription
after induced differentiation of pluripotent cells with retinoic acid (Jin et al., 2012).
In addition, different isoforms of each family of DNMT exist and are specific to
certain periods of embryonic development or certain cell types that result in
possible functional differences adding to the complexity of DNMT regulation
(Bestor, 2000; Chen et al., 2002; Keith D Robertson, 2002). All three DNMTs
have different isoforms and have gene expression regulatory effects independent
of DNA methylation, adding yet another possible layer of function that has yet to
be fully investigated (Bachman et al., 2001; Jin et al., 2012; Lan et al., 2010;
Milutinovic et al., 2004). There are fewer CpG dinucleotides in the mammalian
genome than statistically expected. This may be caused by nucleotide mutation
through two deamination mechanisms, one is a spontaneous deamination and
5

the other is an enzymatically catalyzed deamination of methylated cytosines.
Both processes render a new base, uracil, which is converted to thymine if no
DNA repair enzymes intercede (Lindahl, 1974; Singal & Ginder, 1999). As a
result, methyl binding proteins, which protect methylated cytosines from
deamination, are thought to play a major role in the maintenance of methylation
patterns and may be one mechanism of transcriptional repression (Hendrich &
Bird, 1998; Lan et al., 2010).
If DNA in the human body were laid out in a string from each of the 46
chromosomes, it would measure about two meters long. This large amount of
DNA must be packaged to fit into a nucleus which is only about six microns in
diameter (Alberts et al., 2008). Most of our DNA is wrapped around and bound to
proteins that produce a complex layered hierarchy of packaging that is known in
its most condensed form as chromatin. DNA, and its associated proteins, plus
the proteins that anchor chromatin to the inside of the nuclear membrane, make
up the nuclear architecture, which provides compartmentalization for transcription
and the sequestration of repetitive DNA in the nucleus. DNA methylation also
impacts how DNA is packaged. DNA can be gathered into tightly wound
prohibitive structures and around proteins that inhibit transcription factor and
polymerase binding to suppress gene expression (heterochromatin) or less
prohibitive structures that allow or even facilitate gene expression (euchromatin).
Both utilize histones, and non-histone proteins. There are two types of
heterochromatin, facultative and constitutive. Both types of heterochromatin
markers are heritable from cell-to-cell, however they perform different functions.
6

Constitutive heterochromatin occurs at repetitive DNA that localize principally
near telomeres and centromeres of chromosomes. This structure keeps
chromosomes separated, and stabilizes the genome by preventing transposition
events

or

mutations

in

the

DNA

sequence

by

keeping

it

silenced.

Compartmentally it localizes to the nuclear periphery and historically, has been
considered fixed and irreversible, but recently has been discovered to change
with aging (Kreiling et al., 2011; Oberdoerffer & Sinclair, 2007; Sedivy et al.,
2008).
Facultative heterochromatin (or inducible chromatin) is largely responsible
for, the phenotype of a cell during differentiation, X- chromosome inactivation,
and the phenotypic response of a cell to a changing environment. This type of
heterochromatin is localized to promoter regions and is dependent on
transcriptional repressors and silencing protein complexes, which may include
non-coding RNA. Interestingly, senescent cells associated with aging phenotypes
in culture, show alterations in facultative heterochromatin that disallow cell cycle
re-entry. (Sedivy et al., 2008; Sinclair & Oberdoerffer, 2009)
Histones are proteins that, in binding DNA, form the most basic repeating
unit of structure in chromatin known as a nucleosome. Nucleosomes are
octameric structures made up of dimers of four families of core histone proteins
labeled H2A, H2B, H3, and H4. Histones are highly basic and able to bind DNA
due to its negatively charged backbone making it a very stable complex (Li et al.,
2007). At its smallest repeating unit, approximately 147 base pairs of DNA are
wrapped around each nucleosome. Another histone known as histone H1 is
7

associated with linker DNA, the DNA between each nucleosome and the
nucleosome itself facilitating the next level of more compact nuclear
condensation known as the 30-nm fiber. This structure is then looped and coiled
into a higher order of condensation which is typical of transcriptionally repressive
heterochromatin

by

non-histone

proteins

such

as

condensins,

DNA

topoisomerase, and heterochromatin protein 1 (HP1). Other non-histone proteins
are chromatin remodeling proteins associated with the disruption of histone
binding to DNA in order to promote the transcription of gene encoding sections of
DNA (Alberts et al., 2008).
Histones contain large N-terminal tails of amino acids which are subject to
covalent modifications that further regulate how tightly DNA is wrapped and
sequestered from transcriptional proteins or other elements in the nuclear milieu.
Histone modifications are reversible and include acetylation, methylation,
ubiquitination, sumoylation, along with an abundance of other post-translational
modifications to which large databases such as HIstome have been dedicated in
cataloguing (Khare et al., 2012; Shin et al., 2011). These modifications appear to
carry out specific patterns of transcriptional regulation that are synergistic or
antagonistic depending upon the combination of markers in each histone at any
given time. The acetylation marks and some facultative histone methylation
marks are thought to be more dynamic and responsive to intrinsic or extrinsic
regulation than DNA methylation and more "stable" constitutive heterochromatin
marks which are heritable across cell generations (Barth & Imhof, 2010; Dunn,
2003; Jin et al., 2011). Histone methylation is one of the most well-studied
8

modifications and forms a large part of the regulatory “histone code” that has
been consistently observed as either activating or repressive to transcription
(Strahl & Allis, 2000).
Table 1: A list of histone methylation modifications.
Adapted from (Li et al., 2007).
Modifications

Histone and Position

Lysine Methylation

H3 K4

Activation

H3 K9

Repression, activation

H3 K27

Repression

H3 K79

Activation

H4 K20

Silencing

H3 R2

Activation

H3 R17

Activation

H3 R26

Activation

H4 R3

Activation

Arginine Methylation

Transcriptional Function

Histone methylation also uses the universal methyl group donor, SAM,
similar to DNA methylation. A list of well-known methylation markers and
functions is shown in Table 1. Repressive and silencing markers such as the trimethylation of Histone H3 lysine 9, Histone H4 lysine 20, and histone H3 lysine
27 contribute to constitutive and facultative heterochromatin. These markers are
concentrated in areas of DNA that normally are heavily methylated throughout
adulthood and are resistant to changes in methylation. These include areas of
repetitive DNA, e.g. retroviral ancestral elements, that are thought to contribute
transcriptional “noise”, genomic mutation through retrotransposon insertions, and
cellular dysfunction when expressed (Christensen et al., 2009). Other tri-
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methylation marks such as on Histone H3, lysines 4, 36 and 79, are associated
with transcriptional activation, relaxing the tightly bound DNA allowing access of
regulatory elements by transcriptional proteins. Just as there are variants of each
protein in the DNMT family, there are histone variants of H3, H2, and H1 that are
conducive to transcription or repression. These variants can also participate in
other processes such as DNA repair and cell cycle regulation (Jin et al., 2011).
There are many known histone H1 linker variants in somatic mammalian cells
that stabilize the genome into heterochromatin states and higher compaction. Six
variants of H1 (H1.0- H1.5) are found in somatic mammalian cells while two
variants are specific to testes and oocytes. Histone H1.0 is the most abundant
subtype in terminally differentiated cells while the other subtypes are associated
with cell division and vary depending on cell type (Sancho, Diani, Beato, &
Jordan, 2008). Histone H2 variants reside in heterochromatic areas and promoter
regions poised for transcription (Histone H2A.Z) or areas of active transcription
(H2ABbd) ( Li et al., 2007). Histone H3 variants vary in abundance according to
tissue type and may play a role in determining and maintaining cellular
differentiation (Garcia et al., 2008). However, histone variant H3.3 differs in four
amino acids from canonical histone H3, and deposition is associated with
increased transcription. During transcription histones must be temporarily evicted
for transcriptional machinery access to the DNA elements. Subsequent to histone
methylation marks on histone H3K36 and H3K4, DNA is opened up and histones
are displaced by RNA Polymerase II and chromatin remodeling proteins. Special
histone chaperones act to redeposit histones onto DNA into their appropriate
10

placements (Li et al., 2007). There are many enzymes for adding and subtracting
histone post-translational methylation and the enzymes are methylation marker
specific (Rice & Allis, 2001). Histone post-translational modification is intrinsically
linked to DNA methylation by DNMT association with histone deacetylases
(HDACs), histone methyltransferases (HMTs), chromatin remodeling complexes,
and other transcriptional corepressors altering chromosome structure in tandem
with DNA methylation (Cheung & Lau, 2005; Cockerill, 2011; Shin et al., 2011).
Similar to the complex function of DNMTs, many histone enzyme, histone
variant, and associating protein functions are complex adding more facets to an
already intricate mechanism of regulation.
Recently, a third form of epigenetic regulation has been discovered and
involves the small non-coding RNAs (snRNA). Two types of snRNAs have been
studied, small interfering RNAs (siRNAs) and microRNAs (also known as miRs or
miRNAs). Both siRNAs and miRNAs are involved in mRNA or transcriptional
control. Small interfering RNA is produced by RNA polymerase III, is transcribed
from repetitive DNA, and is involved in heterochromatin formation. MicroRNAs
are primarily transcribed in gene regions by RNA polymerase II and are involved
in mainly posttranscriptional regulation (Nakahara & Carthew, 2004; Yu et al.,
2014). MicroRNAs are approximately 22 nucleotides long and regulate posttranscriptional expression via targeted degradation or translational suppression.
MicroRNA transcripts are highly conserved among different species of mammals
demonstrating the evolutionary importance of this form of regulation (Chuang,
2007). MicroRNA transcription areas can be found in exonic and intronic regions
11

and are processed with a guanine cap and polyadenylated tail before editing.
The discovery of new miRNAs transcripts has increased in surprising numbers,
from 450 transcripts in 2007 to over 1100 transcripts in 2010, with more being
continually discovered and predicted in databases such as rna22 and miRBase
(Chuang, 2007; Kozomara & Griffiths-Jones, 2014; Miranda et al., 2006; Sato et
al., 2011).
MicroRNAs are processed after transcription by RNA polymerase II and
are composed of long stem loop RNA structures known as pri-miRNA. These
molecules then associate with RNase III endonuclease, Drosha, and DGCR8 that
make up the microprocessor complex where it is cleaved into an approximately
70 base pair fragment which is now known as pre-miRNA. From here a complex
of other proteins stabilize and export the pre-miRNA from the nucleus to the
cytosol for further processing by associating with Dicer and Transactivation
Responsive RNA-binding Protein 2 (TARBP2). Dicer has RNase III activity which
facilitates double strand RNA cleavage. The final miRNA double stranded RNA
strand, of approximately 22 base pairs is attached to Argonaut (Ago) which in
participates in miRNA processing to a single stranded RNA. This complex is
then loaded onto RISC (RNA induced silencing complex) for posttranscriptional
regulation

of

mRNAs.

This

regulation

can

occur

either

through

the

complementary base pairing of mRNA transcripts to the miRNA where RISC
degrades the mRNA transcript or through an incomplete complementation
between the miRNA and the 3' UTR region of an mRNA molecule where other
proteins decap and deadenylate the mRNA reducing its stability and promoting
12

degradation (Bian et al., 2013; Chuang Jody C., 2007; F. Sato et al., 2011).
However, miRNA biogenesis, localization, turnover, and activity are all regulated
by RNA binding proteins (RBPs) which can intercede at different processing
stages. DEAD-box helicases, (DDXs) also known as Gem-associated proteins
(Gemins), are a family of putative RNA helicases with a specific amino acid
consensus sequence, which complexes with Ago to guide the miRNA onto RISC.
These are potentially important regulators of miRNA to mRNA targeting and posttranscriptional control. The expression of DEAD-box helicases can be altered in
certain disease states (Van Kouwenhove, Kedde, & Agami, 2011; Wilker et al.,
2010). MicroRNA has the capability of controlling the expression of other
epigenetic factors, such as the DNMTs, histone modifying enzymes, and methyl
binding proteins (Bian et al., 2013; Denis, Ndlovu, & Fuks, 2011; F. Sato et al.,
2011). MicroRNA can be controlled by epigenetic mechanisms through DNA
methylation of miRNA coding regions and in the cytosol by RNA binding proteins.
Genetic and epigenetic stability, aging, and aging pathology
Aging is considered a temporally based physiological decline that occurs
through the accumulation of cellular damage causing cellular dysfunction
accompanied by inappropriate responses of cells to external or internal stimuli
(Gravina & Vijg, 2010; López-otín et al., 2013). However, in genetic and
epigenetic terms, the focus is the damage to molecules in the nucleus and the
disruption of the genome and the epigenome whose regulation is interconnected.
This dysregulation can affect RNA expression, repetitive element expression,

13

and miRNA expression, with effects that ripple outward to create excesses or
deficiencies in cellular protein expression and function.
Proper gene expression of a somatic cell relies on the fidelity of gene
sequences during replication, along with all of their regulatory elements, so that
they may be properly transcribed and translated in concert, providing functional
proteins affecting the overall function of a cell at any given time and condition.
DNA sequence damage and mutations, which involve insertions or deletions, can
cause genetic instability, changing the ability of the cell to function and respond
to internal or external stimuli (Gravina & Vijg, 2010; López-Otín et al., 2013;
Wolters & Schumacher, 2013). Extrinsic DNA sequence damage can be caused
by mechanical, biological, and chemical stressors. Examples of extrinsic forces
include ultraviolet radiation and mutagenic substances. Intrinsically caused DNA
damage can occur through oxidative stress via the production of reactive oxygen
species, spontaneous hydrolytic, deamination, or alkylating reactions, and DNA
replication or repair errors of the cell (Hoeijmakers, 2009; Lindahl, 1974; Shin et
al., 2011; Singal & Ginder, 1999; Wolters & Schumacher, 2013). Genetic
instability accumulates with aging in humans and mice (Vijg & Suh, 2013). It also
occurs in human accelerated aging diseases such as Werner syndrome, Bloom
syndrome, and Hutchinson-Gilford Progeria syndrome (HGPS) and many of
these mutations cause cancer susceptibility associated with aging (Moskalev et
al., 2013; Wolters & Schumacher, 2013). Werner syndrome and HGPS stem
from a mutation in the nuclear lamin A/C gene, from which translated nuclear
membrane proteins define the arrangement and have a regulatory role in gene
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expression. These mutations display phenotypes that correlate with both genetic
and epigenetic instability and many markers of aging. Disruption of DNA repair
mechanisms through mutation causes many aging phenotypes including retinal
degeneration,

progressive

kyphosis,

ataxia,

photosensitivity,

and

neurodegeneration (Barzilai et al., 2008; Burtner & Kennedy, 2010; Laugel et al.,
2010) Cellular mitotic or DNA replication errors producing chromosomal
aneuploidies and variable copy-numbers also increase with aging (Faggioli et
al.,2012;Forsberg et al., 2012) . Repetitive DNA, unlike genes which make up a
small percentage of DNA, makes up 40 to 50% of the genome in mice and
humans respectively (Shapiro & Von Sternberg, 2005; Waterston et al., 2002).
Repetitive elements are also known as interspersed repeats, retroviral elements,
and DNA transposons. Transposable elements (TEs) are a class of repetitive
elements found in mammals including mice and humans which are able to copy
and subsequently insert themselves in different areas of the genome when
expressed (Tomilin, 2008). Transposition of these elements increases with aging
in mouse tissue (De Cecco et al., 2013).
There are four classes of transposable elements in mammals, three of
which appear to be important in cellular differentiation and can be altered in DNA
methylation and expression due to nutritional stressors and age (De Cecco et al.,
2013; Martens et al., 2005; Pogribny et al., 2009). The first class, known as long
interspersed nucleotide elements (LINEs), is independently capable of
transposition. They are considered non-retroviral elements and contain coding
regions for reverse transcriptase (RT) and an endonuclease. They move through
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an RNA intermediate, create DNA copies via RT, and insinuate themselves into
the host genome via an endonuclease. Short interspersed nuclear elements
(SINEs) do not contain RT or endonuclease coding regions, therefore these
elements require LINE transcription to provide these enzymes. Interestingly,
LINEs are located in A-T rich regions in gene poor regions and SINEs are
located in C-G and gene rich areas (Alberts et al., 2008; Waterston et al., 2002).
A third class of transposable element is the retroviral-like retrotransposon. These
repeats are more like the retroviral ancestors from which they probably came.
These include the intracisternal-A particles long terminal repeats (IAP-LTRs)
whose transcription causes small particles to accumulate in the endoplasmic
reticulum during embryogenesis and in tumors (Hojman-Montes de Oca et al.,
1983). LTRs contain RT and integrase coding regions. Their transcription
produces a DNA copy, similar to LINEs, and an integrase implants the DNA into
a new area of the genome (Alberts et al., 2008).
Telomeres are repetitive sequences at the ends of chromosomes that are
rich in guanine and protect DNA from degradation and recombination. Telomere
loss is strongly associated with aging, progeria, and increases vulnerability to
genomic instability (Londoño-Vallejo, 2010; López-Otín et al., 2013; Shin et al.,
2011; Sinclair & Oberdoerffer, 2009; Wolters & Schumacher, 2013). Telomere
sequences attract special proteins that loop the DNA and protect it from damage.
Due to these proteins, DNA replication and repair enzymes have difficulty
accessing these regions which consequently decrease in size over time until they
become truncated enough that the cell enters a state called senescence
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(Londoño-Vallejo, 2010). Cellular senescence is the cellular state where a cell
has permanently left the cell cycle and cannot proliferate even upon exposure to
stimulatory growth factors. Senescent cells also display an aberrant hyperactive
expression and secretory state and aging tissue is thought to accumulate these
types of cells (Blagosklonny, 2011; Campisi & d’Adda di Fagagna, 2007).
During adulthood, epigenetics plays an important role in maintaining cell
differentiation, gene expression, genetic stability, and contributes to the ability of
a somatic cell to change its functions or its state in response to a variable
environment. This is termed phenotypic plasticity. Epigenetic changes are likely
to occur in a group of cells responding to the same stimulus unlike genetic
changes defined by the maintenance of a single cell’s genetic integrity during
DNA synthesis and cellular division, or exposure to chemical, environmental, or
biological stressors (Gravina & Vijg, 2010; López-Otín et al., 2013; Shin et al.,
2011). Epigenetic (unlike genetic changes) are dynamic, which allow phenotypic
plasticity for cellular responses to a stimulus, or reversal of cellular responses
upon the stimulus cessation. Epigenetic stability involves maintaining the fidelity
of DNA and histone markers and replications over time but also the plasticity of
epigenome marker addition, subtraction, or replacement, to changes in intrinsic
and extrinsic cellular signaling. If parts of the epigenome are no longer able to
appropriately change according to the condition in which these cells exist, cell
genome and protein expression can become unresponsive or hyper-responsive,
meaning that necessary genes either are not expressed or are over-expressed in
a manner that is ultimately deleterious to cell function (Burzynski, 2005; Gravina
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& Vijg, 2010). This concept is what is currently proposed to happen during aging
through several mechanisms contributing to epigenetic and genetic instability.
Because genome and epigenome instability are both present in aging cells, it is
currently debated which event precedes the other as a potential early biomarker
of cell dysfunction (Pegoraro & Misteli, 2009). When do epigenetic changes start
to coincide with aging pathology? As yet, there are no firm answers to this
question however, there is surprising evidence that DNA methylation changes
occurring early in the life of mammals (i.e. zero to one month in mice) are
amplified during adulthood and the aging process (Takasugi, 2011). This begs
the question as to which of these DNA methylation changes could be predictive
for later detrimental age-related changes or are part of normal aging
development. Epigenetic stability can be threatened in several ways. The
environment has a well-established effect on epigenetic markers, especially DNA
methylation. Chronically present intrinsic or extrinsic stressors, such as altered
nutritional intake can make lasting differences in epigenetic markers which can
permanently influence signaling in cells (Pogribny et al., 2006). In addition to
environmental inputs or insults, epigenetic markers can be affected by random or
stochastic changes over time which may be defined as epimutations, epigenetic
drift, or even epigenetic recombination. These can result in observable
phenotypic traits that cannot be explained by genetics or the environment that
cause divergent transcriptomes over time (Fraga & Esteller, 2007; Gravina &
Vijg, 2010; R Holliday, 1987; Poulsen et al., 2007). In addition, just as in genetic
replication, epigenetic replication is subject to error as well. In regularly
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proliferating cells, errors can make a significant contribution to epigenetic aging
(Laird et al., 2004). This can promote epigenetic heterogeneity between
monozygotic twins and in in-bred animal strains that are exposed to similar
environments and nutritional access (Wong, Gottesman, & Petronis, 2005).
There are several mechanisms by which the epigenome protects or
enhances genome function in a cell that can go awry during aging causing
genetic instability and ultimately cell dysfunction. Many parts of the DNA
sequence

are

protectively

sequestered

from

mutations

and

undesired

transcription by DNA methylation and epigenetic proteins, such as methylbinding, histone, and non-histone proteins. Areas of normally heavily methylated
DNA regions in adult somatic cells are interspersed repeats and oncogenes. Two
major events appear to be important factors in aging and aging pathologies via
DNA methylation. The first is global hypomethylation in CpG dinucleotides and
concurrent hypomethylation in repetitive elements (Asada et al., 2006; Berdasco
& Esteller, 2012; V Bollati et al., 2011; De Cecco et al., 2013; Jintaridth &
Mutirangura, 2010; Mustafina, 2013; Singhal, Mays-Hoopes, & Eichhorn, 1987;
Thompson,

Atzmon,

&

Gheorghe,

2010).

The

second

event

is

the

hypermethylation of tumor suppressor genes and other normally expressed
genes such as housekeeping genes (Burzynski, 2005; Christensen et al., 2009;
Chuang Jody, 2007; Fraga & Esteller, 2007; Gentilini et al., 2012; Gravina & Vijg,
2010; López-otín et al., 2013; Sedivy et al., 2008; Teschendorff et al., 2010).
While interspersed repeat expression is postulated to threaten genomic stability
and create transcriptional noise, the expression of oncogenes spurs the cell into
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unwarranted cellular proliferation, and appears to be concurrent with silencing of
tumor suppressor genes by increased methylation, laying the foundation for
cellular transformation and tumorigenesis during aging.

Global loss of DNA

methylation is thought to contribute to chronic inflammation and autoimmune
diseases by making DNA more immunogenic to surrounding cells. Therefore
more “self” reactivity can occur resulting in less apoptosis of aberrant cells and
increasing necrosis during aging (Agrawal et al., 2010). DNA methylation
changes during aging have been demonstrated to polarize T cell differentiation
patterns and alter receptor expression contributing to autoimmune diseases such
as systemic lupus erythematosus and rheumatoid arthritis (Goronzy et al., 2010).
Age-related DNA hypomethylation, transcription, translocation, or even partial
translation of endogenous retroviral elements may contribute to the development
of autoimmune diseases (Balada et al., 2010; Perl, 2003). Brains of Alzheimer’s
patients show global changes in DNA methylation, changes in DNA methylation
at repetitive elements, gene specific methylation changes, and changes in
metabolic pathways that affect DNA methylation (Bollati et al., 2011; Coppieters
et al., 2014; Groen, 2010). Gene specific changes in DNA methylation are also
associated with osteoarthritis (Barter et al., 2012). Global DNA hypomethylation
has been associated with aging and is a widespread phenomenon; however
there are exceptions to the accepted paradigm. In vivo tissue does not always
show global hypomethylation with age or in progeroid tissues (Osorio et al.,
2010). As a result, the aging epigenome paradigm might be different for different
tissues and different species of mammals.
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Chromatin structure, histones, and histone modifications can also play
large roles in protecting the cell from genetic and epigenetic instability. As stated
earlier, chromatin structure, histone alterations, and DNA methylation work
cumulatively or synergistically to regulate gene function and DNA accessibility.
There is a strong reorganization of chromatin structure during aging that impacts
global RNA expression. In aging drosophila there is a loss of heterochromatin
and a gain of ribosomal RNA expression associated with aging. In murine tissue,
there is a gain of heterochromatin and loss of total RNA correlated with aging (De
Cecco

et

al.,

2013).

Senescent

cell

types

also

exhibit

changes

in

heterochromatin formation at normally euchromatin associated areas (Sedivy et
al., 2008).
Histone proteins play a role in genomic stability. For instance, DNA
damage repair triggers H2AX phosphorylation, which is a histone H2 variant that
senses DNA damage and helps negatively regulate the cell cycle for DNA repair.
This mechanism helps maintain genomic stability and proper cell function and is
associated with cellular senescence in aging tissues and progerias (Campisi &
d’Adda di Fagagna, 2007; Gravina & Vijg, 2010; Hanasoge & Ljungman, 2007;
Wang et al., 2009). It is also a convenient marker for global DNA damage
because of this role (Pogribny et al., 2010). Histone methyltransferases and
DNMTs form complexes and both attain methyl groups from SAM, the universal
methyl donor. Therefore, it’s not especially surprising to discover that there are
many histone methylation modifications that change with age, just as there are
DNA methylation changes with age across mammalian species and tissue types.
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The constitutive heterochromatic markers, histone H3K9 methylation, H3K27
methylation, and protein HP1 decrease in elderly human cells, senescent cells,
and progeroid cells (Pegoraro & Misteli, 2009; Sedivy et al., 2008; Shin et al.,
2011). Histone H3K27 tri-methylation levels decrease while messenger RNA
increases with age in nematodes but not flies (Han & Brunet, 2012). Histone
H4K20 tri-methylation is also

a heterochromatic transcriptionally repressive

histone marker that increases in senescent cells, rat liver, and progeroid cells but
is

decreased in cancer (Fraga & Esteller, 2007; Shin et al., 2011). Loss of

histone H3K4 methyltransferase, which produces the transcriptionally active trimethylation marker, extends lifespan in nematodes. In addition, loss of the
demethylase for the same marker decreases lifespan for both nematodes and
drosophila. However, in murine and human brain tissue, histone H3K4 trimethylation is decreased with aging (Cheung et al., 2010; Kuzumaki et al.,
2010a). Thus some of the histone markers involved in aging appear to be
specific to mammalian aging and disease. Histone acetylation, which is a more
transient marker, shows some differences in age such as increases in H4K16
acetylation in yeast. In theory, stochastic changes in histone modifications can
occur just as in DNA methylation, which would correlate with increased
stochastic gene expression with age (Gravina & Vijg, 2010). Global acetylation of
histones H4 and H2A also occur in progeroid mice (Osorio et al., 2010).
Cognitive decline in mice is associated with the loss of chromatin plasticity via
deregulated histone acetylation (Peleg et al., 2010).
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Non-coding RNAs have recently been discovered to alter their expression with
age in nematodes, with a decline in total microRNA expression and an increase in
specific miRNA transcripts (Boehm & Slack, 2005; Ibáñez-Ventoso et al., 2006).
However, no specific miRNA over- or under-expression effects have been discovered
to modulate aging directly in mammals, though many have been identified for the
regulation of aging pathways and in cross-sectional studies of aging mammals that
may be potential targets (Bates et al., 2010; Grillari & Grillari-Voglauer, 2010; Maes,
An, Sarojini, & Wang, 2008). Some of these targets are shown to have effects on
DNA methylation regulation, cancer and autoimmune regulation as well (Bian et al.,
2013). Other miRNA transcripts are regulated by other epigenetic mechanisms and
are involved in many different types of cancer, apoptosis, neurogenesis,
neurodegenerative disease, senescence, and genomic imprinting all of which are
affected by, or are correlated with, aging. (Grillari & Grillari-Voglauer, 2010; Sato et al.,
2011). Histone H2AX expression is involved in the DNA damage response and
cellular senescence. This histone variant is also regulated by miRNA expression and
is implicated in DNMT expression as well (Denis et al., 2011; Grillari & GrillariVoglauer, 2010; Ugalde et al., 2011). However, though some bioinformatical and
predictive queries have been started, miRNA expression and functional crossovers
between aging, aging diseases, and epigenetics are still lacking (Inukai & Slack,
2013). Finally, the transcription of repetitive elements, possibly into small interfering
RNA, has been suggested to potentially serve some function in the mammalian cell
and aging in particular, since transcription of some of these families increases with
aging in mice (De Cecco et al., 2013; Grillari & Grillari-Voglauer, 2010).
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The methionine pathway, methylation, and epigenetics
The methionine pathway is central to many important biochemical
reactions and regulation of cellular function. All of the myriad methylation
reactions of a cell and the nucleus are connected to the methionine pathway,
also known as one carbon metabolism or thiol metabolism, through the
production of the methyl donor molecules S-adenosylmethionine (SAM or
AdoMet). As discussed previously, DNA methylation is very important to
transcriptional regulation. Histone methylation and it’s “code” for transcriptional
activation or repression is well studied. Histone methylation marks are more
stable posttranslational modifications than either acetylation or phosphorylation
and have specific measurable markers that contribute to all forms of chromatin
(euchromatin, facultative heterochromatin, and constitutive heterochromatin)
(Barth & Imhof, 2010). The first step of the methionine pathway involves the
conversion of methionine to SAM by methionine adenosyltransferase (MAT). This
step requires ATP and is the rate limiting step of this pathway due to a
triphosphate intermediate (Wallace & Fan, 2010). SAM is then converted to SAH
by many different methyltransferase enzymes unless it is shunted to a salvage
pathway and polyamine synthesis where it is decarboxylated (Cavuoto & Fenech,
2012). S-adenosylmethionine on its own can act as a riboswitch involved in
translation inhibition and transcriptional termination by binding RNA affecting
cellular function. However for methylation reactions, in which it is mostly involved,
SAM is converted to S-adenosylhomocysteine (SAH) by methyltransferase
enzymes which perform different vital functions in the cell. In fact, the use of
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methyl groups is second only to the use of ATP in the cell and is used for the
methylation of DNA, RNA, histones and other proteins, polyamines, and lipid
methylation as well as the methylation of some small molecules, demonstrating
the diverse number of uses for methionine that contribute heavily to cellular
metabolism and homeostasis (Loenen, 2006). The availability and competition for
SAM as a substrate affects methyltransferase activity and expression and
consequently DNA methylation. For instance, induced or inhibitory alteration in
glycine-N-methyltransferase activity, which competes for methyl groups with
DNMT, causes alterations in DNA methylation and DNMT activity (Huang et al.,
2007; Martínez-Chantar et al., 2008; Rowling et al., 2002; Ulrey, et al., 2005;
Wang et al., 2011).

The methionine pathway is also subject to nutritional

supplementation or deficiency of methionine, or other nutrients, cofactors, and
hormones as well. These molecules include choline, vitamins B6 and B12, folate,
insulin, glucagon, growth hormone and glucocorticoids (Aida et al., 1997; BrownBorg, Rakoczy, & Uthus, 2005; Ulrey et al., 2005). Diets that are methyl-deficient
alter the availability of SAM and usually lack one or a combination of choline,
methionine, or folate. These diets are thought to alter the ratio of SAM: SAH
abundance which is widely accepted as a reference for methylation capacity
(Brown-Borg et al., 2005; Cantoni & Chiang, 1980). Nutritional deficiencies or
supplementation of folate, choline and vitamin B12 have been shown to alter the
expression of several methionine metabolic enzymes, which in turn induced
changes in SAM:SAH, global DNA methylation, and histone modifications in
humans, rabbits, and mice in different tissue types (Choi & Friso, 2010; Ulrey et
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al., 2005). Altered SAM and SAH levels are known to contribute to human
disease (Loenen, 2006). S-adenosylhomocysteine is also capable of inhibiting
methyltransferase activity and possibly DNA methylation (Davis & Uthus, 2004;
De Cabo, Santos, & Fernández-Piqueras, 1995).
How is the methionine pathway affected by aging? One of the most
studied hormones involved in aging is growth hormone (GH). Growth hormone is
known to regulate components of the methionine pathway. Several murine
studies, in diverse background strains, show mutant animals deficient in GH
signaling live significantly longer than their non-mutant siblings (Brown-Borg,
2009). Furthermore, there are reports that GH administration to GH deficient
mutants shortens lifespan to wild type levels and greatly affects the enzyme
activities in the methionine pathway, including many methyltransferases (BrownBorg et al., 2005; Panici et al., 2010).
Growth hormone, methionine pathway, and aging
Growth hormone is a protein hormone that is released by somatotrophs in
the anterior pituitary in a pulsatile fashion (Hartman et al., 1993; Vijayakumar et
al.,2011). Several factors diminish or stimulate its release in humans and mice
including exercise, sleep, starvation, steroid hormones, and stress (Cornford et
al., 2011; Hartman et al., 1993; Weltman et al., 2006). GH secretion is affected
by estrogens and androgens and therefore exhibits sexual dimorphism (Ohlsson
et al., 2009). Growth hormone also affects DNA methylation of many genes
based on gender (Takasugi et al., 2013). One molecule of growth hormone from
the serum stimulates the dimerization of two tyrosine kinase receptors which
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facilitates the phosphorylation of the Janus family of tyrosine kinases (JAK2) and
the serine threonine phosphorylation of the GH receptors. A phosphorylation
cascade is initiated which can stimulate the Signal Transducers and Activators of
Transcription (STATs) and many other pathways such as ERK1/2 and MAPK
(Bartke et al.,2013; Vijayakumar et al., 2011). STAT localizes to the nucleus
where it can act as a transcription factor through STAT responsive elements on
many different genes involved in proliferation. GH signaling affects other
pathways including the phosphotidylinositide 3-kinase/Akt pathway (PI3K/Akt)
which is primarily responsible for regulating cellular proliferation, cell survival,
and differentiation (Herrington et al., 2000; Rawlings et al., 2004; Schumacher et
al., 2008) and GH administration to GH deficient dwarf mice affects many
components of this pathway in liver tissue (Masternak et al., 2010; Miquet et al.,
2010). During aging, GH levels decline starting after the age of twenty years in
humans, and since GH stimulates IGF-1 production and secretion from the liver,
this hormone declines as well. IGF-1 is important to somatic and central nervous
system development and brain function (Aberg et al., 1998; Muniyappa et al.,
2007; Ye & D’Ercole, 2006). Though most IGF-1 is produced in the liver, some is
produced by local tissues with autocrine/paracrine effects (Ohlsson et al., 2009).
IGF-1 can also affect GH secretion (Bartke et al., 2013; Vijayakumar et al.,
2011). Insulin shares similar pathway mechanisms with IGF-1 signaling and has
also been implicated in aging across species, including worms, flies, and mice
(López-Otín et al., 2013). Overexpression of growth hormone in mice leads to
reduced lifespans and early onset of aging markers (Bartke et al., 1999; Steger
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et al., 1993). In humans there are a number of indicators that the GH, IGF-1 and
insulin signaling pathways are involved in aging from Laron dwarfs, deficient in
GH signaling, to centenarians. The lack of many age-related diseases such as
cancer and diabetes in Laron dwarfs, and delayed cancer among centenarians,
indicates potential promising cross-over between mice and humans (Bartke et
al., 2013; Guevara-Aguirre et al., 2011; Heemst, 2010; Longo & Finch, 2003;
Salvioli et al., 2009; Suh et al., 2008). However, Laron dwarfism (GH receptor
defect) does not offer any decided prolongation of lifespan in humans as it does
in mice (Aguiar-Oliveira et al., 2010). Although there is a difference between
humans and mice in aging phenotypes, some bioinformatics inquiries are tackling
the species specific similarities and differences in the murine and human
genomes to help guide the scientific community to more translatable paradigms
and hopefully a better understanding of somatotropic signaling and human aging
(Yuan et al., 2011).
The liver as an organ of study for aging and methylation
In some mammalian tissues, cells continue to readily divide in a fully formed
adult organism, such as intestinal wall or skin cells, whereas others are terminally
differentiated and have lost the capacity to divide, such as neurons. One
exception is liver cells, which upon insult or partial removal can reenter the cell
cycle from a quiescent differentiated state to proliferate and replace lost tissue
(Pennisi et al., 2004; Schmucker & Sanchez, 2011). The liver loses volume,
blood flow, and the ability to regenerate with age. Also more Kupffer cells are
activated in aged liver, which may be indicative of some basal inflammation
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associated with aging (Hilmer et al., 2007; Sheedfar et al., 2013). The liver is
responsible for the first pass metabolism of many pharmaceuticals that can
increase drug half-life and drug toxicity in aged humans (Klotz, 2009; Pond &
Tozer, 1984). Therefore, the liver is a very important organ in aging and there is
an excellent reservoir of scientific evidence demonstrating that epigenetic
changes occuring in this organ are related to the methionine pathway and methyl
availability.
Many diseases such as hepatitis steatosis (fatty liver), cirrhosis from
alcoholism, and vascular diseases and inflammation can be correlated with an
altered production of S-adenosylmethionine (SAM) and its corresponding
byproduct after methyl group subtraction, S-adenosylhomocysteine (SAH). Liver
disease and risk of hepatocellular carcinoma increases in humans and animals
with age as well (Sheedfar et al., 2013). The most abundant methyltransferase in
the liver, glycine-N-methyltransferase (GNMT), displays diminished expression in
human hepatocellular carcinoma and GNMT knockout mice show a propensity
for hepatocellular carcinoma accompanied by differences in DNA and histone
methylation (Martínez-Chantar et al., 2008). Experimentally increased or
decreased expression of GNMT in hepatocytes alters DNMT methylation and
activity, which can further be affected by adding another variable, methionine
supplementation ( Wang et al., 2011). The activation of GNMT using retinoic acid
also causes global hypomethylation in rats (Rowling et al., 2002). GNMT is one
of the methyltransferases in the methionine pathway mentioned earlier, and
because it is so abundant, it regulates SAM availability in the liver for other
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methyltransferases (Yeo & Wagner, 1994). By altering separate nutritional
components of the methionine pathway, such as choline, and methionine itself,
many differences can observed in the expression of epigenetic markers and
mechanisms in murine hepatocytes (in vitro) and murine liver (in vivo). Methyldeficient diets induce miRNA expression changes in mice that are associated
with diseases and aging (Choi & Friso, 2010). However, common groups of
miRNAs which simultaneously regulate aging pathways, the methionine pathway,
and the regulation of the epigenome, still remain to be discovered. Methyldeficient diets also alter repetitive element expression which is associated with
genetic instability, hepatic steatosis, and hepatocellular carcinoma (Asada et al.,
2006; Hsieh et al., 1989; Pogribny et al., 2009). Methyl-deficient diets
significantly alter DNA and histone methylation in long-lived inbred strains of
mice compared to short-lived strains and show some interesting differences
(Pogribny et al., 2009). However, none of these epigenetic modifications have
been studied in mutant long-lived mouse models compared to their wild type
siblings, exposing a large gap in the scientific knowledge between aging, the
methionine pathway, and epigenetic mechanisms.
As stated earlier, the liver is very responsive to growth hormone
and primarily responsible for IGF-1 secretion in the body (Bartke et al., 2013;
Brown-Borg, 2009). Liver fibrosis, a condition that increases with aging, displays
differences in DNA methylation and miRNA expression. DNA methyltransferase 1
negatively regulates the phosphatase and tensin homologue (PTEN), that
negatively regulates PI3K/AKT and ERK pathways, and coincidently are
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stimulated by GH through JAK/STAT pathways (Bian et al., 2013). The protein
PTEN is also associated with increased lifespan in many organisms (López-otín
et al., 2013; Salminen & Kaarniranta, 2010; Scrable et al., 2010). However the
connection between GH pathways and DNMT expression has not yet been
demonstrated. Aging mouse liver show higher amounts of γ-H2AX, a marker of
DNA damage demonstrating decreased genomic stability (Wang et al., 2009).
Liver tissue from old mice exhibits multinucleated hepatocytes that increase in
size but without cytokinesis (known as polyploidy). This phenomenon is not well
understood but is similar to senescence in other cell lines and occurs with aging
(Lebel, De Souza-Pinto, & Bohr, 2011).
Ames dwarf mice as a model for epigenetic study and aging
Ames dwarf mice result from a single nucleotide polymorphism in the
Prophet of Pit-1 gene (prop-1) rendering a loss of function mutation that is unable
to stimulate Pit-1 gene expression (Andersen et al., 1995; Schaible & Gowen,
1961; Sornson et al., 1996). This results in an underdeveloped anterior pituitary
gland devoid of secreting somatotropes, lactotropes, and thyrotropes causing the
absences of plasma growth hormone, prolactin, and thyroxine stimulating
hormone, respectively (Bartke, 1964; Sornson et al., 1996). Ames mice exceed
wild type sibling lifespans by 49-68%, with females showing the largest gain
(Brown-Borg et al., 1996). Ames dwarf mice have many physiological and
developmental phenotypic differences from wild type mice including, smaller size,
lower body temperature, female infertility, delayed incidence of neoplastic
disease and less age-related tissue and cell injury in toto at death, and they
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maintain a juvenile appearance in adulthood (Bartke et al., 2001; Bartke et al.,
2013; Brown-Borg et al., 1996; Hunter et al., 1999; Ikeno, Bronson et al., 2003;
Schaible & Gowen, 1961). Other important biochemical characteristics related to
aging in Ames dwarf mice include heightened insulin sensitivity even in old age,
lower glucose levels, very low IGF-1 plasma levels, enhanced resistance to
oxidative stress, and an atypical methionine pathway with altered basal
expression and activity of many enzymes ( Brown-Borg & Rakoczy, 2003; BrownBorg, 2009; Chandrashekar & Bartke, 1993; Louis et al., 2010; L. Y. Sun et al.,
2011; Uthus & Brown-Borg, 2003, 2006). GH is known to oppose the actions of
insulin and contributes to insulin resistance. Another interesting feature of dwarf
mice is that sexual liver dimorphism gene expression seen in wild type mice
disappears between male and female dwarf mice (Amador-Noguez et al., 2005;
Takasugi et al., 2013). When Ames dwarf mice are treated with GH beginning at
2 weeks of age for 6 weeks, their lifespan becomes shorter and more similar to
wild type mice. Thyroxine injections however have no effect on lifespan, only
body weight, illustrating the effects of longevity in dwarf mice is mostly due to a
lack of GH (Panici et al., 2010).
While many of the phenotype differences are interesting, the enzymatic
differences within the methionine pathway have a large potential to alter
epigenome methylation in Ames dwarf mice, and thereby change phenotypic
gene expression. GNMT is an important regulator of methyl donor availability
and dwarf mice show increased activity and expression of this enzyme. There
are also increases in methionine adenosyltransferase, which affects the
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production of methionine into SAM, the universal methyl donor (Uthus & BrownBorg, 2003). Ames dwarf mice have a reduced SAM:SAH ratio, that is usually
associated with reduced methylation capacity, but lack the increased disease
pathology seen in other mice or in humans (Chen et al., 2010; Elmore &
Matthews, 2007). However, Ames mice show greater activity in methylation
enzymes responsible for SAM to SAH conversion, and higher rates of
transmethylation and transulfuration, demonstrating that they most likely do not
have a reduced methylation capacity (Uthus & Brown-Borg, 2006). Also, due to
the fact that the administration of GH in dwarf mice can reverse methionine
enzyme activity and expression to wild type levels suggests growth hormone may
be a powerful factor in epigenomic stability and aging.
The presence of GH diminishes the ability to resist oxidative stress
(Brown-Borg, 2009). Ames dwarf mice also exhibit a high resistance to
oxidative stress from reactive oxygen species and an increased expression
and activity of many antioxidant enzymes including superoxide dismutases
(SODs), catalase, glutathione, peroxidase, and

on enzymatic antioxidants

such as glutathione, and metallothionein (Amador-Noguez et al., 2004; BrownBorg & Rakoczy, 2000; Brown-Borg & Rakoczy, 2002; Brown-Borg et al.,
2005; Meyer et al., 2003; Sharma et al., 2010; Sun et al., 2011; Swindell et al.,
2010). While glutathione expression is regulated through enzymes connected
to the methionine and transulfuration pathways, the heavy metal and free
radical scavenger, metallothionein can be regulated by the DNMTs through
DNA promoter methylation (Kumari et al., 1998; Majumder et al., 2006;
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Majumder, Ghoshal et al., 1993). This is yet another reason why the Ames
dwarf mouse may have the potential for important epigenetic alterations
contributing to aging and longevity.
There are other models deficient in GH signaling, such as Laron dwarf
mice, which lack a functional growth hormone receptor and binding protein
resulting in a mouse resistant to GH (GHRKO mice) (Zhou et al., 1997). These
mice show increased life spans (38-55% longer) along with many other
phenotypic similarities with Ames dwarf mice including small body size, delays
in sexual maturation, oxidative stress resistance, enhanced insulin sensitivity
and an altered expression of methionine enzymes including GNMT and MAT (
Brown-Borg et al., 2009; Brown-Borg, 2009). However, while these mice
display low levels of plasma IGF-1, they also express high levels of plasma
GH and normal levels of thyroid stimulating hormone and typically prolactin
(Al-Regaiey et al., 2005; Coschigano et al., 2000; Coschigano et al., 2003;
Hauck & Hunter, 2001; Zhou et al., 1997). As the Ames dwarf mice exhibit
multiple endocrine deficiencies, growth hormone receptor knockout mice are
thought to be a good model to validate GH effects of aging. However, GHRKO
mice are created on inbred laboratory strains, whereas Ames dwarf mice
come from a genetically heterogeneous background. Epigenetically speaking
there is great variation between laboratory strains alone and in response to
nutritional stressors such as methyl-deficient diets, so this caveat must always
be considered (Hsieh et al., 1989; Pogribny et al., 2009; Stanley et al., 2001).
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Another model used to study the effects of GH and aging are the GH
overexpressing transgenic mice (GH Tg). These mice live approximately half as
long as their wild type littermates (Steger et al., 1993). Phenotypically these mice
are much larger than wild type counterparts, hyperglycemic, insulin resistant,
sexually mature earlier, and have increased cellular oxidative stress and
oxidative damage due to increased metabolic activity (Brown-Borg, 2009). Also
GH transgenic mice show differences in methionine enzyme expression and
metabolite differences of the methionine pathway (Brown-Borg, unpublished
data).
There are human epigenetic differences attributable to longevity. It’s been
reported that centenarians and their offspring tend to maintain higher DNA
methylation levels than people without a family history of longevity demonstrating
additional scientific reasons studying the epigenetic differences of normal and
long living organisms (Gentilini et al., 2012). One of the most highly conserved
(top ten) gene sequences among centenarians is DNMT3a, demonstrating a
potential conservation of important methylation mechanisms. However there are
more heterozygous IGF-1R mutations in centenarians that may alter the IGF-1
pathway in these individuals (Suh et al., 2008). Centenarians also have genetic
telomerase variants that allow retained telomere length contributing to genetic
stability (Atzmon et al., 2010). Human centenarians are known to have delayed
cancer and in liver, the very elderly (>75 years of age) exhibit a reduction in
hepatosteatosis and incidence of hepatocellular carcinoma (Salvioli et al., 2009;
Sheedfar et al., 2013). The GH deficient and transgenic models mentioned have
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not been studied in the context of epigenetic changes due to methyl-donor
capacity and aging. Most aging research in epigenetics is in a developmental or
diseased context, such as in embryonic stem cells and immortal cell lines derived
from cancers. However, given that there are differences in “normal aging” and
“longevity” such as between average life spanned and long-lived humans and
mice, the context of epigenetic information and discovery with aging is
enormously incomplete. The methionine pathway is strongly correlated with
epigenetic differences in mice due to mutational or nutritional stressors, thus we
were interested in potential differences in well-known methylation mechanisms
and markers between GH deficient signaling mice (Ames dwarf and GHRKO
mice) and GH transgenic mice and begin to catalogue important differences due
to GH and aging. We expect to see differences in epigenetic markers that show
increased epigenetic stability indicative of the already greater genetic stability
noted in long-lived models such as Ames dwarf mice (Brown-Borg et al., 2001;
Salmon et al. 2008; Sanz et al., 2002). We also expect to see increased
maintenance of the heterochromatin and DNA methylation and a reduction or
reversal of changes in markers that are considered to promote or correlate with
aging. This research is extremely novel and should have profound implications
and impacts on the study of epigenetics of aging and potential therapeutic targets
that enhance epigenetic stability.
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CHAPTER II
MATERIALS AND METHODS
We designed our cross-sectional age studies to examine DNA methylation
enzyme activity, expression, and DNA methylation in growth hormone signaling
deficient mice and GH overexpressing mice. We investigated interspersed repeat
mRNA expression and methylation in these mice as a tool to investigate genetic
stability and DNA methylation in gene-poor versus gene-rich regions. We also
treated Ames dwarf mice with GH and looked for differences in DNMT and repeat
expression. Primary hepatocytes from Ames mice were isolated and treated with
growth hormone to validate our in vivo DNMT and DNA methylation studies as a
possible future model of pathway investigations. We treated GHRKO (Laron
dwarf) mice with IGF-1 to examine the effects down-stream of GH signaling
through mRNA expression of DNMTs. We also studied a putative posttranscriptional pathway involved in DNMT1 regulation via miRNA expression,
protein expression, and used methylation specific PCR analysis to probe the
methylation difference of gene regions reported to be regulated by DNMT1 in
Ames dwarf and age-matched wild type mice, and mice treated with growth
hormone or saline. We began the characterization of histone methylation
modifications cross-sectionally between Ames dwarf mice and their wild type
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Siblings by immunoblotting of histone extract and included an mRNA expression
pilot study to locate histone modification enzyme targets.
Experimental animals
All mutant and age-matched wild type mice were taken from colonies at
the University of North Dakota animal facility. Ames dwarf mice (df/df) result from
crossing heterozygous (df/+) or homozygous (df/df) male mice with carrier
females (df/+) that are on a heterogenous background. The growth hormone
receptor knockout mice (Laron dwarf or GHRKO) that were originally generated
on an OLA/Balb/cJ background and used in our studies were kindly provided by
Andrzej Bartke (SIU) (Zhou et al., 1997). They were developed by crossing 129
OLA/Balb/cJ wild type (GHR+/-) animals with mice derived from C57BL/6J and
C3HJS strains. These mice were maintained in a closed colony (Panici et al.,
2009). Wild type siblings of both the Ames dwarf and GHRKO mice have median
lifespans of approximately 2 years (24 months) of age and this age was chosen
to represent the oldest group for both strains in cross-sectional studies. Three
months of age was chosen to represent young adult development and twelve
months was chosen for middle-aged adult mice. The GH transgenic (GH Tg)
mice used in these studies were derived from a single male founder (strain
B6SJL) produced by microinjection of the phosphoenolpyruvate carboxykinase
(PEPCK) promoter region (300 bp)/bGH hybrid gene into the male pronucleus of
single-cell embryos. The production and characterization of transgenic animals
(transgenic males crossed to C57Bl/6J x 3C3H/J F1 females) has been
previously described (McGrane et al., 1988; Steger et al., 1994). The GH Tg line
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has a median lifespan of approximately 12 months and at this age we and others
have observed large numbers of liver tumors (Steger et al., 1993; Brown-Borg,
unpublished data). Therefore, to avoid using pathological tissue in our studies,
the oldest group of GH Tg mice used was 10 months of age. Young adult mice at
three months of age and 6-month-old mice (GH Tg middle aged) with agematched wild type controls were used for cross-sectional studies. All of the mice
were kept under standard laboratory conditions with a twelve hour light/dark
cycle, room temperature of 22°C, and fed ad libitum (8640 Teklad 22/5l: 22.6%
crude protein, 5.2% fat, Harland Laboratories) with free access to water. Only
males of GHRKO, GH Tg and their respective wild type siblings and only wild
type males of the Ames dwarf line were used to avoid any variability caused by
sex steroid effects. Groups of Ames dwarf mice groups contained both female
and male mice. Female dwarf mice are infertile and exhibit biochemical
characteristics similar to males in many studies. In addition, it has been reported
that there is a loss of sexual liver dimorphism gene expression in these mice
(Amador-Noguez et al., 2005). All procedures involving animals were reviewed
and approved by the UND Institutional Animal Care and Use Committee in
accordance with the NIH guidelines for the care and use of laboratory animals.
For cross-sectional basal expression studies, liver tissue was collected
from mice at 3, 6, 12 and 24 months of age. Liver tissue was then divided into
portions, rapidly frozen, and stored at -80°C. Live r tissues were utilized to
evaluate mRNA and miRNA expression, DNA methylation and methylation
enzymes, histone methylation, and protein abundance.
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In vivo GH treatment of Ames dwarf mice and IGF-1 treatment of GHRKO
mice
Porcine growth hormone (GH) (NIDDK, National Hormone and Peptide
Program, Torrance, CA,USA) was administered to 4-6 month old Ames dwarf
mice and IGF-1 was administered to 6 month GHRKO mice using methods
published previously to determine whether GH and IGF-1 affects protein
expression, miRNA and mRNA transcripts, and methylation of our enzymes of
interest in the liver listed in later sections (Brown-Borg & Rakoczy, 2003;
Rojanathammanee, Rakoczy, & Brown-Borg, 2013).

Porcine GH in alkaline

saline mixed with 50% polyvinylpyrrolidone (pH 9, 1:1, saline–PVP) was injected
subcutaneously twice daily (25 µg in 50 µl /injection) into one group of dwarf mice
(n= 8-12). The vehicle, saline-PVP was injected subcutaneously (50 µl/injection)
into another group of dwarf mice (n=8-11) and age-matched wild type mice (n=811) in two separate experiments. Insulin-like growth factor 1 was dissolved in
saline solution and one group of GHRKO mice (n=8-12) were administered 13µg
of IGF-1 in 50 µl/injection (Catalogue # CYT-216, ProSpec, Ness-Ziona, Israel).
The vehicle, saline, was injected subcutaneously (50 µl/injection) into another
group of GHRKO mice (n=8-12) and age-matched wild type mice (n=8-12) similar
to the GH administration for Ames dwarf mice. All mice were injected two times
daily (8:00 a.m. and just before lights out at 8:00 p.m.) for 7 days (total of 13
injections). This is done to more closely mimic the pulsatile manner in which GH
is secreted, which consequently is responsible for the secretion of IGF-1 from the
liver (Panici et al., 2010; Waxman et al., 1995). On the morning of the seventh
day, one hour following the last injection of saline-PVP or GH, liver tissue was
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collected from each group of mice, weighed, frozen, and stored at -80°C until
analysis. This experimental protocol has been shown to raise IGF-1 plasma
levels in the dwarf mouse and the somatic changes due to GH are apparent by a
gain in body weight of 1-4 grams (Chandrashekar & Bartke, 1993). To confirm
GH action in the dwarf, the body weight of each mouse was recorded prior to
starting the experiment, during, and following the last GH injection to validate
weight gain in GH-treated animals compared to untreated animals. Liver weights
were also recorded and compared. Liver was collected similarly for GHRKO
treated and untreated GHRKO and wild type mice.
Hepatocyte isolation and GH treatment in vitro
Primary hepatocyte cultures were prepared with liver tissue isolated from 5 –
6 month old Ames dwarf and wild type mice using previously published preperfusion, collection, and culturing methods (Brown-Borg & Rakoczy, 2003;
Kreamer et al., 1986). Briefly, each animal was anesthetized with 2.5%
tribromoethanol (i.p. 100 µl/10 g body wt), the inferior vena cava was cannulated,
and the liver was perfused with 37°C calcium-free H EPES pre-perfusion buffer
(160.8 mM NaCl, 3.15mM KCl, 0.7 mM Na2HPO4-7H2O, 33 mM HEPES, and
0.5mM; pH 7.6) containing 1% penicillin-streptomycin for 15 min followed by
perfusion with a 37°C collagenase solution (pre-per fusion buffer and 1.0 mM CaCl)
until livers displayed a swollen appearance and were altered in color indicating blood
loss and liver digestion (0.033% collagenase [Worthington, Lake Park, NJ]).
Collagenase separates the lobular parenchyma of the liver to release hepatocytes.
Following perfusion, livers were removed, placed into warm transfer buffer and 1%
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pen/strep (37°C), and the outer membrane of the liv er was carefully excised into a
petri dish with warm media under a sterile hood. The remaining connective tissue
was agitated by hand until the media became cloudy indicating the presence of
freed hepatocytes and the connective tissue (extracellular matrix and epithelial
tissue) was discarded. The cells were transferred to a conical centrifuge tube and
pelleted for 3 min at 600 rpm at 4°C and washed thr ee times with ice-cold
hepatocyte wash buffer containing 1% penicillin-streptomycin until the supernatant
was clear (Gibco® Life tecnologies, Grand Island, NY). The final cell pellet was
resuspended in ice-cold serum-free HepatoStim Media containing 1% penicillinstreptomycin (Becton Dickinson, Mountain View, CA, USA). Trypan blue dye
exclusion was used to assess cell viability and integrity. Cell collections with ≥ 95%
viability were used. Cells for each genotype were pooled (n=2-5 mice/genotype),
resuspended in attachment medium containing 1% pen/strep and 15% fetal bovine
serum (to aid in cellular adhesion) and seeded (2 × 106) into MatriGel coated dishes
(Life Technologies, Grand Island, NY, USA). Following cell attachment (2 hours at
37°C and 5% CO 2), the medium was exchanged for serum-free HepatoStim media
(Life Technologies) containing 1% pen/strep and 2 mM glutamine. Serum-free
media favors differentiation and suppresses growth and proliferation. Following
overnight recovery, fresh serum-free media was added and the cells were allowed to
equilibrate (2 hrs.) before GH treatment (0.1, 1.0, 10 and 20 µg porcine GH per ml
media). Twenty-four hours following treatment (37°C and 5% CO2), cells were
collected by washing with cold (4°C) HEPES and appl ying MatriSperse (BD
Biosciences, Franklin Lakes, NJ, USA) for 1 hour on ice.
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Dishes were aspirated to remove dead cells and media, scraped, and cells were
pelleted and washed with ice-cold phosphate buffered saline (PBS) via
centrifugation. Cell pellets were stored at -80°C o r homogenized immediately for
downstream assays (see immunoblotting).
Immunoblotting
Liver tissue and hepatocyte samples were analyzed using standard
immunoblotting procedures previously published (Brown-Borg & Rakoczy, 2003).
Liver tissue was homogenized in lysis buffer (10 mM Tris, 0.15 M NaCl, 5 mM
EDTA, 1% Triton X) containing serine, cysteine, threonine and trypsin protease
inhibitors (1mM phenylmethylsulfonyl fluoride (PMSF), 25 mg/ml leupeptin, and 25
mg/ml aprotinin, or HaltTM Protease and Phosphatase Inhibitor Single-Use Cocktail,
Catalogue # 78442, Thermo Scientific, Rockford, IL, at 10µl per milliliter of lysate) at
4° C using the 24 sample Bullet Blender (Protocol f or Hepatic (Liver) Tissue
Homogenization, Next Advance Inc. Averill Park, NY). Protein abundance was
determined using the Bradford assay (Bradford, 1976). Briefly, a protein standard,
bovine serum albumin, with a starting concentration 80 µg/ml was serially diluted in
sterile water produce a standard curve of six concentrations (80, 60, 40, 20, 10, 5
µg/ml). Sample liver lysates were diluted in sterile water at a 1:700 dilution to gain
absorbance measurements close to our central concentration, 40 µg/ml, for best
detection. Standards (in triplicate) and samples (in duplicate) were loaded at 50 µl
per well of a 96-well plate. Bradford Reagent (Catalogue # 500-0006, BioRad,
Hercules, CA) was diluted with sterile water according to manufacturer directions
and 150 µl per well was loaded to the standards and samples. The plate was read
43

on a spectrophotometer 96-well plate reader (BioTek Instruments, Winooski, VT) at
a wavelength of 595 nm. Standard curves of R2≥ 0.95 were used. Protein dilution
was calculated by comparison to the standard curve. Equivalent protein samples (50
µg per 10 µl volume) were assembled using Laemmli Buffer solution and βmercaptoethanol was added according to manufacturer’s directions (Catalogue #
161-0747, BioRad, Hercules, CA). Before loading samples were briefly centrifuged
and heated in a dry-bath at 95-100°C for 5 minutes and 10 minutes for target
proteins >100kDa. Loading samples were centrifuged again and loaded at 50-75 µg
per lane, unless otherwise specified. Loading samples were resolved by SDS-PAGE
(CriterionTM TGXTM Precast Gels Any kDTM, BioRad, Hercules, CA) running at 100
volts for 3.5-4 hours for proteins >100 kDa (40 minutes to 1 hour for smaller
proteins). PVDF (polyvinylidine diflouride) membranes for transfer were activated in
100% methanol for at least 1 hour before transfer. Proteins were transferred to
PDVF membrane in cold transfer buffer at 100 volts for 30 minutes in cartridges
backed by filter paper and sponges soaked in cold transfer buffer in a transfer case
(CriterionTM, Hercules, CA). Transfer buffer contained 10% methanol for larger
proteins (>100 kDa) and 20% methanol for smaller proteins. After transfer, the blots
were rinsed briefly in tris-buffered saline containing Tween 20 (25mM Tris-Cl, pH8.0;
125mM NaCl; 0.1% Tween 20) and blocked in 5% nonfat dry milk in 0.1% T-TBS for
1 hour at room temperature. Blots were incubated for DNA methyltransferases
DNMT3b and DNMT1, staining in primary antibody in 1% milk/0.1% T-TBS and in
primary with antibody in 5% milk/0.1% T-TBS for all other antibodies. All blots were
rotated overnight at 4° C. Primary antibody (Abcam ®, Cambridge, MA, USA)
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concentrations were as follows: DNMT3a 1:1,000 (ab14291), DNMT1 1:400
(ab13537), DNMT3b 1:250 (ab13604), and DEAD-box helicase 20

1:1000

(ab166913) and glycine-N-methyltransferase (Santa Cruz Biotechnology Inc. Santa
Cruz, CA, USA, sc-166834). After incubation with the primary antibody blots were
washed 4-6 times for 10 minutes to reduce background signaling. Blots were then
incubated and probed for 1.5 hours rotating at room temperature in the appropriate
horse radish peroxidase or alkaline phosphatase conjugate secondary between
1:2000 to 1:5000 dilutions as necessary for each optimized antibody (BioRad,
Hercules, CA). Solutions for secondary antibody probes were 1% milk/0.1%T-TBS
for Dnmt1 and Dnmt3b blots and 5% milk/0.1% T-TBS for all other blots. Blots were
washed 5-6 times in 0.1% T-TBS for 10 minutes to reduce background. Blots were
developed with chemiluminescent substrate for 5 minutes rotating at room
temperature and mean optical density was measured and used for comparative
analysis (UVP Bioimaging system (Upland) with Labworks 4.5 analysis software and
also Omega Lum™ G imaging system (Aplegen™) with UltraQuant Analysis Software
version 13.04.05). Ponceau S staining was used to assess equivalent loading.
Nuclear extraction and DNMT activity assay
Liver nuclear extracts were prepared from frozen liver tissue according
to manufacturer’s directions using an Epiquick Nuclear Extraction Kit
containing premixed proprietary buffers, dithiothreitol (DTT), a positive DNMT
enzyme control, and a protease inhibitor cocktail mix (OP-0002, Epigentek,
Farmingdale, NY, USA). Briefly, liver was homogenized at 4° C (Bullet
Blender, Next Advance Inc. Averill Park, NY) in a nuclear pre-extraction buffer
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containing DTT to lyse the cellular membrane and release intact nuclei from
the cells. Lysate was then incubated on ice for 15 minutes and centrifuged for
10 minutes at 12,000 rpm at 4°C. The supernatant (c ytosolic fraction) was
either kept for negative control in fresh tubes or discarded. To the remaining
nuclear pellet, nuclear extraction buffer, DTT, and a protease inhibitor cocktail
was added. The nuclear extraction was incubated on ice and vortexed for 5
seconds every 3 minutes during incubation for a total 15 minutes. The
suspension was then centrifuged for 12 minutes at 13,200 rpm at 4°C and the
supernatant

containing

nuclear

proteins

was

transferred

to

a

fresh

microcentrifuge tube. Protein abundance was measured using the Bradford
assay as previously mentioned (Bradford, 1976). Protein was immediately
aliquoted for DNMT activity assessment and the remaining nuclear lysate was
stored at -80°C until further use. Activity of DNMT was measured using
Epigentek DNA methyltransferase Activity/Inhibition Assay Ultra Kit following
manufacturer's directions. This assay contains proprietary buffers, colorimetric
solutions, SAM substrates, antibodies, and 8-well microplate strips containing
cytosine-rich DNA substrate that can be used in a 96 well format frame for
spectrophotometry. (P-3009, Epigentek, Farmingdale, NY, USA). These
assays are colorimetric similar to ELISA assays that use color changing
reactions, such as 3,3',5,5'-tetramethylbenzidine, that react to horse radish
peroxidase to yield a blue color when detecting HRP. Then an acidic solution
is applied turning the reaction yellow with a maximum absorbance of 450 nm.
Optimization was determined to be 20 µg of lysate per well by serial dilution of
46

sample to detect an appropriate magnitude of absorbance for maximum
detection. Previously aliquoted protein was diluted to a final concentration of
6.67 µg/µl. Assay buffer was aliquoted into each well (24 µl per well) and 3 µl
of protein solution was added. Blank wells were assayed in buffer alone and
positive wells contained 50 ng of DNMT control and assay buffer. Sadenosylmethionine substrate was diluted to a 1:5 solution and 3 µl added to
each well (final volume of 30 µl per well). Wells were incubated at 37°C for 1.5
hours and the plate was mixed during incubation so the cell sample DNMT
could methylate the coated plate substrate cytosine residues. Wells were
aspirated and washed 3 times with wash buffer and 50 µl of the 5’methylcytosine capture primary antibody (1:1000 wash buffer dilution) was
added. The plate was incubated at room temperature (22°C) for 60 minutes on
an orbital shaker. Wells were aspirated and washed 4 times with wash buffer
and 50 µl of the detection secondary antibody (1:1000 wash buffer dilution)
was added and incubated at room temperature for 30 minutes. Wells were
then aspirated and washed 5 times with wash buffer. Developer solution was
added to each well (100 µl) and incubated at room temperature for 2-10
minutes (with the plate protected from light) until a medium blue hue was seen
indicating a reaction between the solution and the secondary antibody. An
acidic stop solution was added turning the reactions yellow. Samples were
run in triplicate, included one blank well, and one positive control well and
analyzed using dual-wave spectrophotometric analysis (630nm and 450nm).
The amount of methylated DNA is proportional to the enzyme activity and is
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calorimetrically quantified by an ELISA-like reaction. Dnmt activity which is
measured in optical density/hour/milligram was calculated by subtracting the
negative control optical density from the optical density of the reaction. This
value was then divided by the amount of sample protein added in micrograms
that was multiplied by the initial incubation time in hours. This dividend was
then multiplied by 1000 to convert micrograms to milligrams for the final value.
Messenger RNA expression via one-step RT-PCR
Total RNA was isolated using Ultraspec® RNA (Catalogue # BL-10050,
Biotecx, Houston, Texas), based on a previously described method and
measured with a spectrophotometer for quality and purity using the optical
density ratio of 260nm/280nm from 1.8-2.0 (Brown-Borg et al., 2009;
Chomczynski & Sacchi, 1987). The RNA was then diluted and used to
measure expression of genes of interest in 3, 12, and 24 month old Ames
dwarf and GHRKO mice and also 3, 6, and 10 month old GH Tg mice and
compared to age-matched wild type controls. Ames dwarf and wild type 4-6
month old mice used in the GH administration experiments were also studied
for mRNA expression. Genes of interest are listed along with the primers used
for these experiments (Table 2). Primers were obtained from previous
literature (Chen et al., 2005; Ray et al., 2006; Sharma et al., 2010; Uthus &
Brown-Borg, 2006), screened against the whole mouse genome for
unintended targets using NCBI primer blast, and optimized. Reaction
substrates were contained in the QuantiTect SYBR® Green RT-PCR Kit
(Catalogue # 204243, Qiagen, Valencia, CA).
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TABLE 2: Primer pairs utilized for gene specific one-step RT-PCR
Gene

GeneBank
accession no.

Primer 5’- 3’

Annealing
Temperature

β2M

NM_00975

For - AAGTATACTCACGCCACCCA

60°C

Rev - AAGACCAGTCCTTG
Histone
H4

For- ACAACATCCAGGGCATCACG

60°C

Rev- GAAGACCTTCAGCACACCGC
GNMT

NM_010321

For - GCTGGACGTAGCCTGTGG

60°C

Rev - CACGCTCATCACGCTGAA
DNMT1

NM_010066

For - AAAGTGTGATCCCGAAGATCAAC

60°C

Rev TGGTACTTCAGGTTAGGGTCGTCTA
DNMT3a

NM_007872

For – TGCTACATGTGCGGGCATAA

58°C

Rev- GGAGTCGAGAAGGCCAGTCTT
DNMT3b

NM_0010039
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For – CCCAAGTTGTACCCAGCAATTC

59°C

Rev – TGCAATTCCATCAAACAGAGACA
DDX20

NM_ 017397

For - ACATGCATCGGATTGGCAGA

60°C

Rev - CCCAGGCGTTCTTTGAGACT
MT1

NM_013602

For - CCTTCTCCTCACTTACTCC

60°C

Rev -TCCATTCCGAGATCTGGTGAA
MT2

NM_008630

For - TCCTAGAACTCTTCAAACCGATCT
Rev- AAAAGGCTAGGCTTCTACATGGTC
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65°C

The reaction mixtures contained SYBR green, forward and reverse primers,
and QuantiTect RT mix, a Taq DNA polymerase, and assayed using a
SmartCycler instrument (Cepheid, Sunnyvale, CA) or a CFX 96TM Real-Time
PCR Detection System (BioRad, Hercules, CA). Polymerase chain reactions
included an initial reverse transcription step of 50° for 30 minutes, a taq
polymerase activation and denaturation step at 95°C for 15 minutes, PCR
cycling of 95°C for 15 seconds and an annealing tem perature of 50-60°C
(Table 2) for 30 seconds. These reactions were run for 40-45 cycles. Melt
curve analysis and standard curve optimization was used for quality control
of the PCR reaction and detection. No template controls and no reverse
transcriptase treated template controls were used to check for crosscontamination and genomic DNA contamination respectively. Data was
analyzed using the ∆∆Ct, also known as the comparative Ct method, which
calculates in reference to the control (the genomic DNA control specific to
mouse, the reverse transcription control from the cDNA reaction in triplicate,
and the positive PCR control in triplicate). The amount of tested gene cDNA
relative to a control gene (β2-microglobulin) was determined using the ∆∆Ct
(comparative Ct method) as previously published (HM Brown-Borg et al.,
2009; Lupberger et al., 2002). The Ct value is the number of cycles it takes
for a sample to reach the level where the rate of amplification is the greatest
during the exponential phase and the value is inversely proportionate to the
amount of RNA or cDNA in the sample. ∆Ct for each mouse type is
calculated as ∆Ct = Ct

(gene of interest)–Ct (average of β2m RNA).
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∆∆Ct is calculated as

∆∆Ct = ∆Ct

(Ames experimental)

- ∆Ct

(wildtype control)

of the same age group and the

fold change in expression will be calculated as 2

(-∆∆Ct)

. A one-fold change

indicates no change in transcription, a greater than one-fold change
suggests increased transcription, and a less than one-fold change indicates
decreased transcription (Heid et al., 1996).
miRNA expression via two-step RT-PCR
The miRNA 1st-Strand cDNA Synthesis Kit (600036, Agilent Technologies,
Wilmington, DE) was used on isolated total liver RNA (1 µg per reaction) to
polyadenylate and elongate miRNA at the 3’ end of the transcript in the sample
with a bacterial polyadenylate polymerase (PAP). A no PAP control was included
to screen for contamination. All steps were done with samples on ice except
during incubation periods. Then the miRNA is reverse transcribed using a
genetically engineered Moloney murine leukemia virus reverse transcriptase into
cDNA according to the manufacturer’s directions. RNase inhibitors are also
included to prevent miRNA degradation during the process. The RT portion of the
kit also provides a proprietary “RT adaptor primer” which anneals to the 3’ end of
the poly A tail and creates a universal sequence tag during the amplification that
is incorporated into the 5’ region of the transcripts. This tag allows the use of a
proprietary universal reverse primer to be used during real-time qPCR
amplification (Agilent Technologies, 600037, Wilmington, DE). Forward primer
sequences for miR-140-3p and the 5S rRNA control were verified for use in
mouse using miRBase and NCBI GenBank (Table 3; Takata et al. 2012; Bates et
al. 2010). For miRNA expression validation a commercially prepared validated
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control for U6 splicoeosomal RNA (RNU6) (MiScript Primer Assay,Catalogue #
MS00033740, Qiagen, Valencia, CA). RNU6 is an approximately 100 basepair
non-coding RNA that complexes with RNA splicing proteins for mRNA
processing. RT-PCR was performed using the PerfeCta® SYBER® Green
SuperMix (Catalogue # 95054, Quanta Biosciences, Gaithersburg, MD), forward
and reverse primers, nuclease free water and polyadenylated cDNA. Reactions
were run using CFX 96TM Real-Time PCR Detection System (BioRad, Hercules,
CA), reactions beginning with denaturation step of 95 ° C for 3 m inutes, followed
by cycling conditions of 95 ° C for 15 seconds, 60° C for 30 seconds, for 45
cycles. Controls for cross-contamination and genomic DNA contamination were
utilized. Melt curve analysis was used for quality control of the PCR reaction and
detection. The amount of tested gene cDNA relative to a control gene, 5S rRNA,
was determined using the ∆∆Ct (comparative Ct method).
Interspersed repeat transcription two-step RT-PCR
Total RNA was treated with DNase I according to the manufacturer’s protocol to
eliminate genomic DNA contamination through a non-specific endonuclease
action, which degrades DNA in the RNA samples (Catalogue #M0303S/L, New
England Biolabs, Ipswich, MA). All steps were performed with samples on ice
except during incubation. Briefly, 10 µg of RNA was suspended in DNase I
reaction buffer which includes enzyme activating cations such as Ca2+ to a final
volume of 100 µl. Two units of DNase I were added to each sample mixture and
were mixed thoroughly by inverting samples roughly 20-30 times. Reactions were
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briefly centrifuged and put into a dry bath at 37°C for 10 minutes. To terminate
the reaction, 1 µl of 0.5M EDTA was added and the samples were then heat
inactivated for 10 minutes. RNA was converted to cDNA by use of Protoscript
M-Mulv Taq RT-PCR reagents from New England Biolabs, Ipswich, MA) along
with control reactions to verify cDNA

synthesis and the absence of gDNA

contamination (Filkowski et al., 2010; Martens et al., 2005; Pogribny et al., 2009).
DNase I treated RNA (1 µg ) was put into a mix with a random primer mix (2 µl,
60 µM), a deoxynucleotide (dNTP) solution mix (1 µl, 10mM), and nuclease free
water to a final concentration of 16 µl (Catalogue #S1330S, #N0447S/L, New
England Biolabs). The random primers mix is designed to allow the reproduction
of the complete complement of messenger RNA to complimentary DNA in a
sample. This mix was briefly centrifuged and put in a dry bath at 70°C for 5
minutes after which the samples were promptly chilled on ice. Then, to each
reaction 2 µl of 10x RT buffer, 20 units of Murine RNase inhibitor, 200 units of
Moloney Murine Leukemia Virus reverse transcriptase (M-MuLV), and 0.5 µl of
nuclease free water were added. Samples were again briefly centrifuged and
incubated at 25°C for 5 minutes then incubated at 4 2°C for one hour. To
terminate the reaction and inactivate the enzyme, the samples were then
transferred to a dry bath at 80°C for 5 minutes. Nu clease free water was added
to bring the final volume to 50 µl and the reactions were placed on ice.
Successful reaction were validated by PCR using a control primer set (β2microglobulin)

and running a negative control (reactions without the reverse

transcriptase added) alongside reverse transcriptase treated samples on a 2%
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agarose gel. Complementary DNA (cDNA) products were used immediately or
stored at -20°C for downstream PCR applications. Ta ble 3 lists the primers used
which were taken from previous publications or designed via NCBI primerblast
(Lane et al., 2003; Martens et al., 2005). All primers were verified via NCBI
primerblast and/or Repbase, which is a database established purely for repetitive
sequences. Reactions were performed using the QuantiTect SYBR® Green PCR
Kit. The reaction mixtures contained, forward and reverse primers, and
QuantiTect SYBR Green PCR Buffer, a taq DNA polymerase, and assayed using
a SmartCycler instrument (Cepheid, Sunnyvale, CA). Polymerase chain reactions
included an initial taq polymerase activation and denaturation step at 95°C for 15
minutes, PCR cycling of 95°C for 15 seconds, an ann ealing temperature of 6063°C (Table 3) for 30 seconds, and an extension ste p of 72°C for 30 seconds.
These reactions were run for 40 cycles. Standard curves were performed
between the transcripts of interest and β2m, RNA and primer concentration and
reaction conditions were optimized, and standard RT-PCR controls, similar to the
aforementioned experiments, were used. The amount of tested gene cDNA
relative to a control gene (β2m) was determined using the ∆∆Ct (comparative Ct
method) as previously mentioned for one step RT-PCR experiments (Bates et al.,
2010; Brown-Borg et al., 2009; Heid et al., 1996).
McrBC-qPCR DNA methylation assay
McrBC

is

an

endonuclease

which

cleaves

DNA

containing

5-

methylcytosine or 5-hydroxymethylcytosine or N4-methylcytosine on one or both
strands of genomic DNA. McrBC will not act upon unmethylated DNA and
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depends on the presence of guanosine tri-phosphate (GTP) for cleavage
(Sutherland, Coe, & Raleigh, 1992). This allows for the enrichment of nonmethylated genomic DNA which can then be compared to non-digested genomic
DNA following qPCR using the absolute standard method (Filkowski et al., 2010;
Martens et al., 2005; Pogribny et al., 2009).
TABLE 3: Primer pairs utilized for McrBC-PCR and miRNA two-step RT-PCR.
Interspersed
Repeat
LINE1 3’UTR

GeneBank
accession
no.
D84391

Primer 5’- 3’

Annealing
Temperature

For - TTGATCACAGGGCTCCCAATGGAG

60°C

Rev - GTACCGGGGCACACAAAGTCTGCG
IAP-LTR

M17551

For - TGCGCATATGCCGAGGGTGGTT

63°C

Rev - TCTCACGCCCGGCCAGGAAGAAC
SINE B1

J00630
1-203 bp

For - GTGGCGCACGCCTTTAATC

63°C

Rev -GACAGGGTTTCTCTGTGTAG
SINE B2

J00630
506-700 bp

For –GAGATGGCTCAGTGGTTAAG

60°C

Rev- CTGTCTTCAGACACTCCAG
miRNA 1403p
5S rRNA

NR_029553

For – TACCACAGGGTAGAACCACGG

59°C

NR_046144

For-CAGGGTCGGGCCTGGTTAGTACTTG

60°C

DNA was extracted from the liver using a Gentra® Puregene® Tissue Kit
(Catalogue # 154667, Qiagen, Germantown, MD, USA) and was homogenized
using the Bullet BlenderTM. Briefly, 10-15 mg of liver tissue was homogenized in
100 uL of Cell Lysis solution from the Gentra Puregene kit on ice. After the initial
homogenization another 200 µl of Cell Lysis solution from the Gentra Puregene
kit was added to each sample (on ice) and run in the Bullet Blender at a lower
speed for 1 minute to mix thoroughly. Genomic DNA was measured
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spectrophotometrically using OD of 260nm/280nm for purity and samples
measuring

1.8-2.0

were

used

for

the

assay

(Epoch

Micro-Volume

Spectrophotometer System, BioTek Instruments,Inc., Winooski, VT). DNA was
aliquoted into 25-50 µl and kept in -80º C until needed. Genomic DNA was
diluted in TE buffer (10 mM Tris, 1 mM EDTA, at pH8) and sonicated using the
UCD500-Bioruptor XL® (Life Research ©, Scoresby, Victoria, Australia) user
manual version 2.1 to increase the efficiency of downstream restriction enzyme
digestion. After genomic sonication was complete samples were run on a 1%
agarose gel to validate DNA fragment sizes of 3-5 kilobase pairs. Restriction and
mock restriction reactions were set up with nuclease free H20, buffer provided by
New England Biolabs, a GTP substrate, bovine serum albumin, and 1µg of
genomic DNA. Lastly, 3 µl (30 U) of McrBC was in a 50% glycerol solution for
restricted gDNA and for mock restrictions 3 µl 50% glycerol in nuclease free
water. Plasmid DNA was also provided as a positive control for enzyme activity.
(Catalogue # M0272S or M0272L, Ipswich, MA). Final reaction volumes were
100 µl. Sample reactions were gently mixed by tapping the tube lightly, or
inverting the tube gently several times, and incubating overnight at 37 °C
(Holemon et al., 2007; Martens et al., 2005). Reactions were inactivated by
heating the samples to 65°C for 20 minutes. The pos itive control plasmid DNA,
mock restricted, and restricted samples were verified through electrophoresis on
a 1% agarose gel. Table 3 shows all primers that were used which are the same
primer sets used for two-step RT-PCR transcriptional analysis of the interspersed
repeats as previously mentioned. Reactions for mock-restricted and restricted
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samples were assembled and run together in duplicate. Reagent contents,
primers, and thermocycling conditions were equivalent to the previously stated
qPCR measurement of interspersed repeat transcription parameters. As in
previous publications, the absolute quantification analysis of qPCR was used
where the threshold cycle (Ct) is defined as the fractional cycle number that
passes the fixed threshold. Ct values for each repetitive element were converted
into the absolute amount of input DNA using the absolute standard curve
method. An increased amount of input DNA after digestion with McrBC compared
to mock-restricted DNA is indicative of hypomethylation, whereas a decreased
amount of input DNA is indicative of hypermethylation (Filkowski et al., 2010;
Pogribny et al., 2009)
Global methylation assay
Global methylation of isolated genomic DNA (see above in the McrBC-qPCR
methylation assay) was determined using the MethylampTM Global DNA
Methylation Quantification Ultra Kit (Catalogue # P-1014B, Epigentek, Farmingdale,
NY, USA) according to the manufacturer’s instructions. This kit is a colorimetric
assay similar to ELISA reactions that probes for 5’-methylcytosine using antibodies.
The kit includes proprietary buffers including wash buffer, binding buffer, blocking
solution and antibodies, developer and stop solutions and also unmethylated DNA
(negative control, 100 ng per well) and fully methylated DNA (positive control, 10 ng
per well ). The DNA sample (200 ng per well), positive control and negative control
DNA are aliquoted into wells coated with a DNA affinity substance and the DNA
binding solution is added to a final volume of 30 µl per well. The plate was gently
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shaken and incubated uncovered at 37°C for 40 minut es in room air. Afterwards the
samples were incubated at 60°C for 35-40 minutes ev aporating all the solution and
drying the wells. If the wells were not completely dry, wells were aspirated of the
remaining solution with 10 or 20 µl pipette tips or incubated at 60°C for 5-10
minutes more according to manufacturer directions. Blocking solution was then
added at 150 µl per well and incubated at 37°C for 30 minutes. Wells were
aspirated and washed three times with 150 µl of wash buffer at room temperature.
The capture antibody was added in a 1:1000 dilution (1 µg/ml, 50 µl/well) in wash
buffer. The wells were covered and incubated at room temperature (22°C) for 1
hour. Wells were aspirated and washed four times with 150 µl of wash buffer at
room temperature. The detection antibody was added in a 1:5000 dilution (0.08
µg/ml, 50 µl/well) in wash buffer. The wells were covered and incubated at room
temperature (22°C) for 30 minutes. Wells were then aspirated and washed five
times with 150 µl of wash buffer at room temperature. A signal enhancer was
added in a 1:5000 dilution (50 µl/well) in wash buffer. Wells were again, aspirated
and washed five times with 150 µl of wash buffer at room temperature. A developer
solution was added (100 µl/well) and incubated at room temperature (22°C) for 1 to
5 minutes (protected from light). As in the DNMT activity assay previously
mentioned, color development was monitored and stop solution (50 µl/well ) was
applied after the reactions had reached a medium blue color. Samples and controls
were run in triplicate and analyzed using dual wave spectrophotometric analysis
(630 nm and 450 nm). To calculate the percent methylation of the samples, the
negative control absorbance was subtracted from the sample absorbance. This
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number was then divided by 0.42 because there is a 42% DNA GC content in
mouse DNA. This number was then divided by the difference between the positive
control minus the negative control multiplied by 20 since there is a 20 fold
difference in concentration between the sample genomic DNA and the fully
methylated positive control. This number is then multiplied by 100 to obtain a
percentage calculation of methylated DNA. Methylation was normalized to the 3
month wild type mice for GH signaling deficient mice, where in 2 assays, the
positive and negative controls were similar in absorbance and had the same lot
numbers, were averaged (within 2 standard deviations) between assays and thus
were used for subsequent cumulative analysis. For GH Tg assays, differences
between the control absorbance measurements between the two plates were too
large (58% difference), therefore the first assay was normalized to 3 month old wild
type mice, and the second assay was normalized to 6 month wild type mice.
Methylation-specific PCR analysis
Genomic DNA was isolated from dwarf and wild type liver tissue (Gentra
Puregene Tissue Kit; Qiagen, Germantown, MD), and bisulfite treated using the
BisulfFlashTM DNA Modification Kit (Catalogue # P-1026, Epigentek, Farmingdale,
NY). Bisulfite treatment of genomic DNA results in the deamination of cytosines
not protected by methylation, to uracil. Upon PCR amplification of this product,
uracil is converted to thymine thus 2 sets of primers are used to probe for
methylated and unmethylated cytosines of CpG dinucleotides to assess the
methylation status of the target region. This kit contains a proprietary conversion
buffer, a conversion enhancer solution, and a denaturation enhancer which
59

protects DNA from degradation and keeps it denatured during the bisulfite
conversion. These three agents are first mixed together and 200 ng of genomic
sample DNA was added to each reaction and subsequently used for methylationspecific PCR (Herman, Graff, Myöhänen, Nelkin, & Baylin, 1996). Primers (Table
4) were designed for predicted methylated and unmethylated sequences of CpG
dinucleotide islands using the MethPrimer program (Li & Dahiya, 2002).
Thermocycling conditions and primer concentrations were optimized using RTPCR and PerfeCta® SYBR® Green SuperMixTM (Catalogue # 95054, Quanta
Biosciences, Gaithersburg, MD) to ensure end products for agarose gel analysis
were produced during the exponential phase of the reaction for methylation
comparison. This mix contains the same AccuStartTM taq DNA polymerase as the
AccuStartTM II PCR SuperMix used for the MS-PCR experiment reactions
(Catalogue #95127, Quanta Biosciences, Gaithersburg, MD). Reactions contained
AccuStartTM II PCR SuperMix, the forward and reverse primers for each
methylation state (methylated versus unmethylated; 1 µM), and 1µL of bisulfite
treated DNA (10 ng) for a total volume of 15µl. Thermocycler (Eppendorf
Mastercycler) conditions consisted of an initial denaturation step at 95°C for 15
minutes, PCR cycling of 95°C for 15 seconds, an ann ealing temperature of 55°C
for 30 seconds, and an extension step of 72°C for 3 0 seconds. Reactions were
held at 4°C. Samples were run on a 2% agarose gels, stained with ethidium
bromide and band intensities of methylated PCR products were compared to
unmethylated PCR products using Omega LumTM G imaging system (AplegenTM,
Pleasanton, CA) and UltraQuant version 13.04.05.
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TABLE 4: Primer pairs utilized for MS-PCR.
Gene

Predicted
CpG
Island

Primer 5’- 3’

Annealing
Temperature

MT1 methylated

177-328

For - TTTTAGGGAGTTTTGTATTTCGTTC

55°C

Rev - AACAACCTACCCTCTTTATAATCGTT
MT1
unmethylated

177-328

For -TTAGGGAGTTTTGTATTTTGTTTGA
ACATGCATCGGATTGGCAGAACATG
CATCGGATTGGCAGAACATGCATCGGATTGG
Rev
- AACAACCTACCCTCTTTATAATCATT

55°C

MT1 methylated

465-570

For - GAATATTAAGTTGGGATCGTAGAGC

55°C

Rev - AAAACGAATTCTAAAAAAAACCGA
MT1
unmethylated

465-570

For -ATATTAAGTTGGGATTGTAGAGTGG
ACATGCATCGGATTGGCAGAACATG
CATCGGATTGGCAGAACATGCATCGGATTGG
Rev
- AAAACAAATTCTAAAAAAAACCAAA

55°C

MT2 methylated

105-280

For - TTGTTTTACGAGTAAAAAGAGGTC

55°C

Rev -TAACGAAAAATATTAAATCGAACGC
MT2
unmethylated

105-280

For - TTGTTTTACGAGTAAAAAGAGGGTC

55°C

Rev- ATAACGAAAAATATTAAATCGAACG
LINE1 3’ UTR
methylated

150-324

For- GGATTAGAGGATAGGTGTTCGTTC

60°C

Rev- TACCTCAATACCTCTATACTTCCGC
LINE1 3’UTR
Unmethylated

150-324

For- GGATTAGAGGATAGGTGTTTGTTTG

60°C

Rev- ACCTCAATACCTCTATACTTCCACC
LINE1 3’UTR
Methylated

528-676

For- GTTGAGGTAGTATTTTGAGTGGGTC

60°C

Rev- AAACTAATTTCCTAAATTCGACGAA
LINE1 3’UTR
Unmethylated

528-676

For- GTTGAGGTAGTATTTTGAGTGGGTT

60°C

Rev- AAACTAATTTCCTAAATTCAACAAA
IAP-LTR UTR
Methylated

105-298

For- TTATGTGTTTTGTTTTTTTCGTGAC

60°C

Rev- CACAAACCAAAATCTTCTACGAC
IAP-LTR UTR
Unmethylated

105-298

For- ATGTGTTTTGTTTTTTTTGTGATGT
Rev- ACCACAAACCAAAATCTTCTACAAC

61

60°C

Histone extraction and immunoblotting
Histones were extracted from 3, 12, and 24 month old Ames dwarf and wild
type age matched livers using the EpiQuik™ Total Histone Extraction Kits
(OP-0006, Epigentek, Brooklyn, NY, USA) according to the manufacturer’s
protocol. Briefly, weighed pieces of tissue sample were homogenized in a
pre-lysis buffer then centrifuged at 3000 rpm for 5 minutes at 4°C. After
discarding the supernatant, the cellular pellet was re-suspended in lysis
buffer and incubated on ice for 30 minutes. Samples were then centrifuged
at 12,000 rpm for 5 minutes at 4°C and the supernat ant fraction containing
the acid-soluble proteins was transferred into a new microtube. A balance
buffer containing DTT solution was added to the supernatant immediately
and chromatin was quantified using a spectrophotometer using the
Bradford method. Histone extracts (50 µg/ lane) were be separated via
electrophoresis, transferred to PVDF membrane, and specific proteins
detected

using

standard

immunoblotting

techniques

and

chemiluminescence. Antibodies to pan-Histone H3 (07-690) 1:2000 dilution,
trimethyl-Histone H3Lys4 (07-473), trimethyl-Histone H3Lys27 (07-449),
trimethyl-Histone H3Lys9 (07-442), trimethyl-Histone H4Lys20 (04-079,
Millipore, Temecula, CA) were used. Densitometric analysis was conducted
using an Omega Lum™ G imaging system (Aplegen™) and UltraQuant
Analysis Software

version 13.04.05.

GelCode® Blue Stain reagent

(ThermoScientific, Rockford, IL, USA) was used to assess equivalent
protein loading (Kingston, 2010)
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Histone chromatin modification enzyme RT-PCR pilot study
Histone modification enzyme mRNA expression was probed in 3-month-old
Ames dwarf and age-matched wild type mice to look for differences in expression of
these enzymes. For this study the murine Epigenetic Chromatin Modification
Enzymes RT2 Profiler PCR Array was used (Catalogue # PAMM-085A, Qiagen,
Valencia, CA) which contains a 384 well plate coated with mRNA amplification
primers for 4 sets of 84 genes, allowing 4 samples to be assayed at one time (n=2
mice/genotype). The 384 (4 replicate x 96 well) option contains 4 replicate primer
assays for: each of 84 genes in the pathway (DNA methyltransferases, histone
acetylases,

deacetylases,

methylases,

methyltransferases,

phosphorylases,

kinases, and ubiquitination enzymes), primer assays for 5 housekeeping genes, for
genomic DNA controls, 12 wells for reverse-transcription controls, and 12 wells
contain positive PCR controls. Purified RNA was used to perform a reverse
transcription reaction with the RT2 First Strand Kit. Complimentary DNA is used with
the RT2 SYBR Green mix. The reaction mixtures contained SYBR green, forward
and reverse primers, a Taq DNA polymerase, and assayed using a Bio-Rad
CFX384™ (BioRad, Hercules, CA). Briefly, reagents of the RT2 First Strand Kit were
thawed on ice and tubes from the kit were centrifuged (10–15 seconds) to bring the
contents to the bottom of the tubes. A genomic DNA elimination mix for each RNA
sample was prepared containing, a proprietary buffer and RNase-free to a final
volume of 10 µl.

The reaction was mixed gently and briefly centrifuged. The

genomic DNA elimination mix was incubated for 5 min at 42°C then placed
immediately on ice. The reverse-transcription mix was prepared with proprietary
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buffers, a reverse transcriptase, RNase-free water to a total volume of 40 µl for 4
reactions. For the RT reaction 10 µl of the reverse-transcription mix was added to
each tube containing the 10 µl genomic DNA elimination mix (containing sample or
a positive control RNA). This was mixed gently and incubated at 42°C for exactly 15
min. All reactions were stopped simultaneously by incubating at 95°C for 5 min.
RNase-free water (91 µl) was added to each reaction which were gently mixed and
placed on ice. The PCR components mix were prepared in a 5 ml tube, containing a
SYBR Green master mix, the cDNA synthesis reaction, RNase-free water to total
volume of 1300 µl for each sample. The remaining 9 µl cDNA synthesis reaction
was stored at –20°C, for quality control analysis o f the RT reaction. The mixed
components were dispensed into the RT2 Profiler PCR Array 10 µl/ well for 96 wells
per sample. Special covers were provided by the manufacturer for ease of pipetting
and prevention of sample cross-contamination. Thermocycling conditions were
provided by the manufacturer as a program which consisted of 10 min at 95°C for
Taq polymerase activation, followed by 40 cycles of 15 s 95°C, and 30 seconds at
55°C, 30 seconds at 72°C. Data was analyzed using P CR Array Data Analysis
Software (Excel based) provided by Qiagen which automatically performs all ∆∆Ct
based fold-change calculations from the uploaded raw threshold cycle data.
Statistical analysis
Real-time quantitative PCR, interspersed repeat hypomethylation, immunoblotting or
MS-PCR data among three or more groups, and global methylation data were
analyzed with one-way ANOVA or two-way ANOVA (factors: genotype and age;
GraphPad Prism 5.0) with Bonferroni's or Dunnett's post hoc tests as appropriate
64

with a p< 0.05 adjusted significance level. Global methylation of in vivo GH
administration did not pass Levene’s test for equal variances and was analyzed
using

a

Kruskal-Wallis

test

and

Dunn’s

multiple

comparison

post-test.

Immunoblotting, end-point MS-PCR, and DNMT activity data between genotypes
were analyzed using Students t-test (GraphPad Prism 5.0). All data are shown as
mean ± standard error of the mean (SEM). Sample values (n) are listed in the figure
legends.
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CHAPTER III
RESULTS
Ames dwarf liver exhibits alterations in components of the methionine pathway in
the liver. In hepatocellular carcinoma cells and in animal models these alterations
are known to change DNA methylation. Most epigenetic studies are either in
abnormally proliferating cells, such as cancers, or in pre-disease or diseased
states, such as methyl-deficient diets causing hepatosteatosis. To offer a fresh
perspective on epigenetic mechanisms in aging, we examined the epigenetic
methylation mechanisms and markers in Ames dwarf mice that are known to
outlive their wild type counterparts, which is attributable to GH deficiency. We
studied DNA methyltransferase expression basally in cross-sectional studies (3,
12, and 24 months), and with the addition of growth hormone, to study this
hormone, and its effects on epigenetic mechanisms. We also examined global
methylation, histone methylation, and studied as whether one pathway that
regulates DNMT1 in hepatocellular carcinomas, also regulates DNMT1 in dwarf
mice. We ended our studies by performing similar experiments in another GH
signaling deficient long-living mouse, the growth hormone receptor knockout, and
a growth hormone over-expressing short-lived model. We were evaluating these
mice for differences and similarities between the strains that might show patterns
of epigenetic methylation related to aging and growth hormone.
66

GNMT transcription and translation is higher in dwarf mice
Glycine-N-methyltransferase regulates SAM in the liver and the over- or
under-expression of this enzyme has been linked to changes in DNA
methylation. Our lab has previously shown that GNMT mRNA expression
and activity is increased in Ames dwarf mice compared to wild type mice.
However, changes in GNMT expression due to aging had not been
determined, which could affect DNA methylation over the lifespan of an
animal. Given that GNMT is linked to DNA methylation and possible DNA
methyltransferase activity via the methionine pathway, we investigated
GNMT expression in dwarf and wild type mice in our cross-sectional studies.
Similar to previous findings, GNMT liver mRNA is more abundantly
expressed across all three age groups in the Ames dwarf compared to wild
type mice with significance at 3 and 12 months of age (Figure 1). The GNMT
mRNA expression is influenced by genotype (p=0.0001) and age (p=0.0176).
Protein levels of GNMT are also higher in dwarf mice at 12 months of age
when compared to age-matched wild type controls (p=0.0408).
DNA methylation enzyme basal expression and activity is significantly
altered in Ames dwarf mice compared to wild type mice
Next we examined mRNA expression of DNMT1, DNMT3a, and DNMT3b using
RT-PCR analysis of isolated liver RNA. Surprisingly, we found that dwarf mice
show a much higher mRNA expression of both DNMT1 (105%) and DNMT3a
(238%) at 3 months of age (p<0.0001; Figure 2).
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FIGURE 1. GNMT mRNA and protein expression are higher in Ames dwarf mice compared to
their wild type siblings. a) Liver GNMT mRNA expression is shown for dwarf (gray bars) and wild
type mice (open bars) at 3, 12, and 24 months of age (n=7-8). b) GNMT protein levels at 3 (n=1011, p=0.7248) and c) 12 months (n=8-10, p=0.0408) and d) 24 months of age (n=6-8, p=0.6618).
Mean optical densities are shown ± SEM. *p<0.05 and **p<0.01. Ponceau S was used for equal
loading.

Gene expression of DNMT3b mRNA was similar between genotypes at all age
groups studied. Age appeared to be an important factor in the expression of
all three DNMTs. A significant effect of genotype was detected for DNMT1
and DNMT3a however, the genotype by age interaction was significant
confounding the independent effects. The DNMT expression overall shows an
interesting U-shaped pattern with the lowest levels at 12 months of age in
both genotypes compared to the linear decrease in GNMT mRNA expression
(Figure 1). Previous literature noted DNA methyltransferase RNA expression
declined with age and when the expression was normalized to histone H4,
which was used to rule out a more or less proliferative background (Ray et al.,
2006). We compared histone H4 to β2m mRNA expression to detect any
effects of background cellular proliferation that might influence DNMT
transcription results and determined no discernable differences. Therefore
β2m was considered an appropriate transcript for all mRNA normalization in
the liver (Figure 3).
68

Figure 2. DNMT1 and DNMT3a mRNA expression are higher in Ames dwarf mice at 3 months of
age. Liver DNMT mRNA expression is shown for wild type (open bars) and dwarf mice (gray
bars) at 3, 12, and 24 months of age (n=7-8) for DNMT1, DNMT3a, and DNMT3b. Mean relative
changes in expression are shown ± SEM. ****p<0.0001.

Figure 3. Average Ct counts for H4 or β2m transcripts showed similar biological expression
between all age groups and genotypes. Age groups compared are 3, 12, and 24 months (wild
type mice, open bars; dwarf mice, grey bars). β2m normalization was therefore used for all
transcriptional studies. Bars represent mean± S.D.

Protein levels of DNMT1, DNMT3a, and DNMT3b were also compared
between dwarf and wild type mice at 3, 12 and 24 months of age (Figure 4).
To maximize the genotypic comparisons, independent immunoblots for each
age were assayed. Very low levels of DNMT1 protein were observed in the
liver tissue of dwarf mice compared to wild type mice at each age group
examined.
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Figure 4. DNMT protein levels are expressed differently in Ames dwarf and wild type liver tissue
at 3, 12, and 24 months of age. Wild type mice represented by open bars and dwarf mice by gray
bars. DNMT1 protein expression was much lower that wild type mice at 3 months (n=10-11,
p<0.0001), 12 months (n=9, p=0.0427) and 24 months (n=7-9, p=0.0015). DNMT3a protein was
significantly higher in dwarf mice at 3 months (n=10-11, p<0.0001), statistically equivalent at 12
months (n=12, p=0.2464) and much lower in dwarf mice at 24 months (n=8, p=0.0172). DNMT3b
protein was not different between the genotypes at 3 months (n=10, p<0.4000), 12 months (n=1112, p=0.6244) or 24 months (n=9-10, p=0.5621). Mean optical densities are shown ± SEM.
*p<0.05, **p<0.01, and ***p<0.001.
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The variability of protein levels between animals was more pronounced in wild
type DNMT1 and DNMT3a as compared to dwarf mice. DNMT3b expression
was variable in both genotypes at every age. Due to a high variability of
DNMT protein expression among in vivo groups, each immunoblotting assay
was done independently for each group to increase murine sample sizes. DNA
methyltransferase 3a protein levels were higher (193%) in the dwarf mice at 3
months of age (p<0.001), similar at 12 months of age (p=0.2464), and
significantly lower (54%) at 24 months of age (p=0.0172). Compared to wild
type controls, DNMT3b levels were not different between genotypes at any
age, similar to mRNA findings at each age group. We also asked whether
there were differences due to aging in DNMT1 and DNMT3a within genotypes.
We evaluated expression at all three ages within each genotype where we
were limited to a sample of 8 per age group (24 well gel capacity, Figure 7).
We doubled the amount of our dwarf liver lysate and re-optimized for the
detection of DNMT1 since the basal signal was so low. We observed an
increase of DNMT1 expression in the dwarf mouse (p=0.0012) and in the wild
type mouse (p=0.0512) with age. DNMT3a however, had opposite expression
patterns over all three ages when comparing genotypes. Remarkably, dwarf
mice displayed higher DNMT activity in young and similar DNMT activity in
middle aged (3 months, p=0.0214; 12 months, p=0.1704) liver compared to
wild type mice but lower activities in old Ames dwarf liver (24 months,
p=0.0491) (Figure 6). The DNMT activity in the liver more closely resembles
DNMT3a protein expression than DNMT1 or DNMT3b.
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Figure 5. DNMT expression genotype differences due to age run in separate gels. The figures on
the left wild type mice show an increase in DNMT1 and in DNMT3a (One way ANOVA p=0.0512
and p=0.1056 respectively, n=6-8). Dwarf mice also show a significant increase from 3 to 24
months of age in DNMT1 but a no significant decrease in DNMT3a (One way ANOVA p=0.0012
and p=0.0926 respectively, n=6-8). However, for DNMT1 in the dwarf the amount of liver protein
used for dwarf tissue was doubled (and immunoblotting conditions re-optimized) in comparison to
the wild type tissue to generate enough signal to detect by immunoblotting. Bars represent
mean±SEM, ****p<0.0001.

Overall DNMT activity was measured with an ELISA-based colorimetric
assay using nuclear lysates extracted from liver tissue, as DNMT isoform
specific activity assays are not available. Independent assays comparing
dwarf versus wild type for each age group were performed. All samples were
performed in triplicate for accuracy. In conclusion, it appears that DNMT1,
DNMT3a, and GNMT mRNA and protein expression are not directly
correlated with each other though both show significant effects of age and
genotype in transcription.
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DNMT1 protein expression is greatly diminished in dwarf mice at every
age and DNMT3a protein appears to follow DNMT activities, which are all
novel findings. DNMT3b shows no genotype differences in transcription or
protein; however an age difference was noted in transcription.

Figure 6. DNMT activity is higher in Ames dwarf mice at 3 months and lower at 24 months than
age-matched wild type siblings matching the pattern of DNMT3a protein expression. ELISAbased colorimetric activity assay of nuclear liver lysate showing differences in total DNMT activity
in 3 month (n=11, p=0.0214),12 month (n=8-11, p=0.1704) and 24 month old (n=9-12, p=0.0491)
wild type (open bars) and Ames dwarf mice (gray bars). Mean activities expressed as optical
density per mg per hour are shown ± SEM. *p<0.05.

Global DNA methylation is higher in dwarf mice at every age and
resists changes due to age
Global DNA methylation in liver tissue is subject to DNMT activity
alterations and abundance, SAM availability, and alterations of enzyme
expression or activity in the methionine pathway. Because we observed such
interesting differences in DNMT activity and expression, we measured global
methylation using an ELISA-based method with antibodies for methylated
cytosines across all three age groups (Figure 7). Comparison of dwarf versus
wild type mice showed independent factors of genotype (p=0.0635) and age
(p=0.0534) approaching significance. At 3 and 12 months of age, dwarf mice
retained higher methylation than age-matched wild type mice, becoming
equivalent at 24 months of age. Because much of the global loss of DNA
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methylation with aging is thought to take place in interspersed repeats, also
known as repetitive elements and transposable elements, transcription of
these elements is thought to increase and contribute to genetic instability. We
measured the hypomethylation status and transcription of these repeats
between Ames dwarf and wild type mice in another cross-sectional study to
see if this was indeed the case.

Figure 7. Global DNA methylation of Ames dwarf mice is higher at 3 and 12 months of age.
ELISA-based colorimetric activity assay of nuclear liver genomic DNA showing global DNA
methylation in wild type (open bars) and Ames dwarf mice (gray bars). Percentage methylation
was derived using control and sample optical densities, which were then normalized to 3 month
wild type mice± SEM.

We used a well-published technique called the McrBC-qPCR
method. McrBC is an endonuclease that restricts methylated DNA and
degrades it. The treated DNA sample is compared to “mock restricted” sample
of the same genomic DNA which does not contain the restriction enzyme but
has been processed in the same way at the same time. Genomic DNA that is
restricted is enriched for unmethylated DNA, therefore DNA that is less
methylated shows greater abundance levels during quantitative PCR (Figure
8, left panels). Both intracisternal A-particle long transposable repeat (IAP74

LTR) and short interspersed nuclear element B2 (SINE B2) are increasingly
hypomethylated with age in the wild type mouse. Hypomethylation in SINE B2
also increases in the dwarf mice with age. Long interspersed nuclear element
1 (LINE1) hypomethylation approached significance for genotype differences
(p=0.0753) displaying higher levels of hypomethylation in dwarf mice that
decreases over time, whereas wild type mice appear to maintain or only
slightly gain methylation levels. This lack of difference in methylation of wild
type mice is consistent with the most recent literature. Differences in IAP-LTR
hypomethylation between dwarf and normal mice also show genotypic
differences moving toward significance (p=0.0656) where dwarf mice have
more methylation at 3 months and 24 months compared to wild type mice. The
repetitive element SINE B2, which is rodent specific, exhibited statistically
different

levels

of

hypomethylation

affected

by

age

and

genotype

independently (p=0.0140, p=0.0415, respectively). Short interspersed nuclear
element B2 was clearly more methylated in dwarf mice at every age compared
to wild type, yet both genotypes demonstrated a linear increase of
hypomethylation with age. Short interspersed nuclear element B1, which is
homologous to the human Alu repeat, did not display differences in
methylation due to age or genotype, but remained relatively similar at all three
ages studied.
While methylation does regulate transcription in many cases, for the
four interspersed repeats studied, transcription and methylation appear
unrelated or uncoupled. However, there are transcriptional differences
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attributable to age or genotype (Figure 8, right panels). All four repetitive
element transcripts were significantly affected by age, whereas only SINE B1
displayed a significant genotype difference, most likely due to the increase of
transcription in dwarf mice at 24 months of age compared to wild type mice.
Remarkably, transcriptional expression of repetitive elements resembles the
u-shaped curve of expression similar to DNMT transcription. For IAP-LTR this
pattern of mRNA expression due to aging has been noted in mouse liver
before (Gaubatz, Arcement, & Cutler, 1991).It also appears the transcriptional
expression of repetitive elements is greatest at 3 months of age in wild type
mice but not dwarf mice, which can regain an equivalent or increased amount
of transcription in LINE1, SINE B1, and SINE B2.
Since LINE1 makes up approximately 20% of the 40% of genomic DNA
comprised of interspersed repeats in the murine genome, we decided to use
LINE1 and MS-PCR to validate our hypomethylation results (Figure 9). Two
primer sets were used, however, only the set with CpG island prediction
between base pairs 150-324 showed any unmethylated CpGs. The other
LINE1 primer set that probed between base pairs 525-676 only showed highly
methylated products with no difference between dwarf and wild type mice at
any age (data not shown). However, the loss of methylation at 3 months of
age corresponds with our hypomethylation data using the McrBC-qPCR
technique.

At 24 months of age, dwarf mice appear to have increased

methylation compared to wild type mice (p=0.0586).
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Figure 8. Ames dwarf mice show differences in hypomethylation and transcriptional expression of
repetitive elements that may contribute to genetic stability. Using the McrBC-qPCR technique
differences in liver genomic DNA hypomethylation of four interspersed repeats are shown for
dwarf (gray bars) and wild type mice (open bars) (left panels, n=6-8). Liver IR mRNA expression
is shown using two step RT-PCR at 3, 12, and 24 months of age (right panels, n=7-8). Mean
relative changes in expression or hypomethylation are shown ± SEM. **p<0.01.
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Figure 9. Methylation patterns of LINE1 are different in Ames dwarf mice. Ames dwarf mice
display lower methylation at 3 months of age (gray bars, p=0.0351), equivalent methylation at 12
months of age, but higher at 24 months of age (p=0.0586). Wild type mice are represented by
open bars. Mean relative changes in expression and optical densities are shown ± SEM.
*p<0.05.

DNA methylation enzyme expression is significantly affected in growth
hormone treated dwarf mice
Our next question was whether growth hormone, which also alters methionine
pathway enzymes such as GNMT, could significantly affect DNMT expression and
DNA methylation in the dwarf liver. To begin, porcine GH was administered to one
group of 5-6 month old Ames dwarf mice while saline vehicle was administered to wild
type mice and an additional group of dwarf mice as controls. Animals received GH or
saline twice daily for seven days and was replicated with a second experiment.
Growth hormone treated dwarf mice gained 3-4 grams of body weight over the course
of one week compared to saline-treated dwarf mice which is typical of this protocol
(Students t-test; Experiment1:+4.19 ± 0.06 g; p<0.0001, Experiment 2: +3.153±0.2184g,
p<0.0001, Figure 10). Wild type mouse body weights were not different pre- and post-

saline injection. Liver weights were recorded as an additional indicator of GH action
and the mean liver weights of GH injected dwarf mice were approximately 60-76%
higher than saline injected dwarf mice [Experiment 1: 0.70 ± 0.13 g and 0.44 ± 0.05 g
respectively (p<0.0001); Experiment 2: 0.60 ±0.08 g and 0.34 ± 0.09 g respectively
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(p<0.0001)]. The expression of DNMTs was compared between GH and salinetreated Ames dwarf and wild type controls. Liver DNMT1 and DNMT3b mRNA levels
were higher in saline-treated dwarf mice than saline-treated wild type mice and
increased further after GH administration (Figure 11). Transcription of DNMT3a
mRNA abundance was higher in saline-treated dwarf mice compared to saline-treated
wild type mice, and no change was observed after GH treatment.

Figure 10. Body weight is increased by one week of growth hormone injections in Ames dwarf
liver. Liver weight in grams is shown for wild type mice injected with saline (n=9-11, open bars),
dwarf mice injected with saline (n=8-11, gray bars), and dwarf mice injected with growth hormone
(n=8-12, black bars) at 5-6 months of age. One-way ANOVA for body weight p<0.0001 for both
left (Experiment 1) and right graphs Experiment 2). *p<0.05, and ****p<0.0001 using Bonferroni's
Multiple Comparison test. Bars represent means ± SEM.

Figure 11. Liver DNMT mRNA expression For DNMT1 and DNMT3b is increased upon GH
administration. Shown for wild type mice injected with saline (n=10-11, open bars), dwarf mice
injected with saline (n=10-11, gray bars), and dwarf mice injected with growth hormone (n=10,
black bars) at 5-6 months of age. mRNA expression is normalized to β2- macroglobulin. Oneway ANOVA for DNMT1 p=0.0054, for DNMT3a p=0.1202, and for DNMT3b p=0.0129. Bars
represent means ± SEM. *p<0.05 and **p<0.01.
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We next examined DNMT protein. Protein levels of DNMT1 were significantly
lower in saline-treated dwarf than in the saline-treated wild type mice similar to our
aforementioned findings (Figure 12). However with GH treatment, protein expression
of DNMT1 increased in dwarf mice (p<0.05) though not to wild type levels. DNMT3a
protein levels were significantly decreased following GH treatment in Ames dwarf
mice (p<0.05). Yet again, transcriptional differences did not correlate with protein
expression, indicating a post-transcriptional pathway that may be influenced by growth
hormone. DNMT3b protein in growth hormone treated mice was not assessed due to
the absence of genotype differences from previous experiments between dwarf and
wild type mice.

Figure 12. DNMT protein expression is susceptible to growth hormone treatment in Ames dwarf
mouse liver. One-way ANOVA for DNMT1 protein p=0.0021 and for DNMT3a protein
p=0.0367(n=5-8). *p<0.05 and **p<0.01 using Bonferroni's Multiple Comparison test. Bars
represent means ± SEM.

DNA methylation enzyme expression is significantly altered in hepatocytes
following growth hormone treatment
For in vitro study of GH administration effects on DNMT protein expression, we
isolated hepatocytes from 4-6 month old mice and treated them for 24 hours with
different concentrations of porcine GH growth hormone (Figure 13). For this study
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our goal was to demonstrate and verify that the in vitro hepatocytes reflected the in
vivo results for future pathway studies of DNMT regulation that remain to be
elucidated. Significant differences were detected for DNMT1 due to increasing GH
concentrations in dwarf (p=0.0026) and wild type (p=0.0014) mouse hepatocytes.
Ames dwarf mice showed a significant increase in DNMT1 protein expression
following 1.0 and 10µg of GH per plate compared to a media only control. Though
the higher concentration of GH (20 µg) also showed visibly greater protein
expression, only 2 samples were present for quantification and thus statistically
difficult to compare. Protein expression of DNMT1 in hepatocytes from wild type
mice did not show a significant increase compared to a media only control until a
dose 10 times higher than that used in dwarf mice (10 µg GH per plate). The levels
of DNMT3a protein were decreased in primary dwarf hepatocytes following GH
treatment (One-way ANOVA, p=0.0464) independent of GH concentration. Wild
type hepatocytes showed little to no protein expression of DNMT3a and no
difference following GH treatment that could be quantified by our methods.

Figure 13. Ames dwarf hepatocytes are more sensitive to growth hormone treatment which alters
DNMT expression. DNMT1 expression in wild type (One-way ANOVA,p=0.0014) and dwarf (Oneway ANOVA,p=0.0026) hepatocytes with increasing concentrations of growth hormone (0,
0.1,1.0, 10, and 20 µg/ml). DNMT3a expression in dwarf (One-way ANOVA, p=0.0464)
hepatocytes with increasing concentrations of growth hormone (0, 0.1, 1.0, 10, and 20 µg/ml).
DNMT3a not present in wild type hepatocytes.*p<0.05 and **p<0.01 using Dunnett's Multiple
Comparison Test to a media only control. Error bars represent means ± SEM.
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Since growth hormone appears to affect DNMT expression, we were
interested to see if the altered expression of methylation mechanisms could
affect global methylation. Thus, we next examine global DNA methylation by the
same ELISA colorimetric methods as described for the cross-sectional studies
(Figure 14). Dwarf mice treated with growth hormone for one week lost
approximately 15% of global DNA methylation. Because of the dramatic loss of
methylation we next asked whether growth hormone administration could disrupt
the methylation of interspersed repeats observed in many methyl-deficient diets
which affect the methionine pathway.

Figure 14. Growth hormone administration alters global DNA methylation in dwarf mice.
Methylated cytosine by ELISA-based colorimetric assay shown for wild type mice injected with
saline (n=10-11, open bars), dwarf mice injected with saline (n=10-11, gray bars), and dwarf mice
injected with growth hormone (n=10, black bars) at 5-6 months of age (Kruskal-Wallis test,
p=0.0392). *p<0.05 using Dunn's Multiple Comparison Test. Error bars represent means ± SEM.

We used MS-PCR to examine LINE1 in dwarf mice that had been treated
with growth hormone as well as our saline injected wild type and dwarf controls
(Figure 15). We found the GH administration did not seem to alter LINE1
methylation, although there was a large amount of deviation between the means
for wild type and GH injected mice. Dwarf mice were consistent in mean
methylation to each other.
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Figure 15. Growth hormone treatment did not change methylation patterns of LINE1 in Ames
dwarf mice. LINE1 was probed with MS-PCR for wild type mice injected with saline (WT, open
bars), dwarf mice injected with saline (DW, gray bars), and dwarf mice injected with growth
hormone (DW+GH, black bars) at 4-6 months of age (One-way ANOVA p=0.6584, n=6). Mean
relative changes in expression and optical densities are shown ± SEM.

DNMT1 post-transcriptional regulation in Ames dwarf mice
A recent line of investigation observed that DDX20 (a DEAD-box helicase)
contributes to transcriptional up regulation of metallothionein 1 (MT1) and
metallothionein 2 (MT2) via the repression of DNA methylation by DNMT1.
Purportedly, DDX20 assists in pairing miRNA 140-3p with the DNMT1 mRNA
transcript and in conjunction with RISC complex, allows for either degradation of
the mRNA transcript or de-capping the mRNA transcript repressing translation
(Takata et al., 2013; van Kouwenhove et al., 2011).
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Interestingly, our lab and others showed that Ames dwarf mice express
more metallothionein protein and mRNA in liver as well as other tissues
(Amador-Noguez et al., 2004, 2005; Meyer, M.M., Swinscoe, J.C., Brown-Borg,
H.M., Carlson, 2003; L. Y. Sun et al., 2011; Swindell et al., 2010). Coupling the
high MT levels with altered DNMT1 expression in Ames mice, we investigated
the expression DDX20 and miRNA 140-3p involvement in a potential novel
regulatory pathway and whether it may be utilized by dwarf mice to repress
DNMT1 translation in the liver.

Figure 16. Liver DDX20 mRNA expression is affected by age but not genotype and DDX20
protein is more abundant in dwarf mice. Grey bars represent dwarf mice and open bars represent
age-matched wild type mice at 3, 12, and 24 months of age. For mRNA n=7-8 per group and for
protein studies n=6-10 per group. Mean optical densities are shown ± SEM. *p<0.05,

**p<0.01, and ****p<0.0001.

We first looked at DDX20 transcriptional and protein expression in dwarf
mouse liver to see if there were basal differences (Figure 16). While we found no
differences to DDX20 transcriptional expression due to genotype, our study
showed age was a significant factor for both genotypes of mice. Dwarf and wild
type mice appear to lose transcription abundance of DDX20 with age somewhat
reminiscent of GNMT mRNA levels, with a more linear loss observed in wild type
mice. The basal expression of DEAD-box helicase 20 protein levels is more
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abundant at all three age groups in dwarf mice. This correlates with the decrease
in DNMT1 abundance suggesting that this may be a potential pathway for
DNMT1 post-translational regulation. We next asked if basal expression of miR140-3p was also changed in dwarf mice and could be contributing to DNMT1
regulation (Figure 17).

Figure 17. Dwarf mice display decreased expression of miRNA 140-3p at 3 and 24 months of age
but also loss of 5S rRNA transcription at 24 months of age, compared to age-matched wild type
mice. The top left panel displays age and genotype related differences in miRNA 140-3p
expression between dwarf and wild type mice at 3 and 12 months of age, n=6-8. Using Student’s
t-test miRNA 140-3p expression is greater at 24 months in dwarf mice when normalized to 5S
rRNA (Top middle panel, n=7-8, p=0.0207) but upon validation by normalization with RNU6,
transcription of miRNA 140-3p is significantly decreased (Top right panel, n=6-8, p=0.0104).
Differences in transcription can be seen in 5S rRNA Ct values for two separate experiments
(Bottom panels, n=8, p=0.0002 and p<0.0001 respectively). . Error bars represent means ± SEM.
*p<0.05, ***p<0.001and****p<0.0001.

We utilized 5S rRNA for normalization of miRNA 140-3p as suggested in
previous literature (Bates et al., 2010). This ribosomal RNA is part of the
translational machinery of ribosomes. We found that miRNA 140-3p was
significantly decreased at 3 months and increased at 24 months of age.
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However, upon validation with another miRNA normalization transcript, U6
splicoeosomal RNA (RNU6), we showed opposing results, where miRNA 140-3p
was actually decreased, for the 24 month group dwarf only. RNU6 is a small noncoding RNA that is part of the RNA splicing machinery (spliceosome) that
processes pre-messenger RNA in the nucleus. As a result of this finding, we
investigated the normalization Ct values of 5S rRNA and found they were similar
except at one age group in one group of mice.
Our dwarf mice show decreased abundance in 5S rRNA compared to wild
type mice at 24 months of age, which is indicated by higher Ct values. We
replicated this Ct difference with a different set of 24 month old liver samples
from wild type and dwarf mice (Figure 17 Bottom panels, Experiments 1 and 2).
This is a novel finding as increased rRNA expression has been linked to a loss of
heterochromatin in drosophila (Larson et al., 2012).
DDX20 and miRNA-140 suppress DNMT1 translational repression and
affect metallothionein (MT) expression via loss of methylation in CpG regions of
the MT gene and promoter regions in hepatocytes. Ames dwarf mice exhibit
increased basal expression of MT1 and MT2. However, no age-related
differences in MT expression had been studied in the liver. Therefore, we
examined metallothionein transcriptional expression and methylation in dwarf
and wild type mice to determine age-related changes in metallothionein
expression and identify whether methylation of the metallothionein gene and
promoter region in dwarf mice correlated with increased DDX20 protein. We
observed that liver MT1 expression exhibited age-related decreases in dwarf
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mice after 3 months of age (Figure 18). However, there is an approximate 8-fold
increase in wild type transcription at 24 months of age. At 3 months of age MT1
mRNA expression is nearly 150-fold higher in dwarf mice. MT2 transcription was
not detected in the wild type liver, thus expression levels were normalized to
dwarf 3-month-old mice (Figure 18).

Figure18. Liver MT1 mRNA basal expression was higher in dwarf mice and affected by age and
genotype. MT2 was only present in dwarf mice and the linear loss is not significant. MT1 mRNA
expression for wild type (open bars) and dwarf mice (gray bars) at 3, 12, and 24 months of age
(Left panel, n=6-8). Liver MT2 mRNA expression is shown for dwarf mice (gray bars) at 3, 12,
and 24 months of age (Right panel, One-way ANOVA p= 0.1199, n=5-8).

Next we examined whether basal levels of DNA methylation in MT1 and
MT2 gene and promoter regions were different in the Ames dwarf mice
compared to wild type mice as might be expected from the higher
transcriptional rates. Since the largest difference in transcription occurred at 3
months of age, we used tissues from this age group for determining methylation
differences within predicted CpG islands of the MT1 and MT2 genes.
Using MethPrimer to predict CpG islands and primers sequences, MT1
showed a putative CpG island, including its promoter sequence, of
approximately 600 base pairs in length and thus, two sets of primers were
designed and used to maximize coverage (Table 5, Materials and Methods).
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Bisulfite treated DNA is only protected from the cytosine to uracil conversion if
the cytosine is methylated. Therefore two primer sets were designed, one set
probed for converted cytosines (unmethylated cytosines) and the other set
probed for unconverted cytosines (methylated cytosines). Coverage of the 600
base pair posited an MT1 CpG island between base pairs 177 to 328 that
showed an equivalent methylation status between dwarf and wild type mice
(p=0.4422, Figure 19, left panel). This sequence contains several transcription
factor binding sites including metal response elements a,b,c, and d (MRE) and
the metal response transcription factor 1 (MTF-1) that is responsible for an
increase in MT1 due to heavy metal stress, such as the administration of zinc.
The antioxidant response element (ARE) that is responsible for the oxidative
stress response of MT1 is also located in this area (S. R. Davis & Cousins,
2000; Majumder et al., 2002; Park et al., 2013). From base pairs 464 to 570 of
the MT1 predicted CpG island, dwarf mice exhibited decreased methylation
compared to wild type mice (Figure 19, middle panel). This sequence covers an
intergenic region between exons one and two of the MT1 gene. Metallothionein
2 has a putative CpG island between base pairs 86-395 in the MT2 gene. The
MT2 gene is highly unmethylated in dwarf and wild type mice alike (Figure 19,
right panel). Primers designed for this area showed no amplification of
methylated primer sets in both normal and dwarf mice, therefore a ratio
comparison could not be made. The area of regulation for MT2 may lie outside
the gene and promoter regions or may not be subject to methylation regulation.
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Figure 19. Three month old dwarf liver shows less methylation in MT1 at 464-570 bp of the
putative CpG island. U is the product from primers designed to probe CpGs in the same regions
that are unmethylated, M is the product from primers design to probe CpGs that are methylated.
MT1 CpG Island methylation sites from base pairs 177-328 are shown for wild type (open bars)
and dwarf mice (gray bars) at 3 months of age (Left panel, p=0.4422, n=7) and MT1 CpG Island
methylation sites from basepairs 464-570 at 3 months of age (middle panel, n=6, *p<0.05). The
right panel shows MT2 equally unmethylated (U) with no methylation (M) detected. Gels shown
are representative to the mean optical densities of methylated primer products verses
unmethylated primer products. Graphs represent mean ratios ± SEM.

Figure 20. Protein expression of DDX20 is more abundant in dwarf mice treated with growth
hormone. Liver DDX20 mRNA expression is shown for wild type mice injected with saline (WT,
open bars), dwarf mice injected with saline (DW, gray bars), and dwarf mice injected with growth
hormone (DW+GH, black bars) at 5-6 months of age (Left panel, One-way ANOVA p= 0.3490,
n=9-10). DDX20 protein expression for wild type mice injected with saline (WT, open bars), dwarf
mice injected with saline (DW, gray bars), and dwarf mice injected with growth hormone
(DW+GH, black bars) at 5-6 months of age. Mean optical densities are shown ± SEM. *p<0.05,
**p<0.01, and ****p<0.0001.
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Growth hormone administration affects DDX20, metallothionein expression
and methylation
Previously we identified differences in DNA methylation enzyme expression
following one week of growth hormone administration; therefore we queried whether
DDX20, MT1, and MT2 expression and possibly metallothionein methylation would
be affected by GH as well. Growth hormone did not appear to have an effect on
DDX20 transcription in 5-6 month old Ames dwarf mouse liver (Figure 20). Because
DNMT1 protein levels are increased due to GH administration, we expected DDX20
to decrease with growth hormone expression. However, protein levels of DDX20
unexpectedly increased significantly with GH treatment.

Figure 21. Liver miR-140-3p expression does not significantly change with GH administration.
miRNA expression shown for wild type mice injected with saline (WT, open bars), dwarf mice
injected with saline (DW, gray bars), and dwarf mice injected with growth hormone (DW+GH,
black bars) at 5-6 months of age normalized to RNU6 (Left panel, One-way ANOVA p= 0.4139,
n=8) or was normalized to 5S rRNA (Right panel, One-way ANOVA p=0.4631, n=7).

We examined transcription levels of the putative DNMT1 regulator miRNA
140-3p to ascertain whether GH administration would induce effects similar to
that observed with DDX20 protein abundance (Figure 21). We did not see any
significant effects when normalizing to U6 spliceosomal RNA (RNU6) or 5S
ribosomal RNA (5S rRNA). Similar to our 3 and 12 month old miRNA studies, Ct
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values or 5S rRNA were similar at 6 months of age in dwarf and wild type mice.
The two studies produced very similar results indicating that miR-140-3p is not
significantly changed following the administration of GH for one week.
Since DDX20 protein expression was enhanced in dwarf mice treated with
growth hormone but DNMT1 levels were also increased, we measured the
response of metallothionein expression and methylation following growth
hormone treatment (Figure 23). Transcription of MT1 and 2 was increased in
dwarf mice following one week of growth hormone injections, corresponding to
the increase in DDX20 protein.
The methylation of several heavy metal response transcription factor
binding sites including MRE-a,b,c,d, MTF-1, and ARE that are contained in the
177-328 base pair region of the MT1 CpG island, became more methylated with
growth hormone treatment. There was no significant change found in the putative
CpG island fragment between 464-570 base pairs of the MT1 gene region. There
are two binding elements for the signal transducers and activators of transcription
(STAT), one of which is shared with interleukin-6 (IL-6) a cytokine that can
induce transcription. These binding sites are located within the first 150 base
pairs of the MT1 gene, and were missed by the primer sets that probed from 166
to 570 base pairs of CpG dinucleotides we utilized in previous experiments.
Therefore we designed an MT1 STAT primer pair set to probe this region as it
may be sensitive to GH administration and thus activate the JAK/STAT pathway
(Figure 23).
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Figure 22. Growth hormone treatment increases MT1 and MT2 expression and changes
methylation patterns in Ames dwarf mice. Upper-left panel shows MT1 mRNA expression for wild
type mice injected with saline (WT, open bars), dwarf mice injected with saline (DW, gray bars),
and dwarf mice injected with growth hormone (DW+GH, black bars) at 4-6 months of age (Oneway ANOVA p<0.0001, n=9-10). Upper-right panel shows MT2 dwarf mice injected with saline,
and dwarf mice injected with growth hormone at 5-6 months of age (n=8-10). Left-lower panel
shows MT1 CpG Island: 177-328 bps methylation for wild type mice injected with saline, dwarf
mice injected with saline and dwarf mice injected with growth hormone at 5-6 months of age
(One-way ANOVA p= 0.0260,n=6-7). Lower-right panel shows MT1 CpG Island methylation for
wild type mice injected with saline, dwarf mice injected with saline, and dwarf mice injected with
growth hormone at 5-6 months of age (One-way ANOVA p= 0.6338,n=7). Mean relative changes
in expression and optical densities are shown ± SEM. *p<0.05, **p<0.01, and ****p<0.0001.

Figure 23. Panel shows two representative samples MT1 STAT binding CpG Island methylation.
Samples are ordered as follows: wild type mice injected with saline (WT), dwarf mice injected with
saline (DW), and dwarf mice injected with growth hormone at 5-6 months of age (n=6-7).
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Based on the literature, a reasonable expectation would be that methylation should
be diminished in this area at these two binding sites due to the actions of GH
(Figure 23). However, using MS-PCR techniques and primer design, methylated
and unmethylated regions were not quantifiable in relation to each other and thus
no determinations could be made about methylation status of the STAT binding
region of MT2.Even though a pattern is visually apparent when observing the
unmethylated primers of the samples in relation to each other; this result must be
validated by another technique such as pyrosequencing of the STAT binding site
regions before this difference can be substantiated as non-artifact.
Histone markers associated with aging are differentially expressed and
distributed differently in dwarf mice compared to age-matched wild type
mice
Like DNMTs, histone modification enzymes also use methyl groups from
SAM just as DNMT and therefore histone methylation marks are also subject to
methionine pathway disruptions or alterations in enzyme activities or expression.
Based on the literature we chose to examine histone methylation markers between
Ames dwarf mice and age-matched wild type mice. Methylation markers from
dwarf and wild type liver histone extracts were probed to determine the levels of
histone H3 methylation.
Two repressive markers, histone H3 lysine 9 tri-methylation (H3K9me3) and
histone H3 lysine 27 tri-methylation (H3K27me3), and one marker known for
transcriptional activation histone H3 lysine 4 tri-methylation (H3K4me3), were
measured using immunoblotting and coomassie staining (to confirm equal
loading). Interestingly, histone H3 Pan, an antibody used to determine the total
93

amount of histone 3 was much higher in liver tissue dwarf mice at three months
of age (~70%), lower at 12 months of age and was equal at 24 months of age
when compared to age-matched wild type controls (Figure 24, top three panels).

Figure 24. Histone H3 methylation and pan histone levels are expressed differently in Ames dwarf
and wild type liver tissue at 3, 12, and 24 months of age. Wild type mice represented by open
bars and dwarf mice by gray bars (n=7-10). Mean optical densities are shown ± SEM. *p<0.05,
**p<0.01, and ***p<0.001.
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Though used in many manuscripts as a loading control, total histone
H3, has been shown to change with age, and is therefore dynamic. (Larson
et al., 2012; Levine, Worrell, Zimnisky, & Schmauss, 2012). However, with
each genotype, it appears that histone H3 fluctuates more with age in wild
type mice than in dwarf mice (Figure 25).
For the transcriptionally active marker histone H3K4me3, total
abundance in dwarf mice was equivalent at 3 months of age, significantly
lower at 12 months, and higher at 24 months of age compared to agematched wild type controls. Increases or decreases of this marker through
mutations of methyltransferases or demethylases have marked effects on
lower life forms such as C. elegans and Drosophila and have been noted to
increase with aging (Han & Brunet, 2012). The repressive marker histone
H3K27me3, is connected with levels of facultative heterochromatin, and
this histone marker is purported to decrease with age (López-Otín et al.,
2013). When dwarf mice were compared to wild type mice, this marker was
observed to be decreased at 12 months of age, and significantly increased
at 24 months of age. The constitutive H3K9me3 marker is significantly
increased in dwarf mice at three months of age (~ 2 fold) only and only
slightly higher at 12 and 24 months of age. This marker decreases with
aging in worms (Berdasco & Esteller, 2012). When histone markers are
normalized to H3 pan, this exposes the distribution of histone H3 for each
genotype (Figure 26).
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Figure 25. Age-related total histone H3 expression within Ames dwarf and wild type genotypes. In
a separate experiment which compared total liver histone H3 abundance, levels appeared to
have stayed equivalent in dwarf mice over all three age groups (left panel, grey bars One-way
ANOVA p=0.7648, n=7-8) while levels increased linearly in wild type mice (right panel, open
bars, One-way ANOVA p= 0.0065, n=8). Mean optical densities are shown ± SEM, **p<0.01.

Figure 26. When normalized to H3 pan, Histone H3 methylation markers were distributed
differently in dwarf mice at different ages. Histone tri-methylation expressed as normalized to total
histone 3 for each age group, dwarf (gray bars) and wild type mice (open bars). Mean optical
densities are shown ± SEM. *p<0.05, **p<0.01, and ****p<0.0001.
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The abundance of H3 tri-methylation markers compared to total histone
H3 shows that at three months of age, dwarf mice used less total histone H3 for
the active transcription marker H3K4me3 and the facultative marker H3K27me3.
However, amounts of H3K9me3 remained similar in dwarf and wild type mice. At
twelve months of age the distribution of histone H3 to H3K9me3 was much
higher in dwarf mice whereas the other markers distributions remained similar
between genotypes. At 24 months of age, histone H3 is significantly increased in
distribution to the marker H3K4me3 in dwarf liver compared to wild type mice.

Figure 27. Histone H4 lysine 20 tri-methylation and are expressed differently in Ames dwarf and
wild type liver tissue at 3, 12, and 24 months of age. Wild type mice represented by open bars
and dwarf mice by gray bars. H4K20me3 protein expression was much higher that wild type mice
at 3 months and lower at 24 months (n=7-10,). Mean optical densities are shown ± SEM. *p<0.05
and ***p<0.001.

We also probed liver histone extracts for histone H4K20me3 markers
via immunoblotting (Figure 27). This transcriptionally repressive marker is
known to increase with age in rat liver (Sarg, Koutzamani, Helliger, Rundquist,
& Lindner, 2002). In our study dwarf mice at 3 months age had significantly
more of the H4K20me3 marker compared to wild type mice (p=0.0005).
However, at 24 months, the oldest age studied, dwarf mice had less
H4K20me3 (p=0.0389).
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Finally, in a pilot study, we examined 84 genes that included histone
methyltransferases (HMTs) and lysine demethylases (KDMs) to ascertain
possible targets for future mRNA and protein studies between dwarf and wild
type mice (n=2/genotype; Table 5). Since we saw many significant differences at
3 months of age in epigenetic expression overall, we chose to examine 3 month
old mice in this study. We observed a fold-increase of >2.5 in mRNA expression
in many histone modifying enzymes in dwarf compared to wild type mice. Lysine
demethylase 5b (Kdm5b) and histone methyltransferase Setdb2, highlighted in
Table 5, are involved in demethylation of H3K4 tri-methylation and tri-methylation
of H3K9, respectively. Both proteins have the potential to be repressors of
transcription if more abundantly expressed at the translational level and are thus
potential targets that help to explain our results in Figure 24.

Whether GH

modulates these enzymes, as suggested by the genotype differences, remains to
be determined.
Table 5: Histone modification enzymes
Gene
Symbol
Ciita
Kat2a
Ncoa6
Hdac4
Kdm5b
Prmt7
Setd6
Setdb2
Nek6
Dzip3
Mysm1
Ube2a

Function
Acetylation
Acetylation
Acetylation
Deacetylation
Demethylation
Methylation
Methylation
Methylation
Phosphorylation
Ubiquitination
Ubiquitination
Ubiquitination
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Fold-change (Dwarf/Wild
type)
2.65
2.59
3.74
2.98
2.91
2.70
2.83
3.20
2.74
2.89
2.86
2.86

DNA methylation enzymes are differentially expressed in other mutant
mouse models with deficient or excessive GH signaling
To further explore the role of GH signaling, we examined another GH
signaling mutant, the GHRKO mouse and the GH Tg mouse that exhibits an
excess of GH signaling. These mice show respective increases and decreases in
lifespan related to the absence or excessive GH signaling. This makes them very
useful to our studies to elucidate any differences or similarities in epigenetic
methylation or mechanism expression.

Figure 28. GHRKOmice show no genotypic difference in global DNA methylation compared to
wild type mice. GHRKO represented by open bars and wild type mice by open bars (n=7-12).
Percentage methylation was derived using control and sample optical densities, which were then
normalized to 3 month wild type mice± SEM.

To see if overall DNA methylation was different between the two strains we
performed the same colorimetric assay that was used for the dwarf line in a
cross-sectional study. GHRKO mice at ages 3, 12, and 24 months were used
along with their age-matched wild type counterparts. These mice exhibit high
plasma levels of GH but are unable to respond to it due to a mutation in the GH
receptor gene. We first studied global DNA methylation and interspersed repeat
methylation to detect any similarities or differences with Ames dwarf mice (Figure
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28). GHRKO mice showed no genotypic differences in global methylation,
whereas dwarf mice tended to have high levels of methylation consistent across
all three age groups (Figure 7). Our data also suggested age might be a factor
(p=0.0870), but we were limited by sample size in the 24 month old group (n=7)
at the time of this study. To probe for possible differences in interspersed repeat
expression and methylation across age groups and genotype, we applied the
McrBC-qPCR technique and measured hypomethylation of the repetitive
elements IAP-LTR, LINE1, SINE B1, and SINE B2 (left panels, Figure 29).
Similar to our observations in dwarf mice versus wild type mice, GHRKO mice
also show some resistance to the hypomethylation of IAP-LTR. Age-related
differences were also apparent (Figure 29, p=0.0691). In LINE1 there were
genotype effects, especially at 24 months of age, and age effects of
hypomethylation were observed however a significant interaction was detected
that confounds the main effects. The wild type in this strain of mouse shows a
large pattern of hypomethylation over age that was not observed in the Ames
dwarf wild type mice and therefore could be influenced by genetic background.
There

was

a

significant

interaction

between

genotypes

and

age

in

hypomethylation of SINE B1 in GHRKO and wild type mice. SINE B2 was only
affected by age and not genotype, as these elements became hypomethylated in
both genotypes. Similar to dwarf mice, there is higher transcription of IAP-LTR at
three months of age that is significant between GHRKO mice compared to their
wild type counterparts (Figure 29, right panels). The transcription of LINE1 is
affected independently by both age and genotype.
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Figure 29. GHRKO mice show differences in hypomethylation and transcriptional expression of
repetitive elements that may contribute to genetic stability. Using the McrBC-qPCR technique
differences in liver genomic DNA hypomethylation of four IRs are shown for GHRKO(gray bars)
and wild type mice (open bars, left panels, n=6-8). Liver IR mRNA expression is shown using two
step RT-PCR at 3, 12, and 24 months of age (right panels, n=6-8). Mean relative changes in
expression or hypomethylation are shown ± SEM. *p<0.05 and **p<0.01.
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Overall, transcription in the GHRKO mouse is higher compared to wild type mice.
For the dwarf mouse strain, primarily age effects were seen for the crosssectional study. SINE B1 transcription is significantly higher for GHRKO mice at
both 12 and 24 months of age, for Ames dwarf mice, this increased transcription
was only significant at 24 months of age. No age-related differences in SINE B1
were observed in the GHRKO but genotype significantly affected transcription.
SINE B2 also showed age-related changes in the GHRKO strain, similar to the
Ames dwarf strain, although the transcriptional profile is different. Ames dwarf
mice along with their wild type siblings present a consistent u-shaped
transcriptional profile between the ages of 3, 12, and 24 months whereas
GHRKO mice do not.

Figure 30. DNMT1 and DNMT3a mRNA expression are higher GHRKO mice at 12 months of
age. Liver DNMT mRNA expression is shown for wild type (open bars) and GHRKO (gray bars) at
3, 12, and 24 months of age (n=5-8) for DNMT1, DNMT3a, and DNMT3b. Mean relative changes
in expression are shown ± SEM. **p<0.01.

Twelve month old GHRKO mice exhibited alterations in transcriptional
levels of GNMT and other methionine related enzymes, thus we measured the
cross-sectional DNMT expression to determine if there were genotype
differences in transcription between GHRKO and wild type mice (Brown-Borg et
al., 2009). The results in Figure 30 show that DNMT1 and DNMT3a gene
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transcription is higher at 12 months of age in the GHRKO mutant mice compared
to wild type mice of the same age. Similar to Ames dwarf mice, DNMT3b
expression was not different between genotypes, but was impacted by age in this
strain of mouse. However, it is interesting to note that while DNMT3b
transcription seems to increase with age in the Ames dwarf line, the expression
in the GHRKO strain decreases with age, demonstrating the importance of the
genetic background of our mice on epigenetic mechanisms.

Figure 31. Liver DNMT mRNA expression For DNMT1 and DNMT3a is increased upon IGF-1
administration in GHRKO mice. Shown for wild type mice injected with saline (n=7-9, open bars),
GHRKOmice injected with saline (n=7-9, gray bars), and GHRKOmice injected with IGF-1 (n=8-9,
black bars) at 4-6 months of age. One-way ANOVA for DNMT1 p=0.0056, for DNMT3a p=0.0026,
and for DNMT3b p=0.0009). Bars represent means ± SEM. p<0.05 and **p<0.01.

GHRKO mice express growth hormone but lack a functional receptor,
therefore secretion of IGF-1 from the liver is absent. This strain of mouse allows
the unique opportunity of identifying and observing potential independent effects
of IGF-1 apart from GH. We therefore decided to measure DNMT transcriptional
expression in GHRKO mice that have been administered IGF-1 in the same
manner we studied GH in Ames dwarf mice. These mice were also treated at 4-6
months of age. Interestingly, DNMT1 displayed a small increase in transcription
in IGF-1 treated GHRKO mice which without treatment, already showed a greater
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mRNA levels compared to age-matched wild type mice at 6 months of age. This
finding is similar to that observed in GH injected dwarf mice. DNMT3a
transcription, was increased in GHRKO mice, was further elevated by IGF-1
administration, whereas in dwarf mice it was not affected by GH. Surprisingly, at
6 months of age, GHRKO mice expressed less DNMT3b mRNA compared to
wild type mice and these levels remained unaltered with IGF-1 treatment. In
comparison to dwarf mice DNMT3b was more highly expressed basally, and
increased even more with GH administration.

Figure 32. GH Tg mice show a genotypic difference in global DNA methylation compared to wild
type mice at 10 months of age. GH Tg mice are represented by black bars and wild type mice by
open bars (n=7-12). Percentage methylation was derived using control and sample optical
densities, which were then normalized to 3 (left) or 6 (right) month wild type mice± SEM.

Growth hormone transgenic mice (GH Tg) are an excellent model to study
the overexpression of GH in vivo on epigenetic mechanisms. Growth hormone
transgenic mice express approximately 20-50 fold more growth hormone
measured by radioimmunoassay compared to wild type control mice (Sotelo et
al., 1998). GH Tg mice also express more premature aging phenotypes which
are readily apparent as early as 6 months of age and live approximately half as
long (12 months) as their wild type counterparts (Steger et al., 1993; Steger et
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al., 1994). We were interested in evaluating epigenetic differences in GH Tg mice
compared to their wild type counterparts. Because GH Tg mice exhibit excessive
liver tumors at 12 months of age, which is near median lifespan, we chose to
study these animals at earlier ages (3, 6, and 10 months). Unlike the Ames dwarf
and GHRKO mouse assays, assays were not pooled due to excessive variability
between 3 and 6 month and 6 and 10 month assays. The mean raw absorbance
values for the 6 month wild type mice used in the first assay were
0.1882±0.01240, and the same wild type samples measured 0.1386±0.0092 for
the second assay (p= 0.0123, Student’s t test). We saw no real differences
between genotype, although there was a potential age-related difference (Figure
32). However, at 10 months of age, GH Tg mice exhibited significantly increased
amounts of global DNA methylation in liver tissue when compared to wild type
mice, suggesting a large shift in methylation enzyme activity. The assay between
6 and 10 months also showed a potential age difference between the two groups,
but effects of age and genotype were interacting confounding any independent
effects.
We next studied the hypomethylation of GH Tg mice in interspersed
repeats probing for possible genetic instability as we had in dwarf and GHRKO
mice

(left

panels,

Figure

33).

Whereas

there

were

lower

levels

of

hypomethylation in dwarf mice and similar levels in GHRKO mice at 3 months of
age, compared to their respective age-matched controls, GH Tg mice start out
with more hypomethylation, which is essentially less methylation, of these
elements in young adulthood.
105

Figure 33. GH Tg mice show differences in hypomethylation and transcriptional expression of
repetitive elements that may contribute to genetic stability. Using the McrBC-qPCR technique
differences in liver genomic DNA hypomethylation of four IRs are shown for GH Tg (black bars)
and wild type mice (open bars) (left panels, n=6-8). Liver IR mRNA expression is shown using
two step RT-PCR at 3, 12, and 24 months of age (right panels, n=7-8). Mean relative changes in
expression or hypomethylation are shown ± SEM. **p<0.01.
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This genotype difference appears linear with age and approaches
significance (p=0.0575) whereas age is not seen as a factor possibly due to the
loss of differences seen in the wild type mice which age normally. In LINE1
elements GH Tg mice are surprisingly stable in methylation, while in wild type
mice a significant increase in hypomethylation of this element is detected at 6
months of age. However, genotype differences are confounded by interactions
with age effects even though age itself as a factor was not significant. SINE B1
did not show significant changes in methylation due to genotype or age. SINE B2
showed a marked difference of hypomethylation in this strain of mouse shared
between the GH Tg mutants and wild type counterparts which was dependent on
age, nevertheless, there were interactions between the factor approaching
significance (p=0.0671).
We also examined transcriptional differences in the four repetitive
elements (right panels, Figure 33). Interestingly, whereas the longer lived mutant
mice tended to show more transcription of IAP-LTR at 3 months of age, GH Tg
mice had similar transcription until 10 months of age. At this older age
transcription dropped noticeably in the GH Tg mice. There were no differences in
transcription attributable to age in these mice, but an interaction between age
and genotype was apparent. For the interspersed repeat, LINE1, transcription
was lower at 6 and 10 months in the GH Tg mice compared to their wild type
controls. This contrasted with our other mouse lines where dwarf mice were
similar in expression and GHRKO mice had increased transcription in LINE1.
Also the GH deficient mutant strains showed age-related differences in
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expression, whereas this line does not. Still, it must be noted that these studies
are at relatively young ages for the normal mice of this strain, which may have to
be studied more thoroughly at a later date for comparison in age to other strains.
Transcription of SINE B1 did not show any differences attributable to genotype,
as had been seen previously in both GH deficient signaling strains where
transcription

was

increased

and

age-related

differences

in

expression

approached significance (p=0.0678). In the repetitive element, SINE B2, we did
not observe age or genotype related differences in mRNA expression.

Figure 34. DNMT3b mRNA expression was higher in GH Tg mice at 3 months of age. Liver
DNMT mRNA expression is shown for wild type (open bars) and GH Tg mice (black bars) at 3,
12, and 24 months of age for DNMT1, DNMT3a, and DNMT3b (n=6-8). Mean relative changes in
expression are shown ± SEM. ****p<0.0001.

We evaluated DNMT transcription in GH Tg mice at 3, 6, and 10 months in
a cross-sectional study, similar to our GH signaling deficient mouse strains with
their age-matched wild types. For DNMT1 there were no genotype differences in
transcription, in contrast to our previous experiments in GH signaling deficient
mice. DNMT3a however showed significant genotype differences in transcription
with higher levels overall in the GH Tg mice at any particular age. Age-related
effects were not seen for this transcript. However, in stark contrast to both GH
signaling deficient genotypes, DNMT3b transcription was approximately 2-fold
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higher in GH Tg mice at 3 months of age. Age and genotype effects were
significant along with a significant confounding interaction between the two
factors. We completed our studies with some preliminary data on DNMT protein
expression in GH Tg mice versus their wild type counterparts. Interestingly,
DNMT1 expression is decreased in GH Tg mice at 10 months of age, DNMT3a
expression lower in GH Tg mice at every age compared to age-matched wild
type mice, and DNMT3b remains to be probed.

Figure 35. DNMT protein levels are expressed differently in GH Tg and wild type liver tissue at 3,
6, and 12 months of age. Wild type mice are represented by open bars and GH Tg by black bars.
DNMT1 protein expression was much lower than wild type mice at 10 months (n=5-6, p=0.004).
DNMT3a protein was significantly Lower in GH Tg mice at 3 months (n=5-6, p=0.0007), at 6
months (n=5-6, p=0.0397) and lower in GH Tg mice at 24 months (n=8, p=0.0172). DNMT3b
protein was not different between the genotypes at 3 months (n=10, p<0.4000), 12 months (n=1112, p=0.6244) or 24 months (n=9-10, p=0.5621). Mean optical densities are shown ± SEM.
*p<0.05, **p<0.01, and ***p<0.001.
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Thus for each parameter evaluated in the GH Tg mice epigenetic markers,
mechanisms, and elements contrast with expression and methylation observed in
the GH signaling deficient mice. These findings suggest that GH signaling
pathways influence DNA methylation patterns and the expression of epigenetic
methylation mechanisms.
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CHAPTER IV
DISCUSSION
The main hypothesis of this study was that long-living Ames dwarf mice
exhibit differences in epigenetic mechanisms and markers, specifically DNA and
histone methylation. The rationale supporting this hypothesis was that Ames
mice have an altered methionine pathway that is known to contribute to
epigenetic processes. Ames mice are GH-deficient and GH has been shown to
affect expression of components of methionine metabolism. The second part of
this hypothesis was that these alterations in epigenetic markers lead to increased
genetic and epigenetic stability in dwarf mice. Evidence in the literature
consistent with our findings will be discussed. The epigenetic patterns
established in the dwarf appear to remain highly stable through the dwarf life
span, protect the DNA from damage, reduce transcriptional noise, and participate
in an altered pattern of gene expression that resists damage and diseases
associated with aging, favoring the longevity of Ames dwarf mice. This is a novel
hypothesis since as to date, the preponderance of epigenetic studies and
seminal literature has been studied in diseased or pre-disease states. This
dissertation lays essential foundational groundwork to elucidate the epigenetic
markers and mechanisms that promote longevity and disease resistance, and
111

how the master hormone, growth hormone, a chiefly metabolic regulator, can
drastically affect methylation modifications in the epigenetic landscape.
The first aim of our study was to examine age-related and genotype
differences in DNA methylation enzymes and global DNA methylation and
differences of transposable element methylation and expression that could
contribute to genetic stability in Ames dwarf mice compared to wild type mice.
GNMT expression affects DNA methylation so we examined whether GNMT
expression was positively correlated with DNMT epigenetic enzyme expression
in a cross-sectional aging study (Martínez-Chantar et al., 2008; Rowling et al.,
2002; Y. Wang et al., 2011). Activation or suppression of the GNMT enzyme has
been implicated in many studies involved in global DNA methylation changes.
We also studied whether this potential competitor for methyl groups changed
expression with age. We found while GNMT mRNA expression was age-related
in dwarf and wild-type mice, our data did not suggest any correlative relationship
to DNMT mRNA expression. Then we examined the abundance and activity of
DNMT protein between three age groups, and global abundance of DNA
methylation. We found less DNMT1 protein expression in Ames dwarf mice
compared to wild type controls and also that DNMT3a protein expressional
differences in dwarf mice were reflected in overall DNMT activity levels. Next we
evaluated transposable elements (IAP-LTR, LINE-1, SINE B1, and SINE B2)
whose hypomethylation or expression is thought to affect transcriptional function
and genetic stability as it relates to aging (Asada et al., 2006; Valentina Bollati et
al., 2009; Gentilini et al., 2012; Jintaridth & Mutirangura, 2010; Mustafina, 2013).
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In these repetitive areas we found interesting differences due to genotype and
age when studying Ames dwarf mice versus their wild type counterparts. We also
employed another technique to investigate the differences found in LINE-1
between the two genotypes at different ages.
Our second aim was to establish whether growth hormone administration
to a GH deficient mouse model (Ames dwarf) affected DNA methylation and the
enzymatic mechanisms responsible. We have looked on a global scale to define
major differences in possible GH regulation of epigenetic methylation processes.
A sub-aim was to validate the use of primary hepatocyte culture for specific
pathway studies by testing whether dwarf mice showed any alterations in DNMT
signaling at the hepatocyte level similar to the in vivo results. We found that
hepatocyte primary cultures reflected the differences seen in expression in the in
vivo experiments.. In addition, we explored one possible and novel pathway of
DNMT post-transcriptional regulation that has been very recently introduced and
never studied in the context of a longevity mouse model as an additional sub aim
based on our findings and whether it was modulated by GH administration.
For our third aim, we characterized basal histone methylation marker
differences in a cross-sectional study between Ames dwarf and age-matched
wild type mice and identified possible histone modification enzyme targets for
future study. Our final aim consisted of characterizing other mutant mouse strains
with altered GH signaling. Within this aim, we utilized the Laron dwarf or growth
hormone receptor binding protein knockout mouse and the GH transgenic
mouse. This allowed us to identify possible similarities between longevity models
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(Ames dwarf and GHRKO mice) and a short-lived premature aging model (GH
Tg mice), and further establish the potential role of growth hormone in processes
affecting the expression of epigenetic markers and in epigenetic stability.
Specific Aim 1- To examine GNMT, DNMT expression, DNMT activity, and
global DNA methylation cross-sectionally in Ames dwarf and age-matched
wild type mice
Several lines of long-living mice display deficiencies in growth hormone or
growth hormone signaling (Brown-Borg, 2009). Growth hormone influences the
methionine pathway by decreasing the expression and activity of several
enzymes,

including

methionine

adenosyltransferase

and

glycine-N-

methyltransferase, which promote the production of S-adenosylmethionine and
S-adenosylhomocysteine, respectively. Glycine-N-methyltransferase is the most
abundant protein in the liver, about 1% of total protein, and facilitates the
conversion of SAM to SAH. Thus, GNMT is a major regulator of SAM in the
liver(Yeo & Wagner, 1994). S-adenosylmethionine is the major methyl donor for
most methyltransferase reactions in cells. While many methyltransferases,
including DNMTs, are negatively regulated by rising SAH levels, GNMT is
thought to regulate DNMT by an unknown mechanism (Wang, Tang, Chen,
Chen, & Chiang, 2011). Previously, we showed that GNMT activity decreased
between 3 and 12 months of age in Ames dwarf mice (Holly M Brown-Borg et al.,
2005). In our first aim, we investigated cross-sectional GNMT expression in both
genotypes, looking for age-related differences, and expanded our findings to
include protein levels. We found age-related decreases in GNMT mRNA
expression in both genotypes and confirmed increased GNMT gene expression
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in dwarf mice at all three age groups, most significant at 3 and 12 months of age,
in comparison to wild type mice (Figure 1). Protein levels of GNMT were
significantly elevated in dwarf mice (12 months) therefore, our GNMT expression
relates well with current literature and known GNMT activity level differences
between dwarf and wild type mice (Brown-Borg et al., 2009; Holly M Brown-Borg
et al., 2005)
To determine if alterations in DNMTs were associated with GNMT
expression, we examined DNMTs in liver tissue of GH-deficient dwarf and normal
age-matched wild type mice (Figure 2 and 4). Interestingly, all three known
catalytically active DNMTs (1, 3a, and 3b) showed a significant difference in agerelated transcriptional expression but did not correlate with the linear decrease
exhibited in GNMT mRNA expression. Though in dwarf mice, DNMT1 and 3a
expression was significantly higher at 3 months of age and decreased thereafter.
In both genotypes, the lowest levels of DNMT mRNA were observed at 12
months of age with a subsequent increase at 24 months, indicating a u-shaped
pattern of age-related expression. In dwarf mice, the highest levels of DNMT1
and DNMT3a were expressed in the youngest mice. Consequently, the
expression of methyltransferases may be related to aging in both long-living and
normal mice.
The elevated DNMT transcription in 3-month-old dwarf mice is a novel
finding. Compared to the present literature, very few studies have reported agerelated differences in murine DNMT expression. Similar to our findings, DNMT1deficient mouse T cells showed a decrease in DNMT1 transcriptional expression
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with age (Ray et al., 2006). However this landmark study used histone H4 as the
normalizing transcript to rule out increased cellular proliferation skewing the
findings. We also tested H4 in comparison to our normal standardization
transcript β2m to see if cellular proliferation could have influenced our results
(Figure 3). We found that alteration of cellular proliferation was not a factor in our
results and therefore β2m was used for normalization of all DNMT transcription
between mice. Folate and methyl-deficient diets altered methionine metabolism
in rats that, in turn, also decreased DNMT1 and 3a gene expression with age
(Ghoshal et al., 2006). This evidence corroborates a link between DNMT
transcription, the methionine pathway, and age-related expression of DNMTs.
To determine if DNMT transcription was predictive of DNMT protein
abundance, immunoblotting for all three DNMT families was implemented. Liver
protein levels of DNMT1 in dwarf mice were much lower than in their wild type
counterparts at every age examined, even though transcriptional expression was
significantly higher in the dwarf (Figure 4). These particular protein assays were
designed to detect primarily genotype differences and maximize sample numbers
thus; age-related differences were ascertained later in a different experiment
(Figure 5). DNA methyltransferase 3a protein expression in our cross-sectional
study also yielded novel results. At 3 months of age, dwarf mice had
considerably more of this enzyme (almost 2-fold), but equivalent amounts as wild
type mice at 12 months of age. Also at 24 months of age, dwarf mice had
approximately half of the amount of protein expressed compared to age-matched
wild type counterparts. In previous literature, a comparison between long-living
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(C57Bl/6) and short-living (DBA2J) mouse strains indicated that liver DNMT1
decreased in both lines when fed a lipogenic methyl-deficient diet but the longer
living C57Bl/6 mice showed higher liver DNMT3a protein levels. High levels of
DNMT3a were thought to be protective against the more pronounced
demethylation of repetitive elements observed in the DBA2J thereby protecting
epigenetic stability (Pogribny et al., 2009). Additionally, ablation of DNMT3a in
the nervous system of mice causes shortened lifespans even though at birth they
appear healthy and similarly shortens the lifespan of conditional K-ras knockout
mice (Gao et al., 2011; Nguyen et al., 2007). Our results in addition to previous
literature suggest that DNMT3a may be important to longevity and aging.
Our studies also included DNMT protein expression of DNMT1 and
DNMT3a within each genotype to determine age related-differences. Reoptimization of both protein amounts and antibody concentrations was
conducted based on our previous finding that DNMT1 protein expression was
extremely low in dwarf mice. We observed DNMT1 protein expression
increases in both genotypes with age although the change across the three
age groups was statistically more dramatic in dwarf mice (Figure 5). DNA
methyltransferase 3a levels increased in wild type mice with age and
decreased in dwarf mice. However the constraint in sample numbers per gel
(n=8) may have undermined any statistical significance for this enzyme.
Mutant mice deficient in DNMT1 expression showed no detriments or benefits
to longevity (Ray et al., 2006). DNMT1 deficient mice exhibited delayed
autoimmunity due to aging. They also exhibited protective effects from cancer
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or

exhibited a higher incidence of cancer compared to wild type mice

depending on the organ studied (Ray et al., 2006). Therefore, DNMT1 does
not appear to have any independent effects in regards to lifespan. In totum,
our data indicates that DNMT3a levels in young mice may indeed be
protective but expressed later in life may be detrimental, thus DNMT3a protein
abundance during aging may correlate with longevity.

Whether the lower

expression of DNMT1 is required for this action still remains to be verified.
Finally, whether Ames dwarf mice exhibit low DNMT1 in other tissues remains
to be studied but because methylation enzymes and global DNA methylation
changes with age are tissue specific, we suspect that DNMT1 and DNMT3a
differences will be tissue-specific in our animals as well (Maegawa et al.,
2010).
In general, DNMT1 is considered the main DNMT expressed in adulthood
(and somatic cells) and is responsible for maintaining DNA methylation therefore,
it is considered the largest contributor to DNMT activity. Overall, liver DNMT
activity was comparatively higher in the young and lower in old dwarf mice
compared to age-matched controls (Figure 6). The pattern of activity in dwarf
mice may be significantly affected by the contribution DNMT3a since DNMT1
protein is present at markedly lower levels in dwarf mice. Increased DNMT
activity has been widely associated with hepatocellular carcinoma, loss of GNMT
expression, and methyl-deficient diets (Y. Wang et al., 2011). However, tumor
initiation and progression are controlled by the magnitude and timing of DNMT
protein expression changes that can cause substantial alterations in the disease
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phenotype (Gao et al., 2011; Kinney et al., 2010; Yamada et al., 2005).

A

diminished level of DNMT activity concomitant with high GNMT expression in
dwarf mice during old age might delay cancer and aging in dwarf mice in
comparison to wild type mice. It is also possible that DNMT activity is under
greater inhibition in the liver of 24-month-old dwarf mice due to higher SAH
levels. Nonetheless, in young dwarf animals, increased DNMT3a may override
SAH inhibition and GNMT competition for SAM in the liver allowing greater
DNMT activity. From another perspective, early life over-expression of DNMT3a
(before and during 3 months of age) may set up a more stable methylation
pattern for many genes which are maintained and become larger in magnitude
with age, as some research demonstrates, regardless of DNMT protein or activity
changes later on (Takasugi, 2011).
Global methylation was also examined in Ames dwarf mice to
determine the impact DNMT expression may have on the global DNA
methylation landscape (Figure 7). According to current literature, increased
DNMT activity in the liver due to methyl-deficient diets can lead to global
DNA hypomethylation, whereas, in hepatocellular carcinoma cells, the
administration of glucose and insulin can increase DNMT activity and global
methylation.

The induction of GNMT expression has opposite effects

(Chiang et al., 2009; Pogribny et al., 2004; Wang et al., 2011). Ames dwarf
mice retain high insulin sensitivity, high GNMT expression, and low levels of
DNMT1 throughout aging, making it difficult to predict whether these mice
would show any difference in global methylation in the liver. In addition,
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through earlier work, we found no differences in DNA methylation between
18-month-old Ames dwarf and wild type mice (Uthus & Brown-Borg, 2003).
In this cross-sectional study, DNA methylation in Ames mice was similar or
higher than that observed in wild type mice at all three ages (Figure 9;
Armstrong, et al., 2013). Wild type mice exhibited a u-shaped pattern in
global DNA methylation comparable to their DNMT transcription; however,
overall DNA methylation in dwarf mice remained relatively stable. Consistent
with the earlier study using 18 month old mice, the older 24-month-old
groups did not show any difference between genotype. Also our methylation
results showing approximately 16% more methylation in dwarf mice at 12
months of age was consistent with Snell dwarf global methylation
measurements at 9-12 months of age (Armstrong et al., 2013; Vitvitsky et al.,
2013). Snell dwarf mice are phenotypically identical to the Ames dwarf but
have a single nucleotide mutation in pit-1. This gene is a transcript acting
downstream of prop-1 (the mutation in Ames dwarf mice) which is also
responsible

for

the

development

of

somatotropes,

lactotropes

and

thyrotropes in the anterior pituitary. Snell dwarf mice also do not secrete
thyroxin stimulating hormone, prolactin, or growth hormone, and live longer
than their wild type counterparts similar to dwarf mice (Bartke et al., 2001).
Therefore, the similarity of global methylation between the two dwarf
populations at similar ages are strong validation for our results, and suggests
that these results are independent of background strain.
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We did not see a linear progression in hypomethylation in this
particular strain of mice, which has a heterogenous background, contrary to
many laboratory strains. In a widely cited landmark study, C57Bl/6 mouse
liver was shown to lose DNA methylation with age using a linear model
(Wilson, Smith, Mag, & Cutler, 1987). However, in that same study older
mice showed large variations in methylation measurements after 20 months
of age. In addition, another report within the same timeframe found a ushaped pattern of global methylation using a different technique in the same
strain of mice indicating that methylation in the liver does not necessarily
decrease in a linear fashion with age (Singhal et al., 1987). Despite the
contradiction in studies that may be due to murine strain background, the
main finding of this study is that dwarf mice appear resistant to age-related
methylation changes due to age compared to wild type mice.
DNMT1 is required for the activity of de novo methylation of repetitive
elements that make up a large part of murine and human DNA (Liang et al.,
2002). This, as stated earlier, is important to the maintenance of genetic stability
that occurs with retroviral transcription and possible transposition. We
investigated whether the genotype differences discovered in our study contribute
to epigenetic stability as postulated (Figure 8). Also, studying retroviral element
methylation may give a different picture of the methylation landscape since LTRs
and LINEs are found in gene poor regions (rich in A-T sequences) and SINEs are
found in gene rich regions (higher frequency of C-G sequences) (Tomilin, 2008).
Many of these repeats are expressed during embryonic development and
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reduced in expression during induced differentiation (Martens et al., 2005;
Tomilin, 2008). This indicates they could play a regulatory role even though the
functions are unknown. Interestingly, we found differences in the methylation
status of IAP-LTR, LINE-1 and SINE B2 between dwarf and wild type mice due to
age and/or genotype (some differences were nearly statistically significant). We
also found transcription of all four retroviral elements to be affected by age but
found genotype differences only in SINE B1 transcription. Particular transcripts of
the IAP retroviral element have been known for some time to increase with aging
in mice and become hypomethylated with age in different mouse strains and from
methyl-deficient diets (Dupressoir, Puech, & Heidmann, 1995; Mays-Hoopes,
Brown, & Huang, 1983; Pogribny et al., 2009). We found that the IAP-LTR of wild
type mice was hypomethylated with age relative to the Ames dwarf, and
remained less methylated with age. Interestingly, dwarf mice regain some
methylation at 24 months of age. Age and genotype are independent factors that
significantly influence the methylation of this transposable element. Transcription
of IAP-LTR, which by earlier studies was thought to be induced by
hypomethylation, did not correlate with methylation loss or gain. In fact, we
observed the u-shaped transcription expression remarkably similar to DNMT
mRNA expression in all of our retroviral elements for both wild type and dwarf
mice. Transcription of IAP-LTR was higher in dwarf mice at 3 months of age,
though not statistically significant, and was definitively influenced by age for both
genotypes.
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LINE-1 is the most abundant transposable element in the murine and
human genome (Han, Szak, & Boeke, 2004; Waterston et al., 2002). Increased
LINE-1 expression or hypomethylation with age have been noted in several
studies across many species and disease states including rats, mice, humans,
hepatocellular carcinomas, and methyl deficient diets (Asada et al., 2006;
Pogribny et al., 2009; Takai, Yagi, Habib, Sugimura, & Ushijima, 2000). LINE-1
also plays a role in cellular senescence (Baker & Sedivy, 2013). However, agerelated LINE-1 hypomethylation in human studies has had mixed results and
more recent studies have found Alu repeats are better markers of age-related
hypomethylation (Valentina Bollati et al., 2009; Langevin et al., 2011). LINE-1
hypomethylation in our Ames dwarf mice or their wild type controls did not show
age-related statistical differences. Genotype differences come close to
significance, with more hypomethylation being present in dwarf mice at 3 and 12
months of age using a methylation restriction PCR technique (McrBC-qPCR)
(Figure 8). When LINE-1 was further investigated through methylation specificPCR, in which more than one primer set can be designed for better coverage of
the 5’ UTR region, we found that one area from 150-324 base pairs of this region
was significantly less methylated, at three months of age (Figure 9). Also this
area of LINE-1 showed nearly equivalent methylation at 12 months of age, and
more methylation at 24 months of age in dwarf mice. This validates the changes
seen at 3 months in the dwarf mice through McrBC-qPCR. It appears for dwarf
mice LINE-1 methylation is age-related possibly indicating better maintenance of
methylation in gene poor regions in old age. LINE-1 transcription has been
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observed to disrupt genome stability, transcription, and translation in other
human and mouse cell types from aging, cellular senescence, or age-related
diseases (De Cecco et al., 2013; Han et al., 2004; Muotri et al., 2010; Neidhart et
al., 2000; Oricchio et al., 2007). However, as in IAP-LTR transcription, LINE-1
transcription did not appear to be regulated by methylation and changed with age
similarly in dwarf and age-matched wild type controls. Our transcription data
correlates with a recent publication that examined the transcription of
interspersed repeats in C57Bl/6 liver at early and late ages (De Cecco, Criscione,
Peterson, et al., 2013). However, LINE-1 and the other repetitive elements
diminish transcription at 12 months of age regardless of genotype; this may be
an indicator of an important period in adult development whose regulatory
mechanisms are unknown.
Murine SINE B1 is homologous to the human Alu repeat which has been
associated with aging. SINE B1 in the liver also loses methylation in rodents fed
methyl-deficient diets. Its transcription can be increased during embryonic
implantation, by retinoic acid induced differentiation, and cellular or physiological
stress (Kalkkila et al., 2004; Li et al., 1999; Liu et al.,1995; Martens et al., 2005;
Ohnishi et al., 2012; Tryndyak et al., 2006). A subtype of SINE B1 transcripts
may also have gene insulator effects by cooperating or inducing repressive
heterochromatin and forming chromatin barriers to transcription (Román,
González-Rico, & Fernández-Salguero, 2011; Román et al., 2011). In humans,
Alu repeats are thought to control transcription and RNA splicing and play a role
in aging, however except for the study of Alu transcription in senescent adult
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stem cells, to date transcriptional differences in Alu in human aging have yet to
be defined. In our study, hypomethylation of SINE B1 did not differ by age or
genotype (Figure 8). However, transcription was affected by both age and
genotype, showing prominence in dwarf mice at 24 months of age. Wild type
mice showed the highest transcription of SINE B1 at 3 months of age. In
agreement, a recent study also found an increase of SINE B1 transcription in
C56BL/6 mice at 24 months of age corresponding to our findings in dwarf mice
(De Cecco, Criscione, Peterson, et al., 2013). C56BL/6 is one of the longest
living strains among laboratory mice and this paper also noted that calorie
restriction, a long studied and well-documented intervention that increases
longevity in mice, decreased transcription of this SINE B1 as well as LINE-1.
However, SINE B1 expression may be a positive response if it is increased in
longevity models compared to shorter living models of mice.
Specific Aim 2- To examine growth hormone administration effects on DNA
methylation mechanisms, and global DNA methylation.
Ames dwarf do not secrete three hormones, thyroxine stimulating
hormone, prolactin, or growth hormone. However, many studies indicate that
growth hormone is the hormone responsible for life span extension and
increased cellular stress resistance, especially during the early part of adult
development before physiological (reproductive) maturity (Panici et al., 2010).
Some work has shown that GH can alter chromatin modifications on a specific
predefined set of genes known to be affected by or regulate growth hormone
signaling (Chia & Rotwein, 2010). Growth hormone administration to adipocytes
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causes changes in the nuclear architecture forming punctate patterns in the
nucleus indicating a rearrangement of chromatin (Piwien Pilipuk, Galigniana, &
Schwartz, 2003).

Liver tissue regeneration depends on growth hormone

secretion more than cytokine secretion for cellular proliferation (Pennisi et al.,
2004). However, the examination of GH’s possible role on epigenetic methylation
mechanisms, which are affected by the methionine pathway and SAM
abundance in liver, is undefined and unique. Growth hormone regulates GNMT
activity and, though not directly correlative, alterations in GNMT expression and
activity do coincide with differences in DNMT expression, DNMT activity, and
DNA methylation in Ames dwarf mouse liver. In the current study, increases in
the transcription of DNMT1 and DNMT3b were noted upon one week of GH
administration in dwarf liver (Figure 11). DNMT3a transcription, while still
somewhat increased basally in dwarf liver at 6 months of age, showed no
difference, therefore transcription of this gene may be influenced by another
pathway downstream or through a related pathway separate from GH, such as
the insulin pathway. Indeed, there is evidence that the induction of glucose and
insulin pathways in hepatocellular carcinoma cells are able to induce large
increases in DNMT3a mRNA but not DNMT1 or DNMT3b (Chiang et al., 2009).
Glucose and insulin administration also have large effects on the transcription of
many methionine enzymes such as GNMT and MAT along with the methionine
salvage pathway and transulfuration enzymes. Both glucose uptake and insulin
release are greatly influenced by GH signaling in liver (Brown-Borg, 2009; Louis
et al., 2010; Masternak et al., 2010). The insulin pathway is also involved in
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longevity (Bartke et al., 2013). Both young and old dwarf mice are naturally more
insulin sensitive than their wild type counterparts (Bartke et al., 2001; Louis et al.,
2010). It is also possible that differences in DNMT3a transcription do not show
immediate effects by acute GH administration, but may show effects after many
weeks of treatment. Interestingly, our DNMT hepatocyte data does not
correspond to those found in rat primary hepatocytes (Vinken et al., 2010).
However, both species and culture condition differences likely account for this
discrepancy.

For instance, DNMT1 is regulated by glucocorticoid receptor

stimulation by dexamethasone and corticosterone (Yang et al., 2012). Rat
hepatocyte culture protocols require these compounds for primary hepatocyte
cultures contrary to murine protocols.
Measurements of relative protein quantities following in vivo and in vitro
GH administration to GH-deficient dwarf mice displayed a marked increase in
DNMT1 and decreased DNMT3a levels (Figures 12 and 13). A lower
concentration of GH was required by dwarf hepatocytes to stimulate DNMT1
expression when compared to wild type cells suggesting increased sensitivity in
the GH-deficient state. This supports earlier findings that dwarf liver is more
sensitive to GH stimulation than wild type tissue in pathways related to stress
response and cellular proliferation (Brown-Borg & Rakoczy, 2003; Miquet et al.,
2010). As previously noted, wild type cells did not produce enough DNMT3a
protein for us to detect by immunoblotting and may be a consequence of
hepatocyte culture conditions.
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We next examined whether GH alters global DNA methylation in dwarf
mice. GH-treated dwarf mice showed significantly lower global DNA methylation
compared to saline injected wild type and dwarf mice (Figure 7). This novel
finding may be indicative of global chromatin changes and globally increased
gene expression. Therefore determining the genomic location of these DNA
methylation changes would provide insight on the magnitude of gene expression
alterations and possible heterochromatic architectural changes between dwarf
and wild type mice. We examined whether global methylation changes occurred
in the most abundant and highly methylated repetitive element LINE-1, to look for
changes in gene poor regions of the genome due to GH (Figure 9). Previous
publication has shown, decreases in liver LINE-1 methylation are induced by
methyl-deficient diets, which also show alterations in SAM and SAH abundance
(Pogribny et al., 2009). However, in our study, no changes in DNA methylation
were noted in the LINE-1 region either basally between dwarf or wild type mice at
4-6 months of age, or with the addition of growth hormone in the liver. This leads
us to conclude that the majority of DNA hypomethylation related changes due to
GH may be found in gene rich areas of expression or at repeat regions
associated with these areas.
GH administration did not appear to have large effects on mRNA
expression. In addition Ames dwarf mice had higher levels of DNMT1
transcription yet lower levels of protein, especially at 3 months of age. This
suggested that DNMT1 was somehow being post-transcriptionally regulated.
Recently a study discovered a novel pathway of DNMT1 post-transcriptional
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regulation in hepatocellular carcinoma cells and mouse liver (Takata et al., 2013).
They demonstrated a regulatory role for a DEAD-box helicase (DDX20) in
decreasing DNMT1 levels post-transcriptionally via the regulation of microRNA140-3p, which has some complementarity to the 3’ untranslated region (UTR) of
the DNMT1 mRNA sequence. According to miRBase, the miR-140-3p is highly
conserved between species (Kozomara & Griffiths-Jones, 2014). DNMT1
negatively regulates the expression of metallothionein (MT) through promoter
methylation. In human hepatocellular carcinoma lines knockdown of DDX20
decreases metallothionein expression (Takata et al., 2013).
DDX20 is also known as Gemin 3, and is a dead-box helicase that plays a
major role in transcriptional repression through attachments to microRNAs and
other proteins forming a ribonucleoprotein and guiding miRNA to the RNA
induced silencing complex (RISC) (Van Kouwenhove et al., 2011; Wilker et al.,
2010). DDX20 is involved in apoptosis and cellular proliferation, and is deficient
or not functional in many diseases such as cancer, and motor neuron diseases
such as spinal muscular atrophy (Guo, Zhang, Zhao, Li, & Li, 2011; Shpargel &
Matera, 2005; X. Sun et al., 2010; van Kouwenhove et al., 2011; H. Yang et al.,
2008). Increases of DDX20 transcription are observed in murine fibroblasts
exposed to ultraviolet radiation acquiring consequent DNA lesions (Garinis et al.,
2009). Interestingly, these irradiated fibroblasts also exhibit growth hormone and
IGF signaling deficits reminiscent of Ames dwarf mice. DDX20 is definitely
differentially expressed in dwarf mice at the protein level but not at the
transcriptional level (Figure 16). As expected, increased levels of DDX20 protein
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were seen in Ames dwarf mouse liver at 3, 12, and 24 months of age
corresponding with our cross-sectional studies of decreased DNMT1 protein at
all of these ages.
We next investigated whether miRNA 140-3p was basally overexpressed in
dwarf mice, since DNMT1 protein was so diminished compared to wild type mice
(Figure 17). Surprisingly, miRNA 140-3p levels were lower at three months of age
in dwarf mice, and increased at 12 months of age, though not statistically
significant at that age. When we investigated miRNA 140-3p at 24 months of age,
we found significantly diminished levels. We observed that 5S rRNA levels were
decreased (indicated by increased Ct counts in RT-PCR), which would indicate
that 24-month-old dwarf mice have a lowered expression of this transcript. This is
an unexpected finding and may have implications for overall translational function
of dwarf liver cells. One possible explanation for this change is the overall
decrease in total mRNA in aging mice which has been recently documented (De
Cecco, Criscione, Peterson, et al., 2013). This may be a product of increased
transcriptional expression of interspersed repeats. However, the only transcript we
noted as being increased in dwarf mice at 24 months, compared to wild type mice
was SINE B1. In many studies, transient induction of SINE B1 had no effect on 5S
rRNA abundance and was used as a control, however, both are transcribed by
RNA polymerase III (T. Li et al., 1999; Liu et al., 1995). Chronically induced SINE
B1 transcription, could affect RNA polymerase III levels available for ribosomal
RNA transcription, and thereby inhibit translational processes. However, there is
evidence that Alu repeats (similar to SINE B1 transcripts in mice) can repress
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translation by forming complexes with other proteins acting as trans regulatory
factors (Häsler & Strub, 2006). In aging Drosophila, increased ribosomal RNA
transcription is associated with the loss of heterochromatin, which might be
differently affected in mammals, where there is a gain of heterochromatin in
C56BL/6 mouse liver with aging (De Cecco, Criscione, Peterson, et al., 2013;
Kreiling et al., 2011; Larson et al., 2012).
Metallothioneins are free radical scavengers and respond to many cellular
stressors. Metallothioneins 1 and 2 are prevalent in most tissues and decreased
protein expression is associated with hepatocellular carcinoma. Treatment with the
DNMT inhibitor 5-azacytidine restored MT1 expression and tumor regression in rat
hepatomas (Majumder et al., 2002). DDX20 and miRNA 140-3p purportedly
suppressed DNMT1 translational repression and thereby increased metallothionein
(MT) expression via loss of methylation in CpG regions of the MT gene in
hepatocytes. Interestingly, it is documented that Ames dwarf mice exhibit increased
basal expression of MT1 and MT2. We observed that liver MT1 expression is agerelated decreasing in both dwarf and wild type mice after 3 months of age. However
the expression of MT1 and MT2 is greatest in difference between wild type and
Ames dwarf mice at 3 months of age. Therefore, since DNMT1 levels and
methylation of the MT promoter drive mRNA expression, we studied the promoter
regions of MT1 and 2 at 3 months of age in dwarf and wild type mouse liver (Figure
19). Metallothionein 1 showed less methylation in dwarf mice in an area of CpG
methylation that resides between exons 1 and 2 of this gene, rather than
transcription factor binding areas. Using a transcription factor prediction data base
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for this area of the MT-1 gene (TFSearch), several potential transcription factors
including GATA-2 and Ik-2, which are both implicated in controlling the senescence
protein marker-30 in aging rat liver were found and could be potential regulators
(Heinemeyer et al., 1998; Rath, Pandey et al., 2008). Normal metal response
element transcription binding areas of MT1 were not differentially methylated in
dwarf mice compared to wild type mice. However, methylation in these areas of
transcription are induced by the presence of heavy metals such as zinc, ischemia,
and hypothermia, MTF-1, and metal response elements (MREs) (Majumder et al.,
2006; Park et al., 2013).

In addition, preliminary qualitative analysis of whole

genome bisulfite sequencing of young dwarf liver compared to wild type liver is
consistent with dwarf mice exhibiting more methylation differences within gene and
promoter regions (Brown-Borg and Adams, unpublished data). The MT2 gene was
highly unmethylated and methylation-specific PCR provided no evidence of
differential methylation in this region.
Since DNMT1 expression is increased by growth hormone administration,
we thought perhaps that DDX20 would be decreased and miRNA 140-3p might
show decreased expression, in line with what was seen in hepatocellular
carcinoma cultures (Takata et al., 2013). Unexpectedly, we observed DDX20
protein expression significantly increased in the dwarf liver after one week of
growth hormone administration (Figure 20). Previously, we showed that GH
administration increased DNMT1 translational expression in dwarf mice;
however, protein levels were not rescued to wild type levels. This increase in
DDX20 may be an acute or transient response to increased DNMT1 expression
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as part of a negative feedback loop disallowing a full rescue of DNMT1 to wild
type levels. This lack of rescue of GH treated dwarf mice to wild type phenotypes
has been observed in other studies as well. For instance, Ames dwarf mice did
not reach body weights of wild type mice even when exposed to as much as 6
weeks of GH treatment, nor were wild type levels attained in the expression of
proteins, or activation of pathways, regulated by GH such as IGF1 and
phosphorylation of STAT3 respectively (Louis et al., 2010; Panici et al., 2010).
Whether DDX20 expression modulates or associates with these pathways is
currently unknown. Further study is required to elucidate the response of DDX20
expression to long-term GH administration. Interestingly, there was no change in
miRNA 140-3p in response to GH treatment indicating that in normal liver miRNA
140-3p expression is either tightly controlled, or other pathways may influence its
expression (Figure 21).
Growth hormone administration decreased global DNA methylation in
dwarf mouse liver (Figure 14) and because there are significantly higher
metallothionein mRNA expression levels, we investigated whether there were
methylation changes in the metallothionein gene region. Changes in DNA
methylation of this region at 6 months of age in dwarf liver were not significant. In
addition there were no differences between methylation in MT1 methylation at
base pairs covering the area between exons 1 and 2 in dwarf mice with the
administration of growth hormone (Figure 22). The loss of statistical methylation
difference in dwarf liver may be an age-related change that coincides with a large
loss of MT1 transcription after 3 months of age (Figure 18).
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CpG methylation was not significantly different in areas common to metal
transcription factor 1 (MTF-1) or the family of metal response elements (MREs)
probed in Figure 18 between young dwarf and wild type mice. However, GH
administration greatly increased methylation in this area. This increase in
methylation should decrease MT1 transcription and yet it does not. This indicates
the methylation regulation of MT1 is more complex that just the up- or downregulation of DNMT1 or global DNA methylation. Because the MT1 gene
contains many transcription binding factor sites, the increased expression of MT1
due to GH administration may be at binding sites farther upstream from the
transcriptional start site, such as sequences associated with STAT. GH
administration is known to activate JAK/STAT signaling. STAT3 signaling has
also been implicated in the increase of MT1 expression due to hypothermic
protection against induced ischemia (Park et al., 2013). To address this question,
we designed methylation specific primers for the binding sites of STAT and the
STAT response element (which also is a response element for interleukin-6)
within the first 150 base pairs of the MT1 gene (Figure 23). However, the
results were inconclusive for any relative methylation changes in all groups,
(wild type, dwarf, and dwarf treated with growth hormone) and the STAT
binding regions all appeared to be highly unmethylated. More sensitive
measures will have to be undertaken to probe these two methylation sites.
There is also a possibility that because of the increase of methylation in
MREs, GH treated dwarf mice may be more resistant to the heavy metal and
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stress induction of MT1, causing a deficiency in the ability to scavenge free
radicals and heavy metals decreasing oxidative stress resistance.
At any rate, GH associated changes in methylation of the MT1 gene do
not appear to be simply a consequence of global methylation changes caused
by increased DNMT1 as suggested in previous literature, but specific to
regulatory areas of the MT1 gene and promoter regions. Metallothionein
expression due to GH administration may be a transient response that may be
down-regulated during long term GH treatment such as has been indicated in
one study through a six-week treatment of GH in 7-month-old Ames dwarf
mice (Swindell et al., 2010).
To summarize, in contrast to the findings of Takata et al (2013), in our
mice, miRNA 140-3p expression does not appear to be the key factor in
regulating DNMT1 expression. DDX20 protein levels however, still could be
important to DNMT1 regulation if this pathway is a major regulator. High levels
of DDX20 protein may still be regulatory by selectively bringing miR-140-3p to
the RISC complex and therefore offset the much higher transcription of Ames
dwarf mice as seen in our previous work, however, we feel it is unlikely for
several reasons. Firstly, manipulation of DNMT1 expression through DDX20
could involve many different miRNA transcript partners. For instance, only one
of many possible miRNA partners for DDX20 could include miR-148a, which
has been predicted to negatively regulate DNMT1 and is involved in
maintaining the differentiation of hepatocytes and repressing hepatocellular
carcinoma malignancy (Denis et al., 2011; Gailhouste et al., 2013). miR- 148a
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expression has been noted to change with age in murine tissues and is
responsive to calorie restriction, which is a well-known intervention that
increases life span in mice (Dhahbi et al., 2013). Also miR140-3p may be
more important for tissues other than the liver for the suppression of other
pathways such as IGF-1 (Yuan, Shen, Xue, & Fan, 2013). Other factors may
regulate DNMT1 as well, and miRNA regulation may only be a minor player in
regulation. For example, DNMT1 is also regulated in cis by unique RNA
molecules expressed by gene regions (Ruscio et al, 2013).

Several other

factors have also been shown to modulate DNMT expression and activity and
include PCNA, PKA, PKB (Akt), PKC, and GSK3β. GH treatment of dwarf
mice increased liver phosphorylated Akt protein and phosphorylated GSK3β
protein levels when compared to wild type mice or untreated dwarf mice
(Masternak et al., 2010; Miquet et al., 2010; Panici et al., 2010).

GSK3β

regulates pAkt activity and can stabilize DNMT1 affecting its expression and
activity (Sun et al., 2007). PI3K and pAkt are known to be involved in cell
proliferation and aging. Since liver DNMT activity is higher in the dwarf at 3
months and lower at 24 months, there may be additional regulation by PKA,
PKB (Akt), PKC, and other pathways where Ames dwarf mice exhibit
increased responses to GH treatment in the liver. If the increase of DDX20
protein expression is significant in DNMT1 post-transcriptional regulation,
more studies are needed to identify the ways in which DDX20 may be working
with one or several miRNA transcripts to post-transcriptionally regulate
DNMT1 transcription. Together, all of these pathways could modulate DNMT
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expression and represent potential avenues of investigation for posttranscriptional regulation of DNMT in the liver of Ames dwarf mice and in
aging studies, in general. Growth hormone deficiency in the Ames dwarf
mouse may contribute to epigenetic stability by decreasing DNMT1 protein
through a variety of aging-associated pathways, and increasing DNMT3a
protein at young ages. We have data indicating differences between
genotypes in global DNA methylation and preliminary results showing
differences in specific gene regions (Brown-Borg, unpublished data).
Furthermore, GH signaling may also be important to differences in tissues
other than liver such as muscle and fat.

The results of this study do not

exclude potential IGF-1 effects on DNMT expression. DNMT1 also has DNA
methylation independent actions that may be different in dwarf mice and
contribute to cell cycle regulation (Milutinovic et al., 2004).

Specific Aim 3- to examine histone H3 and H4 markers associated with
aging
Histone methyltransferases also use S-adenosylmethionine from the
methionine pathway as a substrate. Therefore these methyltransferases may well
be affected by methionine pathway alterations similar to GNMT and DNMTs. Methyldeficient diets are known to cause alterations in SAM, methionine, and the
expression of methionine enzymes (Pogribny et al., 2009). Alterations in the
methionine pathway due to nutritional alterations, or enzyme loss, such as GNMT
knockout mice, have been shown to prolong life (methionine restriction) or cause
cancer (choline or folate deficient), an age-related disease, in mice (Cavuoto &
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Fenech, 2012; Martínez-Chantar et al., 2008). These factors are also known to alter
the DNA and histone methylation in mice (Davis & Uthus, 2004; Pogribny et al.,
2009). As stated earlier, histone methylation has also been linked to aging in a
variety of species (Figure 36). We found profound changes in histone abundance
and distribution between Ames dwarf and wild type mice during our cross-sectional
studies (Figures 24 and 25). First was the discovery that total H3 was not expressed
similarly between wild type and dwarf mice in liver histone extracts. However when
compared within genotype, dwarf mice showed more stable expression of this
protein through all three age groups, while wild type mice showed a progressive
increase in total histone H3 which led to differences in expression between the two
genotypes at different ages (Figure 25). One of the first studies to note changes in
histone H3 was in Drosophila, and showed that histone H3 decreases with age,
which as stated earlier, suggests a loss of heterochromatin with age (Larson et al.,
2012). In rodents however, heterochromatin increases with age as evidenced by
studies in mice and increases in H4K20me3 in rat liver (De Cecco et al., 2013; Sarg
et al., 2002). In addition, in mice exposed to early life stressors that trigger abnormal
emotive behavior, total H3 is responsive to pharmaceuticals, showing this marker to
be dynamic and impacted by environmental events and chemical interventions
(Levine et al., 2012).
We studied one histone methylation marker associated with transcriptionally
active areas of the genome, H3K4 tri-methylation (H3K4me3). Dwarf mice
compared to wild type mice have altered total expression of this marker at 12 and 24
months. Gains of this marker are associated with aging in c. elegans (Greer et al.,
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2011).

In humans, losses or gains of this marker are associated with cancer

progression and with hepatic steatosis (Blair & Yan, 2012; Jun, Kim, Hoang, & Lee,
2012). Of note, it has been shown that the loss of this H3K4me3 is associated with a
higher activity of DNMT3a; this might be important as dwarf mice exhibit less
DNMT3a protein and more H3K4me3 at 24 months of age (Kuzumaki et al., 2010b;
Ooi et al., 2007). This could be associated with resisting the gain of methylation in
gene regions during aging as our mice demonstrate less global methylation changes
over all in whole genome bisulfite sequencing (Brown-Borg, unpublished data).
The facultative repressive marker histone H3K27me3, is also diminished
in dwarf mice compared to age-matched wild type mice at 12 months of age, and
increased at 24 months of age, similar to H3K4me3 abundance. When examined
in proportion to total histone H3 expression however, less histone H3 is
methylated at lysine 4 at 3 months of age (similar to H3K4me3). Since
H3K27me3 is purportedly decreased in abundance with aging in C. elegans, and
in cells from patients with Hutchinson–Gilford Progeria Syndrome (HGPS) it is
interesting to note that dwarf mice resist this change at 24 months of age (S. Han
& Brunet, 2012; Shumaker et al., 2006).
The constitutive heterochromatin marker H3K9me3 has also been found
to be reduced with age in cells taken from patients with HGPS (Shumaker et al.,
2006). However it increases with age in Drosophila (Han & Brunet, 2012). Dwarf
mice had higher total levels of this marker at 3 months of age and similar levels
at 12 and 24 months of age. However when normalized to total H3 protein at 12
months of age, H3K9me3 is more abundant in dwarf mice and equivalent at 3
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and 24 months of age. Therefore, dwarf mice may be allocating most of the
histone H3 resources into retaining areas of constitutive heterochromatin at this
age. Our studies did not indicate that H3K9me3 was especially altered between
the two genotypes at 24 months of age either in overall abundance or in total
histone H3 distribution. Coupled with the high DNA methylation status in dwarf
mice and the resistance to DNA methylation changes, it appears that areas of
constitutive chromatin are well maintained in dwarf mice compared to wild type
mice even with fluctuations in total histone H3. Locations of these markers may
be more informative in determining their impact on the aging phenotype.
In a preliminary experiment, we noted some changes in methylation
enzymes related to H3K9me3 and H3K4me3 in 3 month old dwarf mice
compared to their wild type counterparts (Table 5). The lysine demethylase
Kdm5 (also known as Jarid1b) is known to participate in cellular senescence, and
its expression affects longevity in c. elegans and cancer in humans, making its
expression

important

as

a

possible

aging

target.

Also,

the

histone

methyltransferase Setdb2 is a marker that hasn’t been identified as an aging
related protein yet, thus this may be a novel finding that warrants further
investigation.
Specific Aim 4- To examine global DNA methylation and DNMT expression
and growth hormone expression mutants.
For our last specific aim, we began investigations to validate some of the
epigenetic methylation differences that we observed in Ames dwarf mice in other
GH mutant mice. We focused on growth hormone receptor binding protein
knockout mice that exhibit high growth hormone but lack the ability to respond to
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it due to a mutated receptor. Global DNA methylation in these mice did not differ
from their age-matched wild type counterparts, but an age-related effect was
nearly significant (Figure 28). For mice overexpressing growth hormone however,
differences were noted at 10 months of age, where aged GH Tg mice display
~50% higher levels of DNA methylation compared to age-matched wild type mice
(Figure 32). This is interesting as these mice live only to approximately 12
months of age and express premature aging phenotypes by six months of age. It
is possible that result may show they accumulate a large increase in
heterochromatin at a younger age, which has been shown in normally aging
mice. However, heterochromatin markers have yet to be studied in this model.
For the methylation assessment of interspersed repeats, some similarities
and differences were noted in GHRKO, GH Tg, and dwarf mice when studied
cross-sectionally. Both long-living GH signaling deficient mice (Ames, GHRKO)
showed some resistance to the hypomethylation of IAP-LTR repeats, although at
different ages (Figures 8 and 29). GH Tg mice however, displayed more
hypomethylation at younger ages, while their wild type counterparts maintained
similar levels of methylation (Figure 33). For wild type mice this could be
expected since the wild type mice from our two other long-lived strains showed
differences at 12 months of age. However, we may have missed potential
changes in methylation as we didn’t look past 12 months of age in the wild type
controls of the GH Tg line. Excitingly, the hypomethylation of IAP-LTR may be a
consistent marker for aging among many mouse strains, and such an early loss
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of methylation in GH Tg mice for IAP-LTR may have huge implications for
genetic instability and chromatin structure in these mice.
In addition, GHRKO mice express more IAP-LTR at 3 months of age than
their wild type counterparts. Though it was not statistically significant, Ames
dwarf mice showed an increase in transcription at this age as well. The GH Tg
mice showed less IAP-LTR transcription at 10 months of age compared to their
wild type counterparts where expression was unchanged with age. This altered
transcription occurred at an age when the premature aging phenotype is already
apparent and there is a large increase of genomic DNA methylation in these
animals. This repeat appears to have some important function in relation to the
aging epigenome and requires further investigation.
LINE-1 was more hypomethylated at 24 months of age in wild type mice
than in the age-matched mutant GHRKO mice. The longer-lived mutant mouse
was able to maintain consistent methylation of this repetitive element.
Interestingly, methylation changes in this repeat in the wild type mice might be
strain specific when they are compared to the wild type mice of the Ames dwarf
strain. LINE-1 hypomethylation during aging has been somewhat controversial as
mentioned earlier. LINE-1 hypomethylation is not always apparent in normally
aging human cells, but is more apparent in cancer, where the knockdown of
expression can abrogate cellular proliferation or metastases (Chalitchagorn et al.,
2004; Oricchio et al., 2007; Takai et al., 2000). In GH Tg mice, LINE-1
hypomethylation does not change in mutant mice compared to a small elevation
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at 6 months methylation loss in its wild type counterpart. The six month increase
is surprising, and will have to be investigated in other mouse lines to see if this is
consistently observed. The transcription of LINE-1 in both lines of dwarf mice is
age-related regardless of genotype, however whereas Ames dwarf mice exhibit
no genotypic differences in expression, GHRKO mice exhibit higher levels of
expression. GH Tg mice exhibit lower amounts of transcription compared to wild
type counterparts. This may be an important factor specific to growth hormone
signaling. These results are somewhat contrary to the current literature where
LINE-1 expression appears to be deleterious with age and promotes cancer.
However, as LINE-1 is usually found in A-T regions in gene-poor regions, loss of
expression in GH Tg mice might be a result of increased heterochromatin
formation at an early age.
SINE B1 GH Tg mice did not show any significant changes in
hypomethylation due to age or genotype. Only the GHRKO line appeared to have
an interactive effect between age and genotype that altered expression of SINE
B1. This is most likely a strain specific difference. SINE B1 transcription however,
showed very interesting results. Just as its transcription was increased in dwarf
mice at 24 months of age, its transcription was increased in GHRKO mutants at
12 and 24 months of age when compared to age-matched controls. In GH Tg
mice, there was no genotype difference between the mice though it decreased
with age. The fact that SINE B1 transcription is higher in two long-living mutants,
and not in short-living GH Tg mice, raises the possibility that the transcription of
this element may indeed be protective in aging, especially when expressed at
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later ages. Further study will be required to assess whether GHRKO mice have
reduced amounts of translation or RNA splicing differences at these older ages
which could be protective mechanisms in the aging of these rodents.
For SINE B2, the rodent specific repeat, hypomethylation assays showed
age-related differences in all three strains of mouse. In the GHRKO and Ames
dwarf mouse lines the hypomethylation was increased with age in both wild type
and mutant mice. Only the Ames dwarf showed resistance to hypomethylation of
this repeat that may or may not be growth hormone associated. In GH Tg mice
both the wild type and mutant mice gain methylation (lost hypomethylation) with
age, however, since this cross-sectional study does not include wild type mice
older than 10 months of age, hypomethylation of this repeat may yet occur. Agerelated transcriptional differences were only seen in the Ames dwarf line, while
there were genotype differences in GHRKO mice, and no differences between
GH Tg and respective age-matched wild type mice. Differences in transcription
appear to be strain specific for the mice overall.
Examination of DNMT transcription yielded fascinating results when
comparing all three lines of mice. DNMT1 transcription was significantly
increased in GHRKO mice compared to their wild type counterparts. At 12
months of age, DNMT3a was also 2-fold higher than wild type transcription
levels. However, Ames dwarf mice showed greater transcription levels of DNMT1
and DNMT3a at 3 months of age. At first this seems as if it may not correlate,
however, earlier reports from our lab showed that methionine pathway gene
expression differences between GHRKO mice and wild type mice do occur until
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12 months of age, and are not as large in magnitude as Ames dwarf mice
(Brown-Borg et al., 2009). The 2-fold increase in DNMT1 and DNMT3a RNA
expression observed at 12 months of age in GHRKO mice is mirrored by the twofold increase in MAT1a and GNMT expression, two important enzymes in the
production and regulation of SAM in the methionine pathway (Brown-Borg et al.,
2009). This substantiates our finding that DNMT1 and DNMT3a transcription
coincide with methionine pathway differences in both strains of long-living dwarf
mice. DNMT1 transcription in both the GHRKO and GH Tg lines of mice
decreased with age, in agreement with the literature that examined DNMT1
transcription in T cells mentioned earlier (Ray et al., 2006). Both GHRKO and GH
Tg are laboratory inbred strains, as are the DNMT1 deficient mice used in the T
cell study, which unlike the Ames dwarf mouse line which is bred on a
heterogenous background. DNMT1 was not altered in transcription in GH Tg
mice compared to wild type mice at any age. DNMT3a however did show
genotypic differences, however the increase in DNMT3a expression did not
approach the magnitude of change detected in the dwarf mouse lines. DNA
methyltransferase 3b was not different between genotypes in GHRKO mutants or
wild type mice at any age, reminiscent of the Ames dwarf line. In contrast,
transcriptional expression of DNMT3b in GH Tg mice at 3 months of age was 2fold higher compared to wild type controls. Age-related differences were noted
between all three strains of mice however, DNMT3b mRNA increased with age in
the Ames dwarf line, while both the GHRKO and growth hormone transgenic
lines decreased with age, indicating strain specific differences. Interestingly,
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DNMT3b differences in transcription of the GH Tg mice had confounding effects
of age and genotype, which frequently reoccurs in all the mouse lines when
studying these transcripts in a cross-sectional manner.
Interestingly, we found background genetics alters the wild type pattern of
expression or hypomethylation, supporting the idea that epigenetic mechanisms
are at least partially controlled through genetic background. However, there is
plasticity in epigenetic expression that can be permanently altered by chronic or
early life events. Strain differences in aging are well-documented and should be
expected when comparing different mutant strains of mice (Yuan et al., 2011).
However, when commonalities between diverse genetic background strains are
discovered due to a lack of hormone signaling, the findings become an even
more potent discovery.
A few other preliminary studies were accomplished to further elucidate the
epigenetic characterization of the GHRKO and GH Tg mutants. Since GH
modulates differences in DNMT expression of Ames dwarf mice, we decided to
see if Insulin-like growth factor-1 administration would alter liver DNMT levels
(Figure 31) in GHRKO mice. IGF-1 administration to Ames dwarf, GH Tg and
age-matched wild type hepatocyte cultures induced significant differences of
expression in

enzymes responsible for oxidative stress response, including

glutathione peroxidase, a transulfuration enzyme which is connected to the
methionine pathway (Brown-Borg et al., 2002). IGF-1 also has feedback effects
on growth hormone secretion, cellular proliferation, mediating many of the
functions of GH, and is affected by the nutritional availability of methionine
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(Bartke et al., 2013; Miller et al., 2005). IGF-1 receptors are not expressed in
liver; however, IGF-1 is able to stimulate insulin receptors, illustrating some
promiscuity in signaling. Interestingly, DNMT1 and DNMT3a mRNA expression
were responsive to IGF-1 injections in the liver of GHRKO mice (Figure31).
Surprisingly, in this genetic background, GHRKO mutant mice at 6 months of age
showed decreased expression basal expression of DNMT3b that remained
unchanged upon IGF-1 treatment. GH, IGF-1, and insulin signaling in the liver
are interconnected. While DNMT1 showed no effects when insulin was applied to
hepatocellular carcinoma cells, differences in insulin signaling between
hepatocellular carcinoma cells and normal liver may have accounted for the
differences (Chiang et al., 2009). The increase in DNMT3a is likely due to the
ability of IGF-1 to influence insulin receptor signaling, similarly to what has been
seen in hepatocellular carcinoma cells. Also IGF-1 signaling through insulin
receptors had no effect on DNMT3b transcription, similar to the literature.
However, IGF-1 has a much smaller affinity for insulin receptors than its own
receptors, therefore applications or injections of insulin would be expected to
produce more drastic alterations in these transcripts, and would be an excellent
future study. More DNA methyltransferase protein studies will be forthcoming
subject to tissue availability.
We also began preliminary studies based on tissue availability for the
expression of DNMT proteins in transgenic mice (Figure 35). For this study, we
expected DNMT1 protein to be higher in these mice since one week of GH
administration in dwarf mice was able to increase DNMT1 protein. Though at 3
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months of age DNMT1 protein appeared to be slightly increased, low samples
sizes may have left any results statistically non-significant (n=5-6). However
there was decreased expression in DNMT1 in 10 month old GH Tg mice
compared to wild type counterparts. This coincided with a large increase in global
methylation. Also DNMT3a protein at every age is significantly lower in
expression in GH Tg mice, a dramatically different expressional profile than
Ames dwarf mice, which showed an increased protein expression at 3 months of
age. DNMT3b protein expression results are still forthcoming, as are replication
of these studies with larger sample sizes when tissue availability allows. From
this data, it appears DNMT3a expression is a vital enzyme to longevity and
possibly delays hepatocellular tumorigenesis as predicted from methyl-deficient
dietary studies (Pogribny et al., 2009). DNMT3b may play an opposing role in
longevity based on the transcriptional studies of GH Tg mice, however further
study of epigenetic methylation mechanisms of GHRKO and GH Tg mice are
warranted.
In conclusion, it has been proposed that epigenetic mechanisms can
contribute greatly to the aging phenotype and genetic instability.

DNA

methylation plays a significant role in development and likely in responses to
early life events, either of which may avert or exacerbate the aging phenotype.
However, due to the lack of GH signaling, Ames dwarf mice remain able to resist
and delay many pathologies of aging such as the hepatocellular carcinoma found
in their wild type siblings (Ikeno et al., 2003). GHRKO mice are also long-lived
mutants, that exhibit GH signaling deficiency and showed some strikingly similar
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features of DNMT mRNA expression and interspersed repeat methylation or
transcription with Ames dwarf mice. Our study demonstrated that Ames dwarf
mice, GHRKO, and GH Tg mice exhibited significant differences in DNMT
expression that change with age. We also demonstrated that GH administration
can have a significant impact on the methylation mechanisms and global DNA
methylation of the Ames dwarf. Similarly, IGF-1 has some transcriptional effects
on methylation enzymes for GHRKO mice as well. The differential expression of
both de novo and maintenance DNMTs between Ames dwarf, GHRKO, and GH
Tg mice, compared to their wild type counterparts affects the methylation of
repetitive elements and specific genes and therefore contributes to epigenetic
stability, or instability in the case of GH Tg mice. Also Ames dwarf mice showed
differences in histone methylation that can offer further clues for chromatin
structure and organization. Continuing studies of these proteins and enzymes in
GH signaling mutant mice are extremely valuable tools to elucidate the changes
of the epigenetic landscape during aging. These novel findings have initiated a
new line of inquiry and contributed to our understanding of the mechanisms
underlying the relationships between GH, longevity and epigenetic stability
associated with aging and aging pathologies.
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